LL-37 (Cathelicidin) Peptide research-grade
LL-37 (Cathelicidin) Peptide
$79.00 Add to cart

LL-37 (Cathelicidin) Peptide

$79.00

Laboratory-grade LL-37 (Cathelicidin) Peptide is a human host-defense cathelicidin-derived antimicrobial peptide used in innate-immunity research. Research buyers select this listing for pre-clinical work on antimicrobial peptide assays and inflammation pathway models—not for clinical, veterinary, or consumer use.

For Research Use Only. Not for human use.

In stock

For Research Use Only — Not for Human Consumption
Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

Accepted Payment Methods

For Research Use Only. Not for human use.

LL-37 (Cathelicidin) Peptide research-grade

Overview

LL-37 (Cathelicidin) Peptide is supplied as a research-grade catalog material for controlled laboratory investigation.

Laboratories choose this item when protocols need clear identification, consistent labeling, and documentation suitable for reproducible experimental workflows.

Catalog packaging and research-use labeling help purchasing and bench teams keep procurement records aligned with the physical vial.

Research Context for LL-37 (Cathelicidin) Peptide

Work involving LL-37 (Cathelicidin) Peptide typically focuses on in vitro systems, assay development, and mechanistic model studies.

Teams confirm lot details before setup so conditions stay traceable across repeats and collaborative sites.

Published literature can inform starting ranges for related experimental designs. Each laboratory should still validate performance with its own instruments, plates, and detection chemistry.

Pilot runs are useful before committing larger plate sets, especially when detection chemistry or incubation windows are being optimized.

Documented Attributes

Key catalog attributes for this material include:

  • Research-grade material intended for laboratory investigation only
  • Catalog labeling aligned with research procurement channels
  • Suitable for method development and comparative assay workflows
  • Documentation packages available where provided for the listed lot

Laboratory Handling Notes

Receiving and Identity Checks

Before opening a vial of LL-37 (Cathelicidin) Peptide, confirm the physical label against the purchase order and packing list.

Retain outer packaging until identity checks are complete, and report damaged seals to purchasing before experimental work continues.

Reconstitution and Aliquoting

Handle this material according to institutional SOPs for weighing, reconstitution, aliquoting, and storage.

Record lot identifiers in laboratory notebooks before reconstitution. Verify solvent compatibility and storage temperature against your validated process.

Prepare assay buffers and consumables before opening the vial to reduce hold time. Keep unused aliquots labeled with date, solvent, and concentration for later repeats.

Chain of Custody

Keep chain-of-custody notes with inventory checks when material moves between freezers or benches.

Use dedicated spatulas and clean balances to avoid cross-contamination between catalog items. Schedule thaw cycles intentionally rather than repeated freeze-thaw of the same aliquot.

Secondary containment trays reduce spill risk during multi-step reconstitution. Cold-chain interruptions should be noted even when the vial remains sealed.

Why Laboratories Source LL-37 (Cathelicidin) Peptide

Procurement and research teams often select this catalog item because it supports:

  • Clear research-use labeling for compliance-aligned purchasing
  • Consistent product identification across multi-lot studies
  • Fit for reference, screening, and mechanistic laboratory models
  • Straightforward catalog support for planning and documentation

Study Planning and Quality Documentation

Before starting experimental work with LL-37 (Cathelicidin) Peptide, review any COA or quality files provided with the shipment.

Align your protocol with institutional research requirements and keep use within the labeled research context.

File catalog documentation with the study records at receipt. These steps help keep experiments comparable over time when using LL-37 (Cathelicidin) Peptide in sequential study phases.

Method Development Tips

Method development often begins with small pilot plates before larger screening panels.

Document buffer lots, incubation times, and detection settings alongside the material lot number.

If results diverge from historical baselines, re-check reconstitution volume and storage history first. Shared equipment logs help explain variance when multiple operators run the same protocol.

Inventory and Training

Update digital inventory immediately after opening a new lot of LL-37 (Cathelicidin) Peptide.

Training new staff on labeling conventions reduces mix-ups across similar catalog SKUs. When transferring methods between sites, share both the written SOP and the lot metadata package.

Dispose of residual solutions according to institutional chemical hygiene rules. Do not repurpose research materials for any non-laboratory application.

Periodic inventory reconciliation keeps expired or depleted lots from entering active workflows. For related catalog options, browse adjacent research categories on this site after confirming your assay needs.

For Research Use Only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.

Peptide Research

For Research Use Only. Not for human use.

PubMed (NIH/NLM) records related to this compound for laboratory literature review. Inclusion does not imply suitability for any use beyond controlled research. Each note below is a research-framed summary using compliance-safe wording.

Showing 932 PubMed records. Displaying 10 per page.

  1. Radic M et al. (2022). LL-37, a Multi-Faceted Amphipathic Peptide Involved in NETosis [PMID: 35954305]

    Laboratory literature summary: LL-37, a Multi-Faceted Amphipathic Peptide Involved in NETosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  2. Aidoukovitch A et al. (2024). Vitamin D triggers hCAP18/LL-37 production: Implications for LL-37-induced research… [PMID: 38642493]

    Laboratory literature summary: Vitamin D triggers hCAP18/LL-37 production: Implications for LL-37-induced research subjects osteoblast cytotoxicity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  3. Suzuki K et al. (2025). Research subjects cathelicidin peptide LL-37 induces endothelial-to-mesenchymal transition [PMID: 40690262]

    Laboratory literature summary: research subjects cathelicidin peptide LL-37 induces endothelial-to-mesenchymal transition. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  4. Chinipardaz Z et al. (2022). Regulation of LL-37 in Bone and Periodontium Regeneration [PMID: 36294968]

    Laboratory literature summary: Regulation of LL-37 in Bone and Periodontium Regeneration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  5. Yang B et al. (2020). Significance of LL-37 on Immunomodulation and Disease Outcome [PMID: 32509872]

    Laboratory literature summary: Significance of LL-37 on Immunomodulation and Disease Outcome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  6. Golec M (2007). Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide [PMID: 17655171]

    Laboratory literature summary: Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  7. Bucki R et al. (2010). Cathelicidin LL-37: a multitask antimicrobial peptide [PMID: 20049649]

    Laboratory literature summary: Cathelicidin LL-37: a multitask antimicrobial peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  8. Fabisiak A et al. (2016). LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity [PMID: 27117377]

    Laboratory literature summary: LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  9. Burton MF et al. (2009). The chemistry and biology of LL-37 [PMID: 19936387]

    Laboratory literature summary: The chemistry and biology of LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  10. Miao S et al. (2024). Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease [PMID: 39615616]

    Laboratory literature summary: Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  11. Lao J et al. (2023). Serum LL-37 and inflammatory cytokines levels in psoriasis [PMID: 36988247]

    Laboratory literature summary: Serum LL-37 and inflammatory cytokines levels in psoriasis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  12. Verjans ET et al. (2016). Molecular mechanisms of LL-37-induced receptor activation: An overview [PMID: 27609777]

    Laboratory literature summary: Molecular mechanisms of LL-37-induced receptor activation: An overview. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  13. Liu Z et al. (2025). Antimicrobial peptide CRAMP/LL-37 mediates ferroptosis resistance in cardiomyocytes by… [PMID: 40517353]

    Laboratory literature summary: Antimicrobial peptide CRAMP/LL-37 mediates ferroptosis resistance in cardiomyocytes by inhibiting cathepsin L. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  14. Bhattacharjya S et al. (2024). LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases [PMID: 38540740]

    Laboratory literature summary: LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  15. Voronko OE et al. (2025). Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications [PMID: 40869425]

    Laboratory literature summary: Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  16. Chen X et al. (2018). Roles and Mechanisms of research subjects Cathelicidin LL-37 in oncology research models [PMID: 29843147]

    Laboratory literature summary: Roles and Mechanisms of research subjects Cathelicidin LL-37 in oncology research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  17. Zsila F et al. (2020). Research subjects host-defense peptide LL-37 targets stealth siderophores [PMID: 32265033]

    Laboratory literature summary: research subjects host-defense peptide LL-37 targets stealth siderophores. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  18. Memariani M et al. (2023). Antifungal properties of cathelicidin LL-37: current knowledge and future research… [PMID: 38057654]

    Laboratory literature summary: Antifungal properties of cathelicidin LL-37: current knowledge and future research directions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  19. Leite ML et al. (2023). The LL-37 domain: A clue to cathelicidin immunomodulatory response? [PMID: 37068711]

    Laboratory literature summary: The LL-37 domain: A clue to cathelicidin immunomodulatory response?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  20. Bandurska K et al. (2015). Unique features of research subjects cathelicidin LL-37 [PMID: 26434733]

    Laboratory literature summary: Unique features of research subjects cathelicidin LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  21. Doss M et al. (2010). Research subjects defensins and LL-37 in mucosal immunity [PMID: 19808939]

    Laboratory literature summary: research subjects defensins and LL-37 in mucosal immunity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  22. Yuan Y et al. (2025). Exploring the Antimicrobial Potential of LL-37 Derivatives: Recent Developments and… [PMID: 40423576]

    Laboratory literature summary: Exploring the Antimicrobial Potential of LL-37 Derivatives: Recent Developments and Challenges. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  23. Sánchez-Peña FJ et al. (2023). LL-37 Triggers Antimicrobial Activity in research subjects Platelets [PMID: 36769137]

    Laboratory literature summary: LL-37 Triggers Antimicrobial Activity in research subjects Platelets. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  24. Memariani H et al. (2023). Antibiofilm properties of cathelicidin LL-37: an in-depth review [PMID: 36781570]

    Laboratory literature summary: Antibiofilm properties of cathelicidin LL-37: an in-depth review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  25. Vera-Cruz A et al. (2021). Antimicrobial Peptide, LL-37, And Its Potential As An Anti-HIV Agent [PMID: 34600462]

    Laboratory literature summary: Antimicrobial Peptide, LL-37, And Its Potential As An Anti-HIV Agent. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  26. Xhindoli D et al. (2016). The research subjects cathelicidin LL-37–A pore-forming antibacterial peptide and… [PMID: 26556394]

    Laboratory literature summary: The research subjects cathelicidin LL-37–A pore-forming antibacterial peptide and host-cell modulator. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  27. Asmamaw D et al. (2026). LL-37-derived peptide shows promising antimicrobial potential against… [PMID: 41485275]

    Laboratory literature summary: LL-37-derived peptide shows promising antimicrobial potential against multidrug-resistance pathogens. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  28. Wang G et al. (2019). Design of Antimicrobial Peptides: Progress Made with research subjects Cathelicidin LL-37 [PMID: 30980360]

    Laboratory literature summary: Design of Antimicrobial Peptides: Progress Made with research subjects Cathelicidin LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  29. Fang Y et al. (2026). Cathelicidin LL-37-ApoB-100 interaction promotes LDL clearance and attenuates… [PMID: 40971038]

    Laboratory literature summary: Cathelicidin LL-37-ApoB-100 interaction promotes LDL clearance and attenuates cholesterol accumulation in the liver. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  30. Bowdish DM et al. (2005). Impact of LL-37 on anti-infective immunity [PMID: 15569695]

    Laboratory literature summary: Impact of LL-37 on anti-infective immunity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  31. Kalimuthu S et al. (2023). A heptadeca amino acid peptide subunit of cathelicidin LL-37 has previously unreported… [PMID: 37150907]

    Laboratory literature summary: A heptadeca amino acid peptide subunit of cathelicidin LL-37 has previously unreported antifungal activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  32. Dürr UH et al. (2006). LL-37, the only research subjects member of the cathelicidin family of antimicrobial… [PMID: 16716248]

    Laboratory literature summary: LL-37, the only research subjects member of the cathelicidin family of antimicrobial peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  33. Chen X et al. (2022). Research subjects antimicrobial peptide LL-37 contributes to neurodegeneration… [PMID: 36138130]

    Laboratory literature summary: research subjects antimicrobial peptide LL-37 contributes to neurodegeneration research models's disease progression. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  34. Piktel E et al. (2016). The Role of Cathelicidin LL-37 in oncology research models Development [PMID: 26395996]

    Laboratory literature summary: The Role of Cathelicidin LL-37 in oncology research models Development. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  35. Zielke C et al. (2024). Between good and evil: Complexation of the research subjects cathelicidin LL-37 with… [PMID: 37919905]

    Laboratory literature summary: Between good and evil: Complexation of the research subjects cathelicidin LL-37 with nucleic acids. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  36. Neshani A et al. (2025). Decoding LL-37: Structure and antimicrobial mechanisms against microbial threats [PMID: 41270816]

    Laboratory literature summary: Decoding LL-37: Structure and antimicrobial mechanisms against microbial threats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  37. Mańkowska A et al. (2025). Significance of the LL-37 Peptide Delivered from research subjects Cathelicidin in the… [PMID: 40960088]

    Laboratory literature summary: Significance of the LL-37 Peptide Delivered from research subjects Cathelicidin in the Pathogenesis, investigation, and analytical…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  38. Nagaoka I et al. (2020). Investigational Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a… [PMID: 32825174]

    Laboratory literature summary: investigational Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  39. Szabó L et al. (2023). Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis [PMID: 37387475]

    Laboratory literature summary: Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  40. Suzuki K et al. (2022). Research subjects Cathelicidin Peptide LL-37 Induces Cell Death in… [PMID: 35387840]

    Laboratory literature summary: research subjects Cathelicidin Peptide LL-37 Induces Cell Death in Autophagy-Dysfunctional Endothelial Cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  41. Sun L et al. (2016). The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease [PMID: 27135484]

    Laboratory literature summary: The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  42. Huang W et al. (2025). LAPTM5 exacerbates STING-mediated inflammation induced by LL-37 through stabilizing… [PMID: 41087666]

    Laboratory literature summary: LAPTM5 exacerbates STING-mediated inflammation induced by LL-37 through stabilizing STING in rosacea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  43. Lee M et al. (2015). Research subjects antimicrobial peptide LL-37 induces glial-mediated neuroinflammation [PMID: 25686659]

    Laboratory literature summary: research subjects antimicrobial peptide LL-37 induces glial-mediated neuroinflammation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  44. Tjabringa GS et al. (2005). The research subjects cathelicidin LL-37: a multifunctional peptide involved in… [PMID: 15939310]

    Laboratory literature summary: The research subjects cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  45. Wang C et al. (2024). Construction of exosome-loaded LL-37 and its protection against zika virus infection [PMID: 38460762]

    Laboratory literature summary: Construction of exosome-loaded LL-37 and its protection against zika virus infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  46. Greer A et al. (2013). Defensins and LL-37: a review of function in the gingival epithelium [PMID: 23931055]

    Laboratory literature summary: Defensins and LL-37: a review of function in the gingival epithelium. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  47. Nijnik A et al. (2009). The roles of cathelicidin LL-37 in immune defences and novel laboratory applications [PMID: 19068548]

    Laboratory literature summary: The roles of cathelicidin LL-37 in immune defences and novel laboratory applications. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  48. Khurshid Z et al. (2017). Significance and analytical assessment Role of Antimicrobial Cathelicidins (LL-37)… [PMID: 29206168]

    Laboratory literature summary: Significance and analytical assessment Role of Antimicrobial Cathelicidins (LL-37) Peptides in Oral Health. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  49. Fahy RJ et al. (2005). Pulmonary defense and the research subjects cathelicidin hCAP-18/LL-37 [PMID: 15778507]

    Laboratory literature summary: Pulmonary defense and the research subjects cathelicidin hCAP-18/LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  50. Kahlenberg JM et al. (2013). Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease [PMID: 24185823]

    Laboratory literature summary: Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  51. Schwitter AM et al. (2026). Single Amino Acid Modulates Antimicrobial Peptide Cooperativity between LL-37 and HNP1 [PMID: 41536269]

    Laboratory literature summary: Single Amino Acid Modulates Antimicrobial Peptide Cooperativity between LL-37 and HNP1. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  52. Esposito TVF et al. (2024). Biodistribution of the cationic host defense peptide LL-37 using SPECT/CT [PMID: 38972467]

    Laboratory literature summary: Biodistribution of the cationic host defense peptide LL-37 using SPECT/CT. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  53. Chieosilapatham P et al. (2018). Tissue-specific Regulation of Innate Immune Responses by research subjects… [PMID: 29589544]

    Laboratory literature summary: Tissue-specific Regulation of Innate Immune Responses by research subjects Cathelicidin LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  54. Su Y et al. (2022). Engineered Exosomes Containing Cathelicidin/LL-37 Exhibit Multiple Biological Functions [PMID: 35930707]

    Laboratory literature summary: Engineered Exosomes Containing Cathelicidin/LL-37 Exhibit Multiple Biological Functions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  55. Kang J et al. (2019). Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms [PMID: 31170191]

    Laboratory literature summary: Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  56. Méndez-Samperio P (2010). The research subjects cathelicidin hCAP18/LL-37: a multifunctional peptide involved in… [PMID: 20600427]

    Laboratory literature summary: The research subjects cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  57. Segreto F et al. (2024). Cathelicidin LL-37 Expression in research subjects Breast Implant Capsules [PMID: 37220260]

    Laboratory literature summary: Cathelicidin LL-37 Expression in research subjects Breast Implant Capsules. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  58. Engelberg Y et al. (2020). The research subjects LL-37(17-29) antimicrobial peptide reveals a functional… [PMID: 32753597]

    Laboratory literature summary: The research subjects LL-37(17-29) antimicrobial peptide reveals a functional supramolecular structure. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  59. Oliveira PN et al. (2021). Inactivation of the antimicrobial peptide LL-37 by pathogenic Leptospira [PMID: 33347965]

    Laboratory literature summary: Inactivation of the antimicrobial peptide LL-37 by pathogenic Leptospira. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  60. Liu Q et al. (2026). LL-37: Biological Mechanisms and Emerging investigational Applications in Intestinal… [PMID: 42095322]

    Laboratory literature summary: LL-37: Biological Mechanisms and Emerging investigational Applications in Intestinal Disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  61. Duan Z et al. (2022). Role of LL-37 in thrombotic complications in research subjects with COVID-19 [PMID: 35596804]

    Laboratory literature summary: Role of LL-37 in thrombotic complications in research subjects with COVID-19. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  62. Lou J et al. (2024). [Progress of researches on the antiparasitic activity of antimicrobial peptide LL-37] [PMID: 38604693]

    Laboratory literature summary: [Progress of researches on the antiparasitic activity of antimicrobial peptide LL-37]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  63. He Y et al. (2025). Cathelicidin LL-37 in periodontitis: current research advances and future prospects -… [PMID: 39954662]

    Laboratory literature summary: Cathelicidin LL-37 in periodontitis: current research advances and future prospects – A review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  64. Shih CC et al. (2023). Laboratory research record on LL-37 (Cathelicidin) [PMID: 36958193]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  65. Keshri AK et al. (2025). LL-37, the master antimicrobial peptide, its multifaceted role from combating… [PMID: 39643165]

    Laboratory literature summary: LL-37, the master antimicrobial peptide, its multifaceted role from combating infections to oncology research models immunity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  66. Ye P et al. (2024). LL-37 and bisphosphonate co-delivery 3D-scaffold with antimicrobial and antiresorptive… [PMID: 39059543]

    Laboratory literature summary: LL-37 and bisphosphonate co-delivery 3D-scaffold with antimicrobial and antiresorptive activities for bone regeneration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  67. Jiang X et al. (2022). Nanomolar LL-37 induces permeability of a biomimetic mitochondrial membrane [PMID: 36413063]

    Laboratory literature summary: Nanomolar LL-37 induces permeability of a biomimetic mitochondrial membrane. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  68. Chernomordik F et al. (2023). Impaired tolerance to the autoantigen LL-37 in acute coronary syndrome [PMID: 37051254]

    Laboratory literature summary: Impaired tolerance to the autoantigen LL-37 in acute coronary syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  69. Yoon SH et al. (2021). Antimicrobial Peptide LL-37 Drives Rosacea-Like Skin Inflammation in an… [PMID: 33745908]

    Laboratory literature summary: Antimicrobial Peptide LL-37 Drives Rosacea-Like Skin Inflammation in an NLRP3-Dependent Manner. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  70. Lappin MJ et al. (2023). The neutralising and stimulatory effects of antimicrobial peptide LL-37 in research… [PMID: 36773560]

    Laboratory literature summary: The neutralising and stimulatory effects of antimicrobial peptide LL-37 in research subjects gingival fibroblasts. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  71. Vandamme D et al. (2012). A comprehensive summary of LL-37, the factotum research subjects cathelicidin peptide [PMID: 23246832]

    Laboratory literature summary: A comprehensive summary of LL-37, the factotum research subjects cathelicidin peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  72. Chen S et al. (2025). Activation of aryl hydrocarbon receptor ameliorates degranulation of LL-37 induced… [PMID: 39736238]

    Laboratory literature summary: Activation of aryl hydrocarbon receptor ameliorates degranulation of LL-37 induced mast cells in rosacea through enhancing autophagy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  73. Iacob SA et al. (2014). Antibacterial function of the research subjects cathelicidin-18 peptide (LL-37)… [PMID: 25101632]

    Laboratory literature summary: Antibacterial function of the research subjects cathelicidin-18 peptide (LL-37) between theory and practice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  74. Palusińska-Szysz M et al. (2022). The research subjects LL-37 peptide exerts antimicrobial activity against Legionella… [PMID: 35231605]

    Laboratory literature summary: The research subjects LL-37 peptide exerts antimicrobial activity against Legionella micdadei interacting with membrane phospholipids. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  75. Li X et al. (2026). Serine protease HtrA promotes Campylobacter jejuni intestinal colonization through… [PMID: 42160414]

    Laboratory literature summary: Serine protease HtrA promotes Campylobacter jejuni intestinal colonization through degrading antimicrobial peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  76. Wan M et al. (2014). Antimicrobial peptide LL-37 promotes bacterial phagocytosis by research subjects… [PMID: 24550523]

    Laboratory literature summary: Antimicrobial peptide LL-37 promotes bacterial phagocytosis by research subjects macrophages. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  77. Wei X et al. (2022). LL-37 transports immunoreactive cGAMP to activate STING signaling and enhance… [PMID: 35649354]

    Laboratory literature summary: LL-37 transports immunoreactive cGAMP to activate STING signaling and enhance interferon-mediated host antiviral immunity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  78. Chessa C et al. (2022). Antiviral Effect of hBD-3 and LL-37 during research subjects Primary Keratinocyte… [PMID: 35891533]

    Laboratory literature summary: Antiviral Effect of hBD-3 and LL-37 during research subjects Primary Keratinocyte Infection with West Nile Virus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  79. Denardi LB et al. (2022). Anti-Pythium insidiosum activity of MSI-78, LL-37, and magainin-2 antimicrobial peptides [PMID: 35018604]

    Laboratory literature summary: Anti-Pythium insidiosum activity of MSI-78, LL-37, and magainin-2 antimicrobial peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  80. Narh JK et al. (2024). LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its… [PMID: 38229302]

    Laboratory literature summary: LL-37_Renalexin hybrid peptide exhibits antimicrobial activity at lower MICs than its counterpart single peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  81. Fang Y et al. (2026). LL-37-ApoB-100 Complex Serves as a Biomarker of Coronary Artery Disease [PMID: 41953980]

    Laboratory literature summary: LL-37-ApoB-100 Complex Serves as a Biomarker of Coronary Artery Disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  82. Zeth K et al. (2021). Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to… [PMID: 34068993]

    Laboratory literature summary: Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  83. Croitoru DO et al. (2021). Cathelicidin LL-37 Ignites Primed NLRP3 Inflammasomes in Rosacea [PMID: 34565561]

    Laboratory literature summary: Cathelicidin LL-37 Ignites Primed NLRP3 Inflammasomes in Rosacea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  84. Svensson D et al. (2017). Apolipoprotein A-I attenuates LL-37-induced endothelial cell cytotoxicity [PMID: 28919413]

    Laboratory literature summary: Apolipoprotein A-I attenuates LL-37-induced endothelial cell cytotoxicity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  85. Lee JY et al. (2020). Cathelicidin LL-37 (an antimicrobial peptide)-induced colistin dependence in… [PMID: 32019695]

    Laboratory literature summary: Cathelicidin LL-37 (an antimicrobial peptide)-induced colistin dependence in Acinetobacter baumannii. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  86. Lee SG et al. (2023). Laboratory profile of multiple administrations of spermicidal LL-37 antimicrobial… [PMID: 37326833]

    Laboratory literature summary: laboratory profile of multiple administrations of spermicidal LL-37 antimicrobial peptide into the mouse research models reproductive tract. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  87. Lokhande KB et al. (2022). An in silico scientific basis for LL-37 as a investigational for Covid-19 [PMID: 34333809]

    Laboratory literature summary: An in silico scientific basis for LL-37 as a investigational for Covid-19. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  88. Pouwels SD et al. (2021). LL-37 and HMGB1 induce alveolar damage and reduce lung tissue regeneration via RAGE [PMID: 34405719]

    Laboratory literature summary: LL-37 and HMGB1 induce alveolar damage and reduce lung tissue regeneration via RAGE. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  89. Yu Y et al. (2017). LL-37-induced research subjects mast cell activation through G protein-coupled… [PMID: 28549244]

    Laboratory literature summary: LL-37-induced research subjects mast cell activation through G protein-coupled receptor MrgX2. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  90. Zarei-Mehrvarz E et al. (2023). The LL-37 Antimicrobial Peptide as a investigation for Systematic Infection of… [PMID: 36177621]

    Laboratory literature summary: The LL-37 Antimicrobial Peptide as a investigation for Systematic Infection of Acinetobacter baumannii in a Mouse Model. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  91. Zhang H et al. (2023). Bactericidal synergism between phage endolysin Ply2660 and cathelicidin LL-37 against… [PMID: 37024490]

    Laboratory literature summary: Bactericidal synergism between phage endolysin Ply2660 and cathelicidin LL-37 against vancomycin-resistant Enterococcus faecalis biofilms. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  92. Asti AL (2026). Β-Amyloid (Aβ) and research subjects Cathelicidin LL-37: Two Sides of the Same Coin? [PMID: 42353177]

    Laboratory literature summary: β-Amyloid (Aβ) and research subjects Cathelicidin LL-37: Two Sides of the Same Coin?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  93. Kusaka S et al. (2018). Expression of research subjects cathelicidin peptide LL-37 in inflammatory bowel disease [PMID: 28872665]

    Laboratory literature summary: Expression of research subjects cathelicidin peptide LL-37 in inflammatory bowel disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  94. Supanchart C et al. (2012). The antimicrobial peptide, LL-37, inhibits in vitro osteoclastogenesis [PMID: 22983411]

    Laboratory literature summary: The antimicrobial peptide, LL-37, inhibits in vitro osteoclastogenesis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  95. Dhiman A et al. (2023). Regulation of Macrophage Cell Surface GAPDH Alters LL-37 Internalization and… [PMID: 37080180]

    Laboratory literature summary: Regulation of Macrophage Cell Surface GAPDH Alters LL-37 Internalization and Downstream Effects in the Cell. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  96. Sadeghi S et al. (2019). Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37 [PMID: 31849468]

    Laboratory literature summary: Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  97. Aidoukovitch A et al. (2020). Antimicrobial peptide LL-37 and its pro-form, hCAP18, in desquamated epithelial cells… [PMID: 31825534]

    Laboratory literature summary: Antimicrobial peptide LL-37 and its pro-form, hCAP18, in desquamated epithelial cells of research subjects whole saliva. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  98. Chen S-Y et al. (2023). Antimicrobial peptide LL-37 disrupts plasma membrane and calcium homeostasis in… [PMID: 37888991]

    Laboratory literature summary: Antimicrobial peptide LL-37 disrupts plasma membrane and calcium homeostasis in Candida albicans via the Rim101 pathway. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  99. Ikutama R et al. (2023). Cathelicidin LL-37 Activates research subjects Keratinocyte Autophagy through the… [PMID: 36455652]

    Laboratory literature summary: Cathelicidin LL-37 Activates research subjects Keratinocyte Autophagy through the P2X₇, Mechanistic Target of Rapamycin, and MAPK Pathways. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  100. Jackson A et al. (2022). Pharmacological characterization of a structural hybrid P2X7R antagonist using ATP and… [PMID: 34863711]

    Laboratory literature summary: Pharmacological characterization of a structural hybrid P2X7R antagonist using ATP and LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  101. Kilari G et al. (2025). Research subjects cathelicidin LL-37 rapidly disrupted colonic epithelial integrity [PMID: 39837472]

    Laboratory literature summary: research subjects cathelicidin LL-37 rapidly disrupted colonic epithelial integrity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  102. Valentin JDP et al. (2024). Colloidal Structure Dictates Antimicrobial observed endpoints in LL-37 Self-Assemblies… [PMID: 39407429]

    Laboratory literature summary: Colloidal Structure Dictates Antimicrobial observed endpoints in LL-37 Self-Assemblies With Glycerol Monooleate. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  103. Friberg C et al. (2020). Research subjects antimicrobial peptide, LL-37, induces non-inheritable reduced… [PMID: 32753585]

    Laboratory literature summary: research subjects antimicrobial peptide, LL-37, induces non-inheritable reduced susceptibility to vancomycin in Staphylococcus aureus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  104. Choi KY et al. (2014). Research subjects cathelicidin LL-37 and its derivative IG-19 regulate… [PMID: 24666281]

    Laboratory literature summary: research subjects cathelicidin LL-37 and its derivative IG-19 regulate interleukin-32-induced inflammation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  105. Xi L et al. (2024). Laboratory research record on LL-37 (Cathelicidin) [PMID: 38423213]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  106. He X et al. (2026). LL-37 selectively targets Plasmodium-infected erythrocytes and exhibits antimalarial… [PMID: 41843625]

    Laboratory literature summary: LL-37 selectively targets Plasmodium-infected erythrocytes and exhibits antimalarial activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  107. Berkestedt I et al. (2008). Endogenous antimicrobial peptide LL-37 induces research subjects vasodilatation [PMID: 18397922]

    Laboratory literature summary: Endogenous antimicrobial peptide LL-37 induces research subjects vasodilatation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  108. Łuckiewicz M et al. (2026). Laboratory research record on LL-37 (Cathelicidin) [PMID: 41791569]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  109. Johnson TS et al. (2020). Protection or Destruction: The LL-37/HNP1 Cooperativity Switch [PMID: 33271082]

    Laboratory literature summary: Protection or Destruction: The LL-37/HNP1 Cooperativity Switch. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  110. Garcia de Carvalho G et al. (2024). Multiple PDT sessions with chlorin-e6 and LL-37 loaded-nanoemulsion provide limited… [PMID: 39241923]

    Laboratory literature summary: Multiple PDT sessions with chlorin-e6 and LL-37 loaded-nanoemulsion provide limited benefits to periodontitis in rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  111. Boge L et al. (2019). Cubosomes for topical delivery of the antimicrobial peptide LL-37 [PMID: 30445164]

    Laboratory literature summary: Cubosomes for topical delivery of the antimicrobial peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  112. Vierthaler M et al. (2020). Fluctuating role of antimicrobial peptide hCAP18/LL‑37 in oral tongue dysplasia and… [PMID: 32627035]

    Laboratory literature summary: Fluctuating role of antimicrobial peptide hCAP18/LL‑37 in oral tongue dysplasia and carcinoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  113. Koro C et al. (2016). Carbamylated LL-37 as a modulator of the immune response [PMID: 26878866]

    Laboratory literature summary: Carbamylated LL-37 as a modulator of the immune response. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  114. Brown KL et al. (2011). Host defense peptide LL-37 selectively reduces proinflammatory macrophage responses [PMID: 21441450]

    Laboratory literature summary: Host defense peptide LL-37 selectively reduces proinflammatory macrophage responses. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  115. Scheenstra MR et al. (2019). Cathelicidins PMAP-36, LL-37 and CATH-2 are similar peptides with different modes of… [PMID: 30886247]

    Laboratory literature summary: Cathelicidins PMAP-36, LL-37 and CATH-2 are similar peptides with different modes of action. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  116. Piller P et al. (2022). Membrane Activity of LL-37 Derived Antimicrobial Peptides against Enterococcus hirae:… [PMID: 35454112]

    Laboratory literature summary: Membrane Activity of LL-37 Derived Antimicrobial Peptides against Enterococcus hirae: Superiority of SAAP-148 over OP-145. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  117. Qin GT et al. (2015). Antimicrobial peptide LL-37 on surfaces presenting carboxylate anions [PMID: 26222596]

    Laboratory literature summary: Antimicrobial peptide LL-37 on surfaces presenting carboxylate anions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  118. Björstad A et al. (2009). The host defense peptide LL-37 selectively permeabilizes apoptotic leukocytes [PMID: 19075071]

    Laboratory literature summary: The host defense peptide LL-37 selectively permeabilizes apoptotic leukocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  119. Salzer S et al. (2014). Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: possible… [PMID: 25306296]

    Laboratory literature summary: Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: possible implications for rosacea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  120. Kozłowska E et al. (2017). Serum levels of peptide cathelicidin LL-37 in elderly research subjects with depression [PMID: 28550757]

    Laboratory literature summary: Serum levels of peptide cathelicidin LL-37 in elderly research subjects with depression. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  121. Xu M et al. (2026). Combined nonoxynol-9 and antimicrobial peptide LL-37 for barrier contraception [PMID: 42246964]

    Laboratory literature summary: Combined nonoxynol-9 and antimicrobial peptide LL-37 for barrier contraception. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  122. Moon JY et al. (2006). Expression and purification of a recombinant LL-37 from Escherichia coli [PMID: 16542635]

    Laboratory literature summary: Expression and purification of a recombinant LL-37 from Escherichia coli. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  123. Miyoshi SI et al. (2022). Inhibitory Effects of Polymyxin B and research subjects LL-37 on the Flagellin… [PMID: 35753794]

    Laboratory literature summary: Inhibitory Effects of Polymyxin B and research subjects LL-37 on the Flagellin Expression in Vibrio vulnificus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  124. Haisma EM et al. (2014). LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from… [PMID: 24841266]

    Laboratory literature summary: LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded research subjects skin equivalents. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  125. Mansbach JM et al. (2017). Serum LL-37 Levels Associated With Severity of Bronchiolitis and Viral Etiology [PMID: 28541502]

    Laboratory literature summary: Serum LL-37 Levels Associated With Severity of Bronchiolitis and Viral Etiology. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  126. Al-Adwani S et al. (2020). Studies on citrullinated LL-37: detection in research subjects airways, antibacterial… [PMID: 32047184]

    Laboratory literature summary: Studies on citrullinated LL-37: detection in research subjects airways, antibacterial effects and biophysical properties. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  127. Lee IH et al. (2017). SP-LL-37, research subjects antimicrobial peptide, enhances disease resistance in… [PMID: 28282452]

    Laboratory literature summary: SP-LL-37, research subjects antimicrobial peptide, enhances disease resistance in transgenic rice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  128. Luan JJ et al. (2017). Pathogenesis of antimicrobial peptides LL-37 and CpG-ODN in ANCA associated vasculitis [PMID: 27476166]

    Laboratory literature summary: Pathogenesis of antimicrobial peptides LL-37 and CpG-ODN in ANCA associated vasculitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  129. Overhage J et al. (2008). Research subjects host defense peptide LL-37 prevents bacterial biofilm formation [PMID: 18591225]

    Laboratory literature summary: research subjects host defense peptide LL-37 prevents bacterial biofilm formation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  130. Martynowycz MW et al. (2019). Salmonella Membrane Structural Remodeling Increases Resistance to Antimicrobial… [PMID: 31083918]

    Laboratory literature summary: Salmonella Membrane Structural Remodeling Increases Resistance to Antimicrobial Peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  131. Hou M et al. (2013). Antimicrobial peptide LL-37 and IDR-1 ameliorate MRSA pneumonia in vivo [PMID: 24021961]

    Laboratory literature summary: Antimicrobial peptide LL-37 and IDR-1 ameliorate MRSA pneumonia in vivo. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  132. Srakaew N et al. (2014). Antimicrobial host defence peptide, LL-37, as a potential vaginal contraceptive [PMID: 24549217]

    Laboratory literature summary: Antimicrobial host defence peptide, LL-37, as a potential vaginal contraceptive. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  133. Murakami T et al. (2018). MrgX2‑mediated internalization of LL‑37 and degranulation of research subjects LAD2… [PMID: 30280189]

    Laboratory literature summary: MrgX2‑mediated internalization of LL‑37 and degranulation of research subjects LAD2 mast cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  134. Smeianov V et al. (2000). Activity of cecropin P1 and FA-LL-37 against urogenital microflora [PMID: 10955957]

    Laboratory literature summary: Activity of cecropin P1 and FA-LL-37 against urogenital microflora. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  135. Turkoglu O et al. (2017). Gingival crevicular fluid and serum hCAP18/LL-37 levels in generalized aggressive… [PMID: 27129587]

    Laboratory literature summary: Gingival crevicular fluid and serum hCAP18/LL-37 levels in generalized aggressive periodontitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  136. Jin H et al. (2024). Tranilast alleviates skin inflammation and fibrosis in rosacea-like mice induced by… [PMID: 39133985]

    Laboratory literature summary: Tranilast alleviates skin inflammation and fibrosis in rosacea-like mice induced by long-term exposure to LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  137. Honda JR et al. (2020). Nontuberculous Mycobacteria Show Differential Infectivity and Use Phospholipids to… [PMID: 31545652]

    Laboratory literature summary: Nontuberculous Mycobacteria Show Differential Infectivity and Use Phospholipids to Antagonize LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  138. Yusuf M et al. (2022). Residual Interactions of LL-37 with POPC and POPE:POPG Bilayer Model Studied by… [PMID: 36362195]

    Laboratory literature summary: Residual Interactions of LL-37 with POPC and POPE:POPG Bilayer Model Studied by All-Atom Molecular Dynamics Simulation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  139. Kai-Larsen Y et al. (2008). The role of the multifunctional peptide LL-37 in host defense [PMID: 18508470]

    Laboratory literature summary: The role of the multifunctional peptide LL-37 in host defense. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  140. Qin X et al. (2019). LL-37 and its analog FF/CAP18 attenuate neutrophil migration in sepsis-induced acute… [PMID: 30537236]

    Laboratory literature summary: LL-37 and its analog FF/CAP18 attenuate neutrophil migration in sepsis-induced acute lung injury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  141. Lin T et al. (2025). Elevated LL-37/FPR2 Axis and its Regulatory Role for Gingival Fibroblasts in Periodontitis [PMID: 41072077]

    Laboratory literature summary: Elevated LL-37/FPR2 Axis and its Regulatory Role for Gingival Fibroblasts in Periodontitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  142. Lee CC et al. (2011). Transmembrane pores formed by research subjects antimicrobial peptide LL-37 [PMID: 21463582]

    Laboratory literature summary: Transmembrane pores formed by research subjects antimicrobial peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  143. Dondalska A et al. (2020). Amelioration of Compound 48/80-Mediated Itch and LL-37-Induced Inflammation by a… [PMID: 33101278]

    Laboratory literature summary: Amelioration of Compound 48/80-Mediated Itch and LL-37-Induced Inflammation by a Single-Stranded Oligonucleotide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  144. Majewska M et al. (2021). Interaction of LL-37 research subjects cathelicidin peptide with a model… [PMID: 34049238]

    Laboratory literature summary: Interaction of LL-37 research subjects cathelicidin peptide with a model microbial-like lipid membrane. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  145. Ordonez SR et al. (2014). Fungicidal mechanisms of cathelicidins LL-37 and CATH-2 revealed by live-cell imaging [PMID: 24492359]

    Laboratory literature summary: Fungicidal mechanisms of cathelicidins LL-37 and CATH-2 revealed by live-cell imaging. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  146. Shurko JF et al. (2018). Evaluation of LL-37 antimicrobial peptide derivatives alone and in combination with… [PMID: 30120393]

    Laboratory literature summary: Evaluation of LL-37 antimicrobial peptide derivatives alone and in combination with vancomycin against S. aureus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  147. Makeudom A et al. (2014). Positive correlations between hCAP18/LL-37 and chondroitin sulphate levels in chronic… [PMID: 24372543]

    Laboratory literature summary: Positive correlations between hCAP18/LL-37 and chondroitin sulphate levels in chronic periodontitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  148. Cirone KM et al. (2020). Synthetic cathelicidin LL-37 reduces Mycobacterium avium subsp. paratuberculosis… [PMID: 31478135]

    Laboratory literature summary: Synthetic cathelicidin LL-37 reduces Mycobacterium avium subsp. paratuberculosis internalization and pro-inflammatory cytokines in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  149. Yang X et al. (2020). Laboratory research record on LL-37 (Cathelicidin) [PMID: 32321591]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  150. Chen Z et al. (2019). Design and antimicrobial activities of LL-37 derivatives inhibiting the formation of… [PMID: 30635992]

    Laboratory literature summary: Design and antimicrobial activities of LL-37 derivatives inhibiting the formation of Streptococcus mutans biofilm. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  151. Spencer JJ et al. (2018). The effects of antimicrobial peptides WAM-1 and LL-37 on multidrug-resistant… [PMID: 29370365]

    Laboratory literature summary: The effects of antimicrobial peptides WAM-1 and LL-37 on multidrug-resistant Acinetobacter baumannii. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  152. Hwang YJ et al. (2014). Serum levels of LL-37 and inflammatory cytokines in plaque and guttate psoriasis [PMID: 25197165]

    Laboratory literature summary: Serum levels of LL-37 and inflammatory cytokines in plaque and guttate psoriasis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  153. Chamorro CI et al. (2009). The research subjects antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes [PMID: 18923446]

    Laboratory literature summary: The research subjects antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  154. Dahl S et al. (2018). The host defense peptide LL-37 triggers release of nucleic acids from research… [PMID: 30308233]

    Laboratory literature summary: The host defense peptide LL-37 triggers release of nucleic acids from research subjects mast cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  155. Brice DC et al. (2018). LL-37 disrupts the Kaposi's sarcoma-associated herpesvirus envelope and inhibits… [PMID: 30076864]

    Laboratory literature summary: LL-37 disrupts the Kaposi's sarcoma-associated herpesvirus envelope and inhibits infection in oral epithelial cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  156. Pastuszak K et al. (2023). Insight into the Mechanism of Interactions between the LL-37 Peptide and Model… [PMID: 37569419]

    Laboratory literature summary: Insight into the Mechanism of Interactions between the LL-37 Peptide and Model Membranes of Legionella gormanii Bacteria. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  157. Ruan Y et al. (2013). Antimicrobial peptide LL-37 attenuates LTA induced inflammatory effect in macrophages [PMID: 23375934]

    Laboratory literature summary: Antimicrobial peptide LL-37 attenuates LTA induced inflammatory effect in macrophages. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  158. Bergman P et al. (2007). The antimicrobial peptide LL-37 inhibits HIV-1 replication [PMID: 17627504]

    Laboratory literature summary: The antimicrobial peptide LL-37 inhibits HIV-1 replication. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  159. Sieprawska-Lupa M et al. (2004). Degradation of research subjects antimicrobial peptide LL-37 by Staphylococcus… [PMID: 15561843]

    Laboratory literature summary: Degradation of research subjects antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  160. Pan XH et al. (2018). [Antimicrobial peptide LL-37 in macrophages promotes colorectal oncology research… [PMID: 29936765]

    Laboratory literature summary: [Antimicrobial peptide LL-37 in macrophages promotes colorectal oncology research models growth]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  161. Pastuszak K et al. (2024). Susceptibility of Legionella gormanii Membrane-Derived Phospholipids to the Peptide… [PMID: 38611802]

    Laboratory literature summary: Susceptibility of Legionella gormanii Membrane-Derived Phospholipids to the Peptide Action of Antimicrobial LL-37-Langmuir Monolayer Studies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  162. Mookherjee N et al. (2009). Intracellular receptor for research subjects host defense peptide LL-37 in monocytes [PMID: 19605696]

    Laboratory literature summary: Intracellular receptor for research subjects host defense peptide LL-37 in monocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  163. Li K et al. (2020). LL-37 restored glucocorticoid sensitivity impaired by virus dsRNA in lung [PMID: 31877496]

    Laboratory literature summary: LL-37 restored glucocorticoid sensitivity impaired by virus dsRNA in lung. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  164. Davidopoulou S et al. (2012). Salivary concentration of the antimicrobial peptide LL-37 in children [PMID: 22336091]

    Laboratory literature summary: Salivary concentration of the antimicrobial peptide LL-37 in children. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  165. Nijnik A et al. (2009). Research subjects cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs [PMID: 19812202]

    Laboratory literature summary: research subjects cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  166. Gedik AH et al. (2017). Cathelicidin (LL-37) and research subjects β2-defensin levels of children with… [PMID: 26073571]

    Laboratory literature summary: Cathelicidin (LL-37) and research subjects β2-defensin levels of children with post-infectious bronchiolitis obliterans. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  167. Amatngalim GD et al. (2011). Cathelicidin peptide LL-37 modulates TREM-1 expression and inflammatory responses to… [PMID: 20811938]

    Laboratory literature summary: Cathelicidin peptide LL-37 modulates TREM-1 expression and inflammatory responses to microbial compounds. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  168. Yang D et al. (2001). Participation of mammalian defensins and cathelicidins in anti-microbial immunity:… [PMID: 11358975]

    Laboratory literature summary: Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of research subjects…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  169. López-Gutierrez J et al. (2023). Evaluation of biocompatibility and angiogenic potential of extracellular matrix… [PMID: 37393490]

    Laboratory literature summary: Evaluation of biocompatibility and angiogenic potential of extracellular matrix hydrogel biofunctionalized with the LL-37 peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  170. Svensson D et al. (2015). Research subjects endogenous peptide p33 inhibits detrimental effects of LL-37 on… [PMID: 24697598]

    Laboratory literature summary: research subjects endogenous peptide p33 inhibits detrimental effects of LL-37 on osteoblast viability. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  171. Byfield FJ et al. (2011). Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial… [PMID: 20943960]

    Laboratory literature summary: Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  172. Sol A et al. (2012). LL-37 induces polymerization and bundling of actin and affects actin structure [PMID: 23189180]

    Laboratory literature summary: LL-37 induces polymerization and bundling of actin and affects actin structure. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  173. Paduszynska MA et al. (2025). Anticandidal Activity of Lipopeptides Containing an LL-37-Derived Peptide Fragment KR12 [PMID: 40286204]

    Laboratory literature summary: Anticandidal Activity of Lipopeptides Containing an LL-37-Derived Peptide Fragment KR12. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  174. Ren SX et al. (2012). Host immune defense peptide LL-37 activates caspase-independent apoptosis and… [PMID: 23100468]

    Laboratory literature summary: Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon oncology research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  175. Yılmaz D et al. (2015). Overexpressions of hBD-2, hBD-3, and hCAP18/LL-37 in Gingiva of Diabetics with… [PMID: 26092093]

    Laboratory literature summary: Overexpressions of hBD-2, hBD-3, and hCAP18/LL-37 in Gingiva of Diabetics with Periodontitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  176. Habibi A et al. (2024). A novel LL-37@NH2@Fe3O4 inhibits the proliferation of the leukemia K562 cells:… [PMID: 39333586]

    Laboratory literature summary: A novel LL-37@NH2@Fe3O4 inhibits the proliferation of the leukemia K562 cells: in-vitro study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  177. Henkel A et al. (2015). Boswellic acids target the research subjects immune system-modulating antimicrobial… [PMID: 26361729]

    Laboratory literature summary: Boswellic acids target the research subjects immune system-modulating antimicrobial peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  178. Turner J et al. (1998). Activities of LL-37, a cathelin-associated antimicrobial peptide of research subjects… [PMID: 9736536]

    Laboratory literature summary: Activities of LL-37, a cathelin-associated antimicrobial peptide of research subjects neutrophils. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  179. Kumagai Y et al. (2020). Antimicrobial peptide LL-37 ameliorates a murine sepsis model via the induction of… [PMID: 32600088]

    Laboratory literature summary: Antimicrobial peptide LL-37 ameliorates a murine sepsis model via the induction of microvesicle release from neutrophils. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  180. Sol A et al. (2013). LL-37 opsonizes and inhibits biofilm formation of Aggregatibacter… [PMID: 23836819]

    Laboratory literature summary: LL-37 opsonizes and inhibits biofilm formation of Aggregatibacter actinomycetemcomitans at subbactericidal concentrations. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  181. Starner TD et al. (2005). Expression and activity of beta-defensins and LL-37 in the developing research… [PMID: 15661923]

    Laboratory literature summary: Expression and activity of beta-defensins and LL-37 in the developing research subjects lung. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  182. Tsai PW et al. (2014). Responses of Candida albicans to the research subjects antimicrobial peptide LL-37 [PMID: 24879350]

    Laboratory literature summary: Responses of Candida albicans to the research subjects antimicrobial peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  183. Oottamasathien S et al. (2013). Physiological relevance of LL-37 induced bladder inflammation and mast cells [PMID: 23313203]

    Laboratory literature summary: Physiological relevance of LL-37 induced bladder inflammation and mast cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  184. Svensson D et al. (2016). LL-37-induced host cell cytotoxicity depends on cellular expression of the globular… [PMID: 26508735]

    Laboratory literature summary: LL-37-induced host cell cytotoxicity depends on cellular expression of the globular C1q receptor (p33). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  185. Bogefors J et al. (2014). LEAP-2, LL-37 and RNase7 in tonsillar tissue: downregulated expression in seasonal… [PMID: 24821514]

    Laboratory literature summary: LEAP-2, LL-37 and RNase7 in tonsillar tissue: downregulated expression in seasonal allergic rhinitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  186. Rekha RS et al. (2015). Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of… [PMID: 26218841]

    Laboratory literature summary: Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of Mycobacterium tuberculosis in research subjects macrophages. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  187. Drab E et al. (2020). Cooperative Function of LL-37 and HNP1 Protects Mammalian Cell Membranes from Lysis [PMID: 33157121]

    Laboratory literature summary: Cooperative Function of LL-37 and HNP1 Protects Mammalian Cell Membranes from Lysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  188. Bouzari N et al. (2009). Defense of the skin with LL-37 [PMID: 19322157]

    Laboratory literature summary: Defense of the skin with LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  189. Hu Z et al. (2014). Antimicrobial cathelicidin peptide LL-37 inhibits the LPS/ATP-induced pyroptosis of… [PMID: 24454930]

    Laboratory literature summary: Antimicrobial cathelicidin peptide LL-37 inhibits the LPS/ATP-induced pyroptosis of macrophages by dual mechanism. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  190. Zhang X et al. (2016). The cationic peptide LL-37 binds Mac-1 (CD11b/CD18) with a low dissociation rate and… [PMID: 26876535]

    Laboratory literature summary: The cationic peptide LL-37 binds Mac-1 (CD11b/CD18) with a low dissociation rate and promotes phagocytosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  191. Koczulla R et al. (2003). An angiogenic role for the research subjects peptide antibiotic LL-37/hCAP-18 [PMID: 12782669]

    Laboratory literature summary: An angiogenic role for the research subjects peptide antibiotic LL-37/hCAP-18. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  192. Anders E et al. (2018). LL-37-induced research subjects osteoblast cytotoxicity and permeability occurs… [PMID: 29729269]

    Laboratory literature summary: LL-37-induced research subjects osteoblast cytotoxicity and permeability occurs independently of cellular LL-37 uptake through…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  193. Shaykhiev R et al. (2005). Research subjects endogenous antibiotic LL-37 stimulates airway epithelial cell… [PMID: 15964896]

    Laboratory literature summary: research subjects endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  194. Wei J et al. (2021). Evaluation of antimicrobial peptide LL-37 for investigation of Staphylococcus aureus… [PMID: 34871207]

    Laboratory literature summary: Evaluation of antimicrobial peptide LL-37 for investigation of Staphylococcus aureus biofilm on titanium plate. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  195. Biswas D et al. (2021). LL-37-mediated activation of host receptors is critical for defense against group A… [PMID: 33657368]

    Laboratory literature summary: LL-37-mediated activation of host receptors is critical for defense against group A streptococcal infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  196. Torres-Juarez F et al. (2015). LL-37 immunomodulatory activity during Mycobacterium tuberculosis infection in macrophages [PMID: 26351280]

    Laboratory literature summary: LL-37 immunomodulatory activity during Mycobacterium tuberculosis infection in macrophages. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  197. Juszczak M et al. (2024). Complexation of fungal extracellular nucleic acids by host LL-37 peptide shapes… [PMID: 38384468]

    Laboratory literature summary: Complexation of fungal extracellular nucleic acids by host LL-37 peptide shapes neutrophil response to Candida albicans biofilm. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  198. Wang G et al. (2014). Transformation of research subjects cathelicidin LL-37 into selective, stable, and… [PMID: 25061850]

    Laboratory literature summary: Transformation of research subjects cathelicidin LL-37 into selective, stable, and potent antimicrobial compounds. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  199. Nagaoka I et al. (2005). Augmentation of the bactericidal activities of research subjects cathelicidin… [PMID: 15750713]

    Laboratory literature summary: Augmentation of the bactericidal activities of research subjects cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  200. Nireeksha et al. (2024). Potential role of salivary vitamin D antimicrobial peptide LL-37 and interleukins in… [PMID: 38218769]

    Laboratory literature summary: Potential role of salivary vitamin D antimicrobial peptide LL-37 and interleukins in severity of dental caries: an exvivo study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  201. Casanova V et al. (2020). Citrullination Alters the Antiviral and Immunomodulatory Activities of the research… [PMID: 32117246]

    Laboratory literature summary: Citrullination Alters the Antiviral and Immunomodulatory Activities of the research subjects Cathelicidin LL-37 During Rhinovirus Infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  202. Torossian A et al. (2007). Effects of the antimicrobial peptide LL-37 and hyperthermic preconditioning in septic rats [PMID: 17721246]

    Laboratory literature summary: Effects of the antimicrobial peptide LL-37 and hyperthermic preconditioning in septic rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  203. Edfeldt K et al. (2006). Involvement of the antimicrobial peptide LL-37 in research subjects atherosclerosis [PMID: 16645154]

    Laboratory literature summary: Involvement of the antimicrobial peptide LL-37 in research subjects atherosclerosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  204. Chen CI et al. (2004). Beta-defensins and LL-37 in bronchoalveolar lavage fluid of research subjects with… [PMID: 15463886]

    Laboratory literature summary: Beta-defensins and LL-37 in bronchoalveolar lavage fluid of research subjects with cystic fibrosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  205. Porto WF et al. (2023). In silico assessment of missense point mutations on research subjects cathelicidin LL-37 [PMID: 36335830]

    Laboratory literature summary: In silico assessment of missense point mutations on research subjects cathelicidin LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  206. Lin MF et al. (2015). OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii [PMID: 26484669]

    Laboratory literature summary: OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  207. Kamysz E et al. (2023). Influence of Lipidation Pattern of the KR12 Fragment of Peptide LL-37 on Its… [PMID: 36982579]

    Laboratory literature summary: Influence of Lipidation Pattern of the KR12 Fragment of Peptide LL-37 on Its Antibacterial and Hemolytic Activities. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  208. Grönberg A et al. (2011). Laboratory research record on LL-37 (Cathelicidin) [PMID: 21547341]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  209. Patiño Vargas MI et al. (2020). Polyplexes System to Enhance the LL-37 Antimicrobial Peptide Expression in research… [PMID: 31805827]

    Laboratory literature summary: Polyplexes System to Enhance the LL-37 Antimicrobial Peptide Expression in research subjects Skin Cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  210. Ericksen B (2022). Enhancement of the activity of the antimicrobial peptides HNP1 and LL-37 by bovine… [PMID: 37360940]

    Laboratory literature summary: Enhancement of the activity of the antimicrobial peptides HNP1 and LL-37 by bovine pancreatic ribonuclease A. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  211. Tomasinsig L et al. (2008). The research subjects cathelicidin LL-37 modulates the activities of the P2X7 receptor… [PMID: 18765670]

    Laboratory literature summary: The research subjects cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  212. Chi Z et al. (2014). Cathelicidin antimicrobial peptide LL-37 in cholesteatoma enables keratinocyte… [PMID: 24383796]

    Laboratory literature summary: Cathelicidin antimicrobial peptide LL-37 in cholesteatoma enables keratinocyte reactivity with cytosolic DNA. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  213. Kanthawong S et al. (2012). Antimicrobial and antibiofilm activity of LL-37 and its truncated variants against… [PMID: 22005071]

    Laboratory literature summary: Antimicrobial and antibiofilm activity of LL-37 and its truncated variants against Burkholderia pseudomallei. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  214. Niemirowicz K et al. (2017). Formulation and candidacidal activity of magnetic nanoparticles coated with… [PMID: 28676673]

    Laboratory literature summary: Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  215. Tanabe G et al. (2026). LL-37 and bacterial DNA complexes in dental plaque: Implications for biofilm… [PMID: 41862276]

    Laboratory literature summary: LL-37 and bacterial DNA complexes in dental plaque: Implications for biofilm structure, innate immunity, and periodontal pathogenesis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  216. Balachandran Megha K et al. (2024). Development of a 3D multifunctional collagen scaffold impregnated with peptide LL-37… [PMID: 38199447]

    Laboratory literature summary: Development of a 3D multifunctional collagen scaffold impregnated with peptide LL-37 for vascularised bone tissue regeneration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  217. Tripathi S et al. (2014). LL-37 modulates research subjects neutrophil responses to influenza A virus [PMID: 25082153]

    Laboratory literature summary: LL-37 modulates research subjects neutrophil responses to influenza A virus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  218. Scott MG et al. (2002). The research subjects antimicrobial peptide LL-37 is a multifunctional modulator of… [PMID: 12244186]

    Laboratory literature summary: The research subjects antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  219. Morizane S et al. (2012). Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity… [PMID: 21850017]

    Laboratory literature summary: Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  220. Kandler K et al. (2006). The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands [PMID: 17041145]

    Laboratory literature summary: The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  221. Jacobsen AS et al. (2012). Research subjects cathelicidin LL-37 prevents bacterial biofilm formation [PMID: 22917247]

    Laboratory literature summary: research subjects cathelicidin LL-37 prevents bacterial biofilm formation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  222. Chuang CM et al. (2009). Investigation with LL-37 peptide enhances antitumor effects induced by CpG… [PMID: 19272013]

    Laboratory literature summary: investigation with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian oncology research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  223. Suzuki K et al. (2011). Research subjects anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced… [PMID: 21393634]

    Laboratory literature summary: research subjects anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  224. von Haussen J et al. (2008). The host defence peptide LL-37/hCAP-18 is a growth factor for lung oncology research… [PMID: 17764778]

    Laboratory literature summary: The host defence peptide LL-37/hCAP-18 is a growth factor for lung oncology research models cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  225. Oliveira-Bravo M et al. (2016). LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells [PMID: 28038684]

    Laboratory literature summary: LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  226. Goo J et al. (2010). Expression of antimicrobial peptides such as LL-37 and hBD-2 in nonlesional skin of… [PMID: 20653851]

    Laboratory literature summary: Expression of antimicrobial peptides such as LL-37 and hBD-2 in nonlesional skin of atopic individuals. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  227. Żochowski K et al. (2026). Oncology research models cell migration under control of research subjects… [PMID: 41916132]

    Laboratory literature summary: oncology research models cell migration under control of research subjects cathelicidin LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  228. Tzitzilis A et al. (2020). Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the… [PMID: 32567085]

    Laboratory literature summary: Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  229. Kamysz E et al. (2020). Lipidated Analogs of the LL-37-Derived Peptide Fragment KR12-Structural Analysis,… [PMID: 32019109]

    Laboratory literature summary: Lipidated Analogs of the LL-37-Derived Peptide Fragment KR12-Structural Analysis, Surface-Active Properties and Antimicrobial Activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  230. Ma D et al. (2025). Prolonged Immunomodulator Delivery Boosts Monocyte Exosome Secretion and Elevates… [PMID: 39700070]

    Laboratory literature summary: Prolonged Immunomodulator Delivery Boosts Monocyte Exosome Secretion and Elevates Cathelicidin/LL-37 Content. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  231. Noore J et al. (2013). Cationic antimicrobial peptide LL-37 is effective against both extra- and… [PMID: 23274662]

    Laboratory literature summary: Cationic antimicrobial peptide LL-37 is effective against both extra- and intracellular Staphylococcus aureus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  232. Neumann A et al. (2014). The antimicrobial peptide LL-37 facilitates the formation of neutrophil extracellular… [PMID: 25181554]

    Laboratory literature summary: The antimicrobial peptide LL-37 facilitates the formation of neutrophil extracellular traps. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  233. Conner K et al. (2002). The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatum… [PMID: 12196742]

    Laboratory literature summary: The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatum and verruca vulgaris. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  234. Alalwani SM et al. (2010). The antimicrobial peptide LL-37 modulates the inflammatory and host defense response… [PMID: 20140902]

    Laboratory literature summary: The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of research subjects neutrophils. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  235. Hurtado P et al. (2010). LL-37 promotes rapid sensing of CpG oligodeoxynucleotides by B lymphocytes and… [PMID: 20042575]

    Laboratory literature summary: LL-37 promotes rapid sensing of CpG oligodeoxynucleotides by B lymphocytes and plasmacytoid dendritic cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  236. Zielke C et al. (2026). Research subjects cathelicidin peptide LL-37 compacts nucleic acids and alters… [PMID: 42156793]

    Laboratory literature summary: research subjects cathelicidin peptide LL-37 compacts nucleic acids and alters neutrophil extracellular trap structure. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  237. Sun W et al. (2014). LL-37 attenuates inflammatory impairment via mTOR signaling-dependent mitochondrial… [PMID: 24984264]

    Laboratory literature summary: LL-37 attenuates inflammatory impairment via mTOR signaling-dependent mitochondrial protection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  238. Golla RM et al. (2020). Resistome of Staphylococcus aureus in Response to research subjects Cathelicidin LL-37… [PMID: 32343547]

    Laboratory literature summary: Resistome of Staphylococcus aureus in Response to research subjects Cathelicidin LL-37 and Its Engineered Antimicrobial Peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  239. Kim ST et al. (2003). Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease [PMID: 12625579]

    Laboratory literature summary: Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  240. Zuyderduyn S et al. (2006). The antimicrobial peptide LL-37 enhances IL-8 release by research subjects airway… [PMID: 16750994]

    Laboratory literature summary: The antimicrobial peptide LL-37 enhances IL-8 release by research subjects airway smooth muscle cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  241. Säll J et al. (2013). The antimicrobial peptide LL-37 alters research subjects osteoblast Ca2+ handling and… [PMID: 23406612]

    Laboratory literature summary: The antimicrobial peptide LL-37 alters research subjects osteoblast Ca2+ handling and induces Ca2+-independent apoptosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  242. Neville F et al. (2007). Electrochemical screening of anti-microbial peptide LL-37 interaction with phospholipids [PMID: 16949887]

    Laboratory literature summary: Electrochemical screening of anti-microbial peptide LL-37 interaction with phospholipids. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  243. Wang Y et al. (1998). Apolipoprotein A-I binds and inhibits the research subjects antibacterial/cytotoxic… [PMID: 9837875]

    Laboratory literature summary: Apolipoprotein A-I binds and inhibits the research subjects antibacterial/cytotoxic peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  244. Fan D et al. (2015). Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans… [PMID: 26053625]

    Laboratory literature summary: Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  245. Jönsson D et al. (2012). The antimicrobial peptide LL-37 is anti-inflammatory and proapoptotic in research… [PMID: 22066867]

    Laboratory literature summary: The antimicrobial peptide LL-37 is anti-inflammatory and proapoptotic in research subjects periodontal ligament cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  246. Macleod T et al. (2019). Antimicrobial Peptide LL-37 Facilitates Intracellular Uptake of RNA Aptamer Apt 21-2… [PMID: 31068939]

    Laboratory literature summary: Antimicrobial Peptide LL-37 Facilitates Intracellular Uptake of RNA Aptamer Apt 21-2 Without Inducing an Inflammatory or Interferon Response. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  247. Majewski K et al. (2017). Serum level of cathelicidin LL-37 in research subjects with active tuberculosis and… [PMID: 28956425]

    Laboratory literature summary: Serum level of cathelicidin LL-37 in research subjects with active tuberculosis and other infectious diseases. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  248. Neville F et al. (2006). Lipid headgroup discrimination by antimicrobial peptide LL-37: insight into mechanism… [PMID: 16299073]

    Laboratory literature summary: Lipid headgroup discrimination by antimicrobial peptide LL-37: insight into mechanism of action. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  249. Hosokawa I et al. (2006). Innate immune peptide LL-37 displays distinct expression pattern from beta-defensins… [PMID: 17034573]

    Laboratory literature summary: Innate immune peptide LL-37 displays distinct expression pattern from beta-defensins in inflamed gingival tissue. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  250. Coffelt SB et al. (2009). The pro-inflammatory peptide LL-37 promotes ovarian oncology research models… [PMID: 19234121]

    Laboratory literature summary: The pro-inflammatory peptide LL-37 promotes ovarian oncology research models progression through recruitment of multipotent mesenchymal…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  251. Ma H et al. (2025). Neurotransmitter 5-HT Further Promotes LL-37-Induced Rosacea-like Inflammation Through… [PMID: 40243950]

    Laboratory literature summary: Neurotransmitter 5-HT Further Promotes LL-37-Induced Rosacea-like Inflammation Through HTR3A. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  252. Zhang Z et al. (2015). Mitochondrial DNA-LL-37 Complex Promotes Atherosclerosis by Escaping from Autophagic… [PMID: 26680206]

    Laboratory literature summary: Mitochondrial DNA-LL-37 Complex Promotes Atherosclerosis by Escaping from Autophagic Recognition. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  253. White JK et al. (2022). A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory… [PMID: 35821354]

    Laboratory literature summary: A stable cyclized antimicrobial peptide derived from LL-37 with host immunomodulatory effects and activity against uropathogens. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  254. Schauber J et al. (2008). [Cathelicidin LL-37. A central factor in the pathogenesis of inflammatory dermatoses?] [PMID: 18209993]

    Laboratory literature summary: [Cathelicidin LL-37. A central factor in the pathogenesis of inflammatory dermatoses?]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  255. McGee DJ et al. (2011). Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37 [PMID: 21464244]

    Laboratory literature summary: Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  256. Rico-Mata R et al. (2013). Effect of antimicrobial peptides derived from research subjects cathelicidin LL-37 on… [PMID: 23274811]

    Laboratory literature summary: Effect of antimicrobial peptides derived from research subjects cathelicidin LL-37 on Entamoeba histolytica trophozoites. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  257. Xu B et al. (2021). IL-27 induces LL-37/CRAMP expression from intestinal epithelial cells: implications… [PMID: 34432564]

    Laboratory literature summary: IL-27 induces LL-37/CRAMP expression from intestinal epithelial cells: implications for immunotherapy of Clostridioides difficile infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  258. Bucki R et al. (2007). Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis… [PMID: 17215317]

    Laboratory literature summary: Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  259. Bąbolewska E et al. (2015). Research subjects-derived cathelicidin LL-37 directly activates mast cells to… [PMID: 25577339]

    Laboratory literature summary: research subjects-derived cathelicidin LL-37 directly activates mast cells to proinflammatory mediator synthesis and migratory response. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  260. Wollny T et al. (2022). Sphingosine-1-Phosphate-Triggered Expression of Cathelicidin LL-37 Promotes the Growth… [PMID: 35806446]

    Laboratory literature summary: Sphingosine-1-Phosphate-Triggered Expression of Cathelicidin LL-37 Promotes the Growth of research subjects Bladder oncology research…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  261. Suphasiriroj W et al. (2013). Specificity of antimicrobial peptide LL-37 to neutralize periodontopathogenic… [PMID: 22443521]

    Laboratory literature summary: Specificity of antimicrobial peptide LL-37 to neutralize periodontopathogenic lipopolysaccharide activity in research subjects oral…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  262. Dave K et al. (2026). Overcoming LPS-mediated resistance in gram-negative pathogens: a review of LL-37… [PMID: 42183878]

    Laboratory literature summary: Overcoming LPS-mediated resistance in gram-negative pathogens: a review of LL-37 analogs and computational design strategies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  263. Ju Y et al. (2008). Glucosamine, a naturally occurring amino monosaccharide modulates LL-37-induced… [PMID: 18949387]

    Laboratory literature summary: Glucosamine, a naturally occurring amino monosaccharide modulates LL-37-induced endothelial cell activation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  264. van der Does AM et al. (2012). Induction of the research subjects cathelicidin LL-37 as a novel investigation against… [PMID: 22701042]

    Laboratory literature summary: Induction of the research subjects cathelicidin LL-37 as a novel investigation against bacterial infections. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  265. Gunasekera S et al. (2018). Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key… [PMID: 29430821]

    Laboratory literature summary: Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  266. Rivas-Santiago B et al. (2013). Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26… [PMID: 23141114]

    Laboratory literature summary: Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  267. Yang YH et al. (2003). Expression of LL-37/hCAP-18 gene in research subjects leukemia cells [PMID: 12860015]

    Laboratory literature summary: Expression of LL-37/hCAP-18 gene in research subjects leukemia cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  268. Tada H et al. (2016). Vitamin D3 analog maxacalcitol (OCT) induces hCAP-18/LL-37 production in research… [PMID: 27356607]

    Laboratory literature summary: Vitamin D3 analog maxacalcitol (OCT) induces hCAP-18/LL-37 production in research subjects oral epithelial cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  269. Bandholtz L et al. (2006). Antimicrobial peptide LL-37 internalized by immature research subjects dendritic cells… [PMID: 16764694]

    Laboratory literature summary: Antimicrobial peptide LL-37 internalized by immature research subjects dendritic cells alters their phenotype. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  270. Deshpande D et al. (2020). Super-Resolution Microscopy Reveals a Direct Interaction of Intracellular… [PMID: 32937921]

    Laboratory literature summary: Super-Resolution Microscopy Reveals a Direct Interaction of Intracellular Mycobacterium tuberculosis with the Antimicrobial Peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  271. Masadeh M et al. (2022). Functional and Toxicological Evaluation of MAA-41: A Novel Rationally Designed… [PMID: 35792128]

    Laboratory literature summary: Functional and Toxicological Evaluation of MAA-41: A Novel Rationally Designed Antimicrobial Peptide Using Hybridization and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  272. Andrault PM et al. (2015). Antimicrobial Peptide LL-37 Is Both a Substrate of Cathepsins S and K and a Selective… [PMID: 25884905]

    Laboratory literature summary: Antimicrobial Peptide LL-37 Is Both a Substrate of Cathepsins S and K and a Selective Inhibitor of Cathepsin L. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  273. Wang X et al. (2025). LL-37 and Its Truncated Fragments Modulate Amyloid-β Dynamics, Aggregation and… [PMID: 40916348]

    Laboratory literature summary: LL-37 and Its Truncated Fragments Modulate Amyloid-β Dynamics, Aggregation and Toxicity Through Hetero-Oligomer and Cluster Formation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  274. Johansson J et al. (1998). Conformation-dependent antibacterial activity of the naturally occurring research… [PMID: 9452503]

    Laboratory literature summary: Conformation-dependent antibacterial activity of the naturally occurring research subjects peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  275. Hou Y et al. (2026). Aggregation-State Dynamics Drive Double Cooperativity Between Antimicrobial Peptides… [PMID: 41923698]

    Laboratory literature summary: Aggregation-State Dynamics Drive Double Cooperativity Between Antimicrobial Peptides LL-37 and HNP1. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  276. Bergman P et al. (2005). Neisseria gonorrhoeae downregulates expression of the research subjects antimicrobial… [PMID: 15953032]

    Laboratory literature summary: Neisseria gonorrhoeae downregulates expression of the research subjects antimicrobial peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  277. Chennupati SK et al. (2009). Effects of an LL-37-derived antimicrobial peptide in an animal model of biofilm… [PMID: 19379612]

    Laboratory literature summary: Effects of an LL-37-derived antimicrobial peptide in an animal model of biofilm Pseudomonas sinusitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  278. Agier J et al. (2018). Cathelicidin LL-37 Affects Surface and Intracellular Toll-Like Receptor Expression in… [PMID: 29670923]

    Laboratory literature summary: Cathelicidin LL-37 Affects Surface and Intracellular Toll-Like Receptor Expression in Tissue Mast Cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  279. Kanthawong S et al. (2010). Antimicrobial activities of LL-37 and its truncated variants against Burkholderia… [PMID: 20685090]

    Laboratory literature summary: Antimicrobial activities of LL-37 and its truncated variants against Burkholderia thailandensis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  280. Zaiou M et al. (2003). Antimicrobial and protease inhibitory functions of the research subjects cathelicidin… [PMID: 12713586]

    Laboratory literature summary: Antimicrobial and protease inhibitory functions of the research subjects cathelicidin (hCAP18/LL-37) prosequence. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  281. Yason JA et al. (2016). Blastocystis Isolate B Exhibits Multiple Modes of Resistance against Antimicrobial… [PMID: 27217421]

    Laboratory literature summary: Blastocystis Isolate B Exhibits Multiple Modes of Resistance against Antimicrobial Peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  282. Schmidtchen A et al. (2002). Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial… [PMID: 12366839]

    Laboratory literature summary: Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  283. Pazgier M et al. (2013). Structural and functional analysis of the pro-domain of research subjects… [PMID: 23406372]

    Laboratory literature summary: Structural and functional analysis of the pro-domain of research subjects cathelicidin, LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  284. Durnaś B et al. (2016). Candidacidal Activity of Selected Ceragenins and research subjects Cathelicidin LL-37… [PMID: 27315208]

    Laboratory literature summary: Candidacidal Activity of Selected Ceragenins and research subjects Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  285. Li Z et al. (2020). Antibacterial Fusion Protein BPI21/LL-37 Modification Enhances the investigational… [PMID: 32445625]

    Laboratory literature summary: Antibacterial Fusion Protein BPI21/LL-37 Modification Enhances the investigational observed endpoints of hUC-MSCs in Sepsis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  286. Takahashi T et al. (2016). A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and… [PMID: 27105895]

    Laboratory literature summary: A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  287. Ogawa Y et al. (2013). Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV… [PMID: 23332157]

    Laboratory literature summary: Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  288. Babikir IH et al. (2018). The impact of cathelicidin, the research subjects antimicrobial peptide LL-37 in… [PMID: 29310594]

    Laboratory literature summary: The impact of cathelicidin, the research subjects antimicrobial peptide LL-37 in urinary tract infections. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  289. Hoffmann MH et al. (2013). The cathelicidins LL-37 and rCRAMP are associated with pathogenic events of arthritis… [PMID: 23172753]

    Laboratory literature summary: The cathelicidins LL-37 and rCRAMP are associated with pathogenic events of arthritis in research subjects and rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  290. Tang X et al. (2015). P2X7 Receptor Regulates Internalization of Antimicrobial Peptide LL-37 by research… [PMID: 26116509]

    Laboratory literature summary: P2X7 Receptor Regulates Internalization of Antimicrobial Peptide LL-37 by research subjects Macrophages That Promotes Intracellular…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  291. Choi H et al. (2017). Oxidative stress induced in E. coli by the research subjects antimicrobial peptide LL-37 [PMID: 28665988]

    Laboratory literature summary: Oxidative stress induced in E. coli by the research subjects antimicrobial peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  292. Xhindoli D et al. (2014). Native oligomerization determines the mode of action and biological activities of… [PMID: 24117320]

    Laboratory literature summary: Native oligomerization determines the mode of action and biological activities of research subjects cathelicidin LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  293. Lakshmaiah Narayana J et al. (2021). Short and Robust Anti-Infective Lipopeptides Engineered Based on the Minimal… [PMID: 33890759]

    Laboratory literature summary: Short and Robust Anti-Infective Lipopeptides Engineered Based on the Minimal Antimicrobial Peptide KR12 of research subjects LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  294. Steinstraesser L et al. (2014). Laboratory research record on LL-37 (Cathelicidin) [PMID: 24394186]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  295. Lee HY et al. (2009). LL-37 inhibits serum amyloid A-induced IL-8 production in research subjects neutrophils [PMID: 19307752]

    Laboratory literature summary: LL-37 inhibits serum amyloid A-induced IL-8 production in research subjects neutrophils. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  296. Chung MC et al. (2015). Acyl carrier protein is a bacterial cytoplasmic target of cationic antimicrobial… [PMID: 26188040]

    Laboratory literature summary: Acyl carrier protein is a bacterial cytoplasmic target of cationic antimicrobial peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  297. Aidoukovitch A et al. (2021). Exogenous LL-37 but not homogenates of desquamated oral epithelial cells shows… [PMID: 33687301]

    Laboratory literature summary: Exogenous LL-37 but not homogenates of desquamated oral epithelial cells shows activity against Streptococcus mutans. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  298. Scott A et al. (2011). Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo [PMID: 22028895]

    Laboratory literature summary: Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  299. Fukumoto K et al. (2005). Effect of antibacterial cathelicidin peptide CAP18/LL-37 on sepsis in neonatal rats [PMID: 15645239]

    Laboratory literature summary: Effect of antibacterial cathelicidin peptide CAP18/LL-37 on sepsis in neonatal rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  300. Aghazadeh H et al. (2020). Interactions of GF-17 derived from LL-37 antimicrobial peptide with bacterial… [PMID: 33009624]

    Laboratory literature summary: Interactions of GF-17 derived from LL-37 antimicrobial peptide with bacterial membranes: a molecular dynamics simulation study. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  301. Henzler Wildman KA et al. (2003). Mechanism of lipid bilayer disruption by the research subjects antimicrobial peptide,… [PMID: 12767238]

    Laboratory literature summary: Mechanism of lipid bilayer disruption by the research subjects antimicrobial peptide, LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  302. Jiang W et al. (2013). Differential regulation of research subjects cathelicidin LL-37 by free fatty acids… [PMID: 24140860]

    Laboratory literature summary: Differential regulation of research subjects cathelicidin LL-37 by free fatty acids and their analogs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  303. Krahulec J et al. (2010). High level expression and purification of antimicrobial research subjects cathelicidin… [PMID: 20625720]

    Laboratory literature summary: High level expression and purification of antimicrobial research subjects cathelicidin LL-37 in Escherichia coli. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  304. Yang H et al. (2017). Escherichia coli PagP Enzyme-Based De Novo Design and In Vitro Activity of… [PMID: 28550277]

    Laboratory literature summary: Escherichia coli PagP Enzyme-Based De Novo Design and In Vitro Activity of Antibacterial Peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  305. Davidopoulou S et al. (2013). Salivary concentration of free LL-37 in edentulism, chronic periodontitis and healthy… [PMID: 23778112]

    Laboratory literature summary: Salivary concentration of free LL-37 in edentulism, chronic periodontitis and healthy periodontium. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  306. Tjabringa GS et al. (2006). Research subjects cathelicidin LL-37 is a chemoattractant for eosinophils and… [PMID: 16557028]

    Laboratory literature summary: research subjects cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  307. Porcelli F et al. (2008). NMR structure of the cathelicidin-derived research subjects antimicrobial peptide… [PMID: 18439024]

    Laboratory literature summary: NMR structure of the cathelicidin-derived research subjects antimicrobial peptide LL-37 in dodecylphosphocholine micelles. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  308. Hu Z et al. (2016). Antimicrobial cathelicidin peptide LL-37 inhibits the pyroptosis of macrophages and… [PMID: 26746575]

    Laboratory literature summary: Antimicrobial cathelicidin peptide LL-37 inhibits the pyroptosis of macrophages and improves the survival of polybacterial septic mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  309. Sun CL et al. (2011). LL-37 expression in the skin in systemic lupus erythematosus [PMID: 21562016]

    Laboratory literature summary: LL-37 expression in the skin in systemic lupus erythematosus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  310. Wnorowska U et al. (2015). Bactericidal activities of cathelicidin LL-37 and select cationic lipids against the… [PMID: 25870055]

    Laboratory literature summary: Bactericidal activities of cathelicidin LL-37 and select cationic lipids against the hypervirulent Pseudomonas aeruginosa strain LESB58. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  311. Niyonsaba F et al. (2002). A cathelicidin family of research subjects antibacterial peptide LL-37 induces mast… [PMID: 11972628]

    Laboratory literature summary: A cathelicidin family of research subjects antibacterial peptide LL-37 induces mast cell chemotaxis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  312. Alt JA et al. (2015). Topical cathelicidin (LL-37) an innate immune peptide induces acute olfactory… [PMID: 26346056]

    Laboratory literature summary: Topical cathelicidin (LL-37) an innate immune peptide induces acute olfactory epithelium inflammation in a mouse model. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  313. Majewski K et al. (2017). Circulating cathelicidin LL-37 in adult research subjects with pulmonary infectious… [PMID: 28218580]

    Laboratory literature summary: Circulating cathelicidin LL-37 in adult research subjects with pulmonary infectious diseases. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  314. Sun J et al. (2013). The antimicrobial peptide LL-37 induces synthesis and release of cysteinyl… [PMID: 23330796]

    Laboratory literature summary: The antimicrobial peptide LL-37 induces synthesis and release of cysteinyl leukotrienes from research subjects eosinophils–implications…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  315. Pennone V et al. (2025). Development of Silk Fibroin-Based Sponges Loaded with LL-37-Derived Peptides for the… [PMID: 40869096]

    Laboratory literature summary: Development of Silk Fibroin-Based Sponges Loaded with LL-37-Derived Peptides for the Control of Orthopedic Infections. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  316. Podaza E et al. (2020). Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia [PMID: 33054065]

    Laboratory literature summary: Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  317. Murakami M et al. (2014). Vesicular LL-37 contributes to inflammation of the lesional skin of palmoplantar… [PMID: 25330301]

    Laboratory literature summary: Vesicular LL-37 contributes to inflammation of the lesional skin of palmoplantar pustulosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  318. Zong Y et al. (2014). [A review: the role of antimicrobial peptide LL-37 in chronic sinusitis] [PMID: 24738326]

    Laboratory literature summary: [A review: the role of antimicrobial peptide LL-37 in chronic sinusitis]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  319. Iaccio A et al. (2009). FPRL1-mediated induction of superoxide in LL-37-stimulated IMR90 research subjects… [PMID: 18996352]

    Laboratory literature summary: FPRL1-mediated induction of superoxide in LL-37-stimulated IMR90 research subjects fibroblast. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  320. Senyürek I et al. (2009). Dermcidin-derived peptides show a different mode of action than the cathelicidin LL-37… [PMID: 19364862]

    Laboratory literature summary: Dermcidin-derived peptides show a different mode of action than the cathelicidin LL-37 against Staphylococcus aureus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  321. Shi P et al. (2014). [Effect of antibacterial peptide LL-37 on the integrity of Acinetobacter baumannii… [PMID: 24670464]

    Laboratory literature summary: [Effect of antibacterial peptide LL-37 on the integrity of Acinetobacter baumannii biofilm]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  322. McCrudden MT et al. (2013). LL-37 in periodontal health and disease and its susceptibility to degradation by… [PMID: 23952216]

    Laboratory literature summary: LL-37 in periodontal health and disease and its susceptibility to degradation by proteinases present in gingival crevicular fluid. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  323. Wan M et al. (2014). Cathelicidin LL-37 induces time-resolved release of LTB4 and TXA2 by research subjects… [PMID: 24736410]

    Laboratory literature summary: Cathelicidin LL-37 induces time-resolved release of LTB4 and TXA2 by research subjects macrophages and triggers eicosanoid generation in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  324. de Miguel Catalina A et al. (2019). The C-Terminal VPRTES Tail of LL-37 Influences the Mode of Attachment to a Lipid… [PMID: 31016971]

    Laboratory literature summary: The C-Terminal VPRTES Tail of LL-37 Influences the Mode of Attachment to a Lipid Bilayer and Antimicrobial Activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  325. Pan WL et al. (2018). Overexpression of CXCR4 synergizes with LL-37 in the metastasis of breast oncology… [PMID: 30251699]

    Laboratory literature summary: Overexpression of CXCR4 synergizes with LL-37 in the metastasis of breast oncology research models cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  326. Li D et al. (2004). Expression of LL-37, research subjects beta defensin-2, and CCR6 mRNA in research… [PMID: 15587410]

    Laboratory literature summary: Expression of LL-37, research subjects beta defensin-2, and CCR6 mRNA in research subjects with psoriasis vulgaris. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  327. Zhang YY et al. (2016). The modulatory effect of TLR2 on LL-37-induced research subjects mast cells activation [PMID: 26778002]

    Laboratory literature summary: The modulatory effect of TLR2 on LL-37-induced research subjects mast cells activation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  328. Zhu Y et al. (2019). Rigidification of the Escherichia coli cytoplasm by the research subjects… [PMID: 30598442]

    Laboratory literature summary: Rigidification of the Escherichia coli cytoplasm by the research subjects antimicrobial peptide LL-37 revealed by superresolution…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  329. Bachrach G et al. (2006). Salivary LL-37 secretion in individuals with Down syndrome is normal [PMID: 16998135]

    Laboratory literature summary: Salivary LL-37 secretion in individuals with Down syndrome is normal. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  330. Sol A et al. (2014). Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial… [PMID: 24947511]

    Laboratory literature summary: Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial proteases. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  331. Mori T et al. (2021). Enhancing the anticancer observed endpoints of a LL-37 peptide fragment analog using… [PMID: 34324984]

    Laboratory literature summary: Enhancing the anticancer observed endpoints of a LL-37 peptide fragment analog using peptide-linked PLGA conjugate micelles in oncology…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  332. Flick-Smith HC et al. (2013). Assessment of antimicrobial peptide LL-37 as a post-exposure research protocol to… [PMID: 23500517]

    Laboratory literature summary: Assessment of antimicrobial peptide LL-37 as a post-exposure research protocol to protect against respiratory tularemia in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  333. Zhang Z et al. (2009). Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on… [PMID: 19750480]

    Laboratory literature summary: Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on research subjects neutrophils. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  334. Abdelaal NH et al. (2017). Cathelicidin (LL-37) level in the scalp hair of research subjects with tinea capitis [PMID: 27915299]

    Laboratory literature summary: Cathelicidin (LL-37) level in the scalp hair of research subjects with tinea capitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  335. Kim HJ et al. (2011). LL-37 suppresses sodium nitroprusside-induced apoptosis of systemic sclerosis dermal… [PMID: 21732986]

    Laboratory literature summary: LL-37 suppresses sodium nitroprusside-induced apoptosis of systemic sclerosis dermal fibroblasts. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  336. Golec M et al. (2014). Cathelicidin LL-37 in bronchoalveolar lavage and epithelial lining fluids from healthy… [PMID: 24750793]

    Laboratory literature summary: Cathelicidin LL-37 in bronchoalveolar lavage and epithelial lining fluids from healthy individuals and sarcoidosis research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  337. Zhang Y et al. (2024). Discovery of novel antibacterial agent for the infected wound investigation:… [PMID: 38323312]

    Laboratory literature summary: Discovery of novel antibacterial agent for the infected wound investigation: all-hydrocarbon stapling optimization of LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  338. Sood R et al. (2008). Cholesterol, lanosterol, and ergosterol attenuate the membrane association of… [PMID: 18358828]

    Laboratory literature summary: Cholesterol, lanosterol, and ergosterol attenuate the membrane association of LL-37(W27F) and temporin L. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  339. Mumcu G et al. (2012). Salivary levels of antimicrobial peptides Hnp 1-3, Ll-37 and S100 in Behcet's disease [PMID: 22153317]

    Laboratory literature summary: Salivary levels of antimicrobial peptides Hnp 1-3, Ll-37 and S100 in Behcet's disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  340. Cirioni O et al. (2008). Observed endpoints of LL-37 and granulocyte colony-stimulating factor in a neutropenic… [PMID: 18391859]

    Laboratory literature summary: observed endpoints of LL-37 and granulocyte colony-stimulating factor in a neutropenic murine sepsis due to Pseudomonas aeruginosa. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  341. van der Does AM et al. (2010). LL-37 directs macrophage differentiation toward macrophages with a proinflammatory… [PMID: 20610648]

    Laboratory literature summary: LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  342. Elgarhy LH et al. (2025). Study of cathelicidin (LL-37) immunoexpression in the skin of vitiligo research subjects [PMID: 39873762]

    Laboratory literature summary: Study of cathelicidin (LL-37) immunoexpression in the skin of vitiligo research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  343. Mabuchi T et al. (2016). Binding Affinity and Interaction of LL-37 with HLA-C*06:02 in Psoriasis [PMID: 27189829]

    Laboratory literature summary: Binding Affinity and Interaction of LL-37 with HLA-C*06:02 in Psoriasis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  344. Hemshekhar M et al. (2019). Immunomodulatory Functions of the research subjects Cathelicidin LL-37 (aa… [PMID: 31540479]

    Laboratory literature summary: Immunomodulatory Functions of the research subjects Cathelicidin LL-37 (aa 13-31)-Derived Peptides are Associated with Predicted…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  345. Sigurgrimsdottir H et al. (2021). Keratinocytes secrete multiple inflammatory and immune biomarkers, which are regulated… [PMID: 35872634]

    Laboratory literature summary: Keratinocytes secrete multiple inflammatory and immune biomarkers, which are regulated by LL-37, in a psoriasis mimicking microenvironment. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  346. Yu X et al. (2018). LL-37 inhibits LPS-induced inflammation and stimulates the osteogenic differentiation… [PMID: 30287143]

    Laboratory literature summary: LL-37 inhibits LPS-induced inflammation and stimulates the osteogenic differentiation of BMSCs via P2X7 receptor and MAPK signaling pathway. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  347. Abou Alaiwa MH et al. (2014). PH modulates the activity and synergism of the airway surface liquid antimicrobials… [PMID: 25512526]

    Laboratory literature summary: pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  348. Nan YH et al. (2012). Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides… [PMID: 22521196]

    Laboratory literature summary: Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the research subjects antimicrobial…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  349. Kulkarni NN et al. (2021). Sequence determinants in the cathelicidin LL-37 that promote inflammation via… [PMID: 34048712]

    Laboratory literature summary: Sequence determinants in the cathelicidin LL-37 that promote inflammation via presentation of RNA to scavenger receptors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  350. Oliveira Junior LR et al. (2019). Association of vitamin D3, VDR gene polymorphisms, and LL-37 with a laboratory form of… [PMID: 31508781]

    Laboratory literature summary: Association of vitamin D3, VDR gene polymorphisms, and LL-37 with a laboratory form of Chagas Disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  351. Aarbiou J et al. (2006). Mechanisms of cell death induced by the neutrophil antimicrobial peptides… [PMID: 16673155]

    Laboratory literature summary: Mechanisms of cell death induced by the neutrophil antimicrobial peptides alpha-defensins and LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  352. Cirioni O et al. (2006). LL-37 protects rats against lethal sepsis caused by gram-negative bacteria [PMID: 16641434]

    Laboratory literature summary: LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  353. Hong IP et al. (2007). Recombinant expression of research subjects cathelicidin (hCAP18/LL-37) in Pichia pastoris [PMID: 17028774]

    Laboratory literature summary: Recombinant expression of research subjects cathelicidin (hCAP18/LL-37) in Pichia pastoris. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  354. Uhlmann J et al. (2016). LL-37 Triggers Formation of Streptococcus pyogenes Extracellular Vesicle-Like… [PMID: 26641861]

    Laboratory literature summary: LL-37 Triggers Formation of Streptococcus pyogenes Extracellular Vesicle-Like Structures with Immune Stimulatory Properties. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  355. Kraaij MD et al. (2017). CATH-2 and LL-37 increase mannose receptor expression, antigen presentation and the… [PMID: 28715682]

    Laboratory literature summary: CATH-2 and LL-37 increase mannose receptor expression, antigen presentation and the endocytic capacity of chicken mononuclear phagocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  356. Santos PA et al. (2026). Optimized LL-37-Derived Peptides Exhibit Antitubercular Activity, Induce Membrane… [PMID: 42194015]

    Laboratory literature summary: Optimized LL-37-Derived Peptides Exhibit Antitubercular Activity, Induce Membrane Disruption, and P-Type ATPase Transcriptional…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  357. Singh D et al. (2013). The research subjects antimicrobial peptide LL-37, but not the mouse ortholog, mCRAMP,… [PMID: 23386607]

    Laboratory literature summary: The research subjects antimicrobial peptide LL-37, but not the mouse ortholog, mCRAMP, can stimulate signaling by poly(I:C) through a…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  358. Byfield FJ et al. (2011). Cathelicidin LL-37 increases lung epithelial cell stiffness, decreases transepithelial… [PMID: 22095714]

    Laboratory literature summary: Cathelicidin LL-37 increases lung epithelial cell stiffness, decreases transepithelial permeability, and prevents epithelial invasion by…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  359. Wlodarczyk J et al. (2025). Increased cathelicidin LL-37 colonic expression is associated with oncology research… [PMID: 41569060]

    Laboratory literature summary: Increased cathelicidin LL-37 colonic expression is associated with oncology research models progression in colorectal oncology research…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  360. Currie SM et al. (2013). The research subjects cathelicidin LL-37 has antiviral activity against respiratory… [PMID: 24023689]

    Laboratory literature summary: The research subjects cathelicidin LL-37 has antiviral activity against respiratory syncytial virus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  361. Zsila F et al. (2019). Disorder-to-helix conformational conversion of the research subjects immunomodulatory… [PMID: 30716372]

    Laboratory literature summary: Disorder-to-helix conformational conversion of the research subjects immunomodulatory peptide LL-37 induced by antiinflammatory drugs,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  362. Brandenburg LO et al. (2008). Role of glial cells in the functional expression of LL-37/rat cathelin-related… [PMID: 18957897]

    Laboratory literature summary: Role of glial cells in the functional expression of LL-37/rat cathelin-related antimicrobial peptide in meningitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  363. Guo YJ et al. (2016). Research subjects cathelicidin LL-37 enhance the antibiofilm effect of EGCG on… [PMID: 27659310]

    Laboratory literature summary: research subjects cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  364. Pinheiro da Silva F et al. (2013). Neutrophils LL-37 migrate to the nucleus during overwhelming infection [PMID: 23742816]

    Laboratory literature summary: Neutrophils LL-37 migrate to the nucleus during overwhelming infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  365. Otte JM et al. (2009). Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity [PMID: 19328825]

    Laboratory literature summary: Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  366. Koziel J et al. (2014). Citrullination alters immunomodulatory function of LL-37 essential for prevention of… [PMID: 24771854]

    Laboratory literature summary: Citrullination alters immunomodulatory function of LL-37 essential for prevention of endotoxin-induced sepsis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  367. Golec M et al. (2012). Cathelicidin LL-37 in bronchoalveolar lavage and epithelial lining fluids from COPD… [PMID: 23241112]

    Laboratory literature summary: Cathelicidin LL-37 in bronchoalveolar lavage and epithelial lining fluids from COPD research subjects and healthy individuals. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  368. Xhindoli D et al. (2015). New aspects of the structure and mode of action of the research subjects cathelicidin… [PMID: 25378136]

    Laboratory literature summary: New aspects of the structure and mode of action of the research subjects cathelicidin LL-37 revealed by the intrinsic probe…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  369. Zhang J et al. (2026). LL-37 Inhibits EV71 Infection by Upregulating STAC via the EGFR-ERK Signaling Pathway [PMID: 42043231]

    Laboratory literature summary: LL-37 Inhibits EV71 Infection by Upregulating STAC via the EGFR-ERK Signaling Pathway. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  370. An LL et al. (2005). Marked reduction of LL-37/hCAP-18, an antimicrobial peptide, in research subjects with… [PMID: 15717688]

    Laboratory literature summary: Marked reduction of LL-37/hCAP-18, an antimicrobial peptide, in research subjects with acute myeloid leukemia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  371. Sainz B Jr et al. (2015). Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by… [PMID: 25841238]

    Laboratory literature summary: Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its oncology research models stem cell compartment. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  372. Tripathi S et al. (2015). Antiviral Activity of the research subjects Cathelicidin, LL-37, and Derived Peptides… [PMID: 25909853]

    Laboratory literature summary: Antiviral Activity of the research subjects Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  373. Park HJ et al. (2009). Collagen synthesis is suppressed in dermal fibroblasts by the research subjects… [PMID: 18923445]

    Laboratory literature summary: Collagen synthesis is suppressed in dermal fibroblasts by the research subjects antimicrobial peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  374. Patiño MI et al. (2021). Nonviral Expression of LL-37 in a research subjects Skin Equivalent to Prevent… [PMID: 33980038]

    Laboratory literature summary: Nonviral Expression of LL-37 in a research subjects Skin Equivalent to Prevent Infection in Skin Wounds. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  375. Dannehl C et al. (2013). Surface activity and structures of two fragments of the research subjects… [PMID: 23624281]

    Laboratory literature summary: Surface activity and structures of two fragments of the research subjects antimicrobial LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  376. Yoshioka M et al. (2008). Research subjects cathelicidin CAP18/LL-37 changes mast cell function toward innate… [PMID: 18239275]

    Laboratory literature summary: research subjects cathelicidin CAP18/LL-37 changes mast cell function toward innate immunity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  377. Wang X et al. (2017). Arginine-lysine positional swap of the LL-37 peptides reveals evolutional advantages… [PMID: 28450045]

    Laboratory literature summary: Arginine-lysine positional swap of the LL-37 peptides reveals evolutional advantages of the native sequence and leads to bacterial probes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  378. Mader JS et al. (2011). The research subjects cathelicidin, LL-37, induces granzyme-mediated apoptosis in… [PMID: 21389875]

    Laboratory literature summary: The research subjects cathelicidin, LL-37, induces granzyme-mediated apoptosis in regulatory T cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  379. Niemirowicz K et al. (2015). Magnetic nanoparticles enhance the anticancer activity of cathelicidin LL-37 peptide… [PMID: 26082634]

    Laboratory literature summary: Magnetic nanoparticles enhance the anticancer activity of cathelicidin LL-37 peptide against colon oncology research models cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  380. Smith ME et al. (2017). Endotoxin Exposure Increases LL-37 – but Not Calprotectin – in Healthy research… [PMID: 28605742]

    Laboratory literature summary: Endotoxin Exposure Increases LL-37 – but Not Calprotectin – in Healthy research subjects Airways. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  381. Ballardini N et al. (2009). Enhanced expression of the antimicrobial peptide LL-37 in lesional skin of adults with… [PMID: 19309368]

    Laboratory literature summary: Enhanced expression of the antimicrobial peptide LL-37 in lesional skin of adults with atopic eczema. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  382. Gudmundsson GH et al. (1996). The research subjects gene FALL39 and processing of the cathelin precursor to the… [PMID: 8681941]

    Laboratory literature summary: The research subjects gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  383. Bryzek D et al. (2020). Citrullination-Resistant LL-37 Is a Potent Antimicrobial Agent in the Inflammatory… [PMID: 33266231]

    Laboratory literature summary: Citrullination-Resistant LL-37 Is a Potent Antimicrobial Agent in the Inflammatory Environment High in Arginine Deiminase Activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  384. Jiao D et al. (2017). Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial… [PMID: 28500314]

    Laboratory literature summary: Activation of Eosinophils Interacting with Bronchial Epithelial Cells by Antimicrobial Peptide LL-37: Implications in Allergic Asthma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  385. Nijnik A et al. (2012). Signaling pathways mediating chemokine induction in keratinocytes by cathelicidin… [PMID: 22516952]

    Laboratory literature summary: Signaling pathways mediating chemokine induction in keratinocytes by cathelicidin LL-37 and flagellin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  386. Lofton H et al. (2013). Mechanisms and fitness costs of resistance to antimicrobial peptides LL-37, CNY100HL… [PMID: 23894360]

    Laboratory literature summary: Mechanisms and fitness costs of resistance to antimicrobial peptides LL-37, CNY100HL and wheat germ histones. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  387. Golec M et al. (2009). Cathelicidin LL-37, granzymes, TGF-beta1 and cytokines levels in induced sputum from… [PMID: 20047264]

    Laboratory literature summary: Cathelicidin LL-37, granzymes, TGF-beta1 and cytokines levels in induced sputum from farmers with and without COPD. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  388. Chen PH et al. (2004). The expression of research subjects antimicrobial peptide LL-37 in the research… [PMID: 15706986]

    Laboratory literature summary: The expression of research subjects antimicrobial peptide LL-37 in the research subjects nasal mucosa. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  389. Nell MJ et al. (2006). Development of novel LL-37 derived antimicrobial peptides with LPS and LTA… [PMID: 16274847]

    Laboratory literature summary: Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for investigational…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  390. Lau YE et al. (2005). Interaction and cellular localization of the research subjects host defense peptide… [PMID: 15618198]

    Laboratory literature summary: Interaction and cellular localization of the research subjects host defense peptide LL-37 with lung epithelial cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  391. Lima SMF et al. (2017). Antimicrobial and immunomodulatory activity of host defense peptides, clavanins and… [PMID: 28712894]

    Laboratory literature summary: Antimicrobial and immunomodulatory activity of host defense peptides, clavanins and LL-37, in vitro: An endodontic perspective. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  392. Schauber J et al. (2004). Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells [PMID: 15261456]

    Laboratory literature summary: Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  393. Thomas AJ et al. (2017). LL-37 causes cell death of research subjects nasal epithelial cells, which is… [PMID: 28837619]

    Laboratory literature summary: LL-37 causes cell death of research subjects nasal epithelial cells, which is inhibited with a synthetic glycosaminoglycan. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  394. Harcourt JL et al. (2016). Research subjects cathelicidin, LL-37, inhibits respiratory syncytial virus infection… [PMID: 26732674]

    Laboratory literature summary: research subjects cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  395. Leung TF et al. (2012). Circulating LL-37 is a biomarker for eczema severity in children [PMID: 21518024]

    Laboratory literature summary: Circulating LL-37 is a biomarker for eczema severity in children. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  396. Barns KJ et al. (2013). Real-time attack of LL-37 on single Bacillus subtilis cells [PMID: 23454084]

    Laboratory literature summary: Real-time attack of LL-37 on single Bacillus subtilis cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  397. Fox MA et al. (2012). Design and characterization of novel hybrid antimicrobial peptides based on cecropin… [PMID: 22289499]

    Laboratory literature summary: Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  398. Smyth D et al. (2014). DrsG from Streptococcus dysgalactiae subsp. equisimilis inhibits the antimicrobial… [PMID: 24664506]

    Laboratory literature summary: DrsG from Streptococcus dysgalactiae subsp. equisimilis inhibits the antimicrobial peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  399. Sigurdardottir T et al. (2006). In silico identification and biological evaluation of antimicrobial peptides based on… [PMID: 16940092]

    Laboratory literature summary: In silico identification and biological evaluation of antimicrobial peptides based on research subjects cathelicidin LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  400. Zhang Z et al. (2008). Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin [PMID: 18524973]

    Laboratory literature summary: Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  401. Mader JS et al. (2011). The research subjects cathelicidin, LL-37, induces granzyme-mediated apoptosis in… [PMID: 21134367]

    Laboratory literature summary: The research subjects cathelicidin, LL-37, induces granzyme-mediated apoptosis in cytotoxic T lymphocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  402. Sigurgrímsdóttir H et al. (2025). Skin-Homing Potential of Peripheral Immune Cells From Psoriasis research subjects and… [PMID: 41236028]

    Laboratory literature summary: Skin-Homing Potential of Peripheral Immune Cells From Psoriasis research subjects and the Effects of LL-37 on Their Secretion of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  403. Kozłowska E et al. (2018). Circulating cathelicidin LL-37 level is increased in euthymic research subjects with… [PMID: 29239826]

    Laboratory literature summary: Circulating cathelicidin LL-37 level is increased in euthymic research subjects with bipolar disorder. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  404. Hizal M et al. (2015). Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? [PMID: 25597616]

    Laboratory literature summary: Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  405. Huang LC et al. (2006). Multifunctional roles of research subjects cathelicidin (LL-37) at the ocular surface [PMID: 16723446]

    Laboratory literature summary: Multifunctional roles of research subjects cathelicidin (LL-37) at the ocular surface. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  406. Gambade A et al. (2016). Activation of TRPV2 and BKCa channels by the LL-37 enantiomers stimulates calcium… [PMID: 26993604]

    Laboratory literature summary: Activation of TRPV2 and BKCa channels by the LL-37 enantiomers stimulates calcium entry and migration of oncology research models cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  407. Zhang C et al. (2012). Vitamin D status and expression of vitamin D receptor and LL-37 in research subjects… [PMID: 21755299]

    Laboratory literature summary: Vitamin D status and expression of vitamin D receptor and LL-37 in research subjects with spontaneous bacterial peritonitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  408. Rapala-Kozik M et al. (2015). Inactivation of the antifungal and immunomodulatory properties of research subjects… [PMID: 25847962]

    Laboratory literature summary: Inactivation of the antifungal and immunomodulatory properties of research subjects cathelicidin LL-37 by aspartic proteases produced by…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  409. Tanaka D et al. (2000). Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the… [PMID: 11154407]

    Laboratory literature summary: Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: a cathelicidin found in…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  410. Gutner M et al. (2009). Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of… [PMID: 19805540]

    Laboratory literature summary: Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  411. Barlow PG et al. (2010). The research subjects cathelicidin LL-37 preferentially promotes apoptosis of infected… [PMID: 20097832]

    Laboratory literature summary: The research subjects cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  412. Johansson L et al. (2008). Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in research… [PMID: 18490458]

    Laboratory literature summary: Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  413. He Y et al. (2018). The fabrication and in vitro properties of antibacterial polydopamine-LL-37-POPC… [PMID: 29874631]

    Laboratory literature summary: The fabrication and in vitro properties of antibacterial polydopamine-LL-37-POPC coatings on micro-arc oxidized titanium. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  414. Leszczyńska K et al. (2010). Modulation of exogenous antibiotic activity by host cathelicidin LL-37 [PMID: 20955455]

    Laboratory literature summary: Modulation of exogenous antibiotic activity by host cathelicidin LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  415. Sol A et al. (2015). Interaction of the core fragments of the LL-37 host defense peptide with actin [PMID: 26726303]

    Laboratory literature summary: Interaction of the core fragments of the LL-37 host defense peptide with actin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  416. Durnaś B et al. (2017). Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected… [PMID: 28747178]

    Laboratory literature summary: Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  417. Martineau AR et al. (2007). IFN-gamma- and TNF-independent vitamin D-inducible research subjects suppression of… [PMID: 17513768]

    Laboratory literature summary: IFN-gamma- and TNF-independent vitamin D-inducible research subjects suppression of mycobacteria: the role of cathelicidin LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  418. Ciornei CD et al. (2005). Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization,… [PMID: 15980359]

    Laboratory literature summary: Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  419. Ding B et al. (2013). Physiologically-relevant modes of membrane interactions by the research subjects… [PMID: 23676762]

    Laboratory literature summary: Physiologically-relevant modes of membrane interactions by the research subjects antimicrobial peptide, LL-37, revealed by SFG experiments. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  420. Koziel J et al. (2010). Proteolytic inactivation of LL-37 by karilysin, a novel virulence mechanism of… [PMID: 20375548]

    Laboratory literature summary: Proteolytic inactivation of LL-37 by karilysin, a novel virulence mechanism of Tannerella forsythia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  421. Giraldo-Lorza JM et al. (2026). How cholesterol modulates LL-37 function: A biophysical study in eukaryotic-like… [PMID: 42134226]

    Laboratory literature summary: How cholesterol modulates LL-37 function: A biophysical study in eukaryotic-like membrane systems. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  422. Hensel JA et al. (2011). LL-37 as a investigational target for late stage prostate oncology research models [PMID: 20957672]

    Laboratory literature summary: LL-37 as a investigational target for late stage prostate oncology research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  423. Sood R et al. (2008). Binding of LL-37 to model biomembranes: insight into target vs host cell recognition [PMID: 18166145]

    Laboratory literature summary: Binding of LL-37 to model biomembranes: insight into target vs host cell recognition. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  424. Aghazadeh H et al. (2019). The activity and action mechanism of novel short selective LL-37-derived anticancer… [PMID: 30120878]

    Laboratory literature summary: The activity and action mechanism of novel short selective LL-37-derived anticancer peptides against laboratory isolates of Escherichia coli. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  425. Yin J et al. (2010). Laboratory research record on LL-37 (Cathelicidin) [PMID: 19797203]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  426. Dombrowski Y et al. (2012). Cathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis [PMID: 22509827]

    Laboratory literature summary: Cathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  427. Schögler A et al. (2016). Vitamin D represses rhinovirus replication in cystic fibrosis cells by inducing LL-37 [PMID: 26585423]

    Laboratory literature summary: Vitamin D represses rhinovirus replication in cystic fibrosis cells by inducing LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  428. Thwaite JE et al. (2006). Proteolytic degradation of research subjects antimicrobial peptide LL-37 by Bacillus… [PMID: 16801407]

    Laboratory literature summary: Proteolytic degradation of research subjects antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  429. Rivas-Santiago B et al. (2008). Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in… [PMID: 18160480]

    Laboratory literature summary: Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in research subjects alveolar macrophages, monocytes,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  430. Liu A et al. (2019). [laboratory significance of antibacterial peptide LL-37 in early analytical assessment… [PMID: 31657329]

    Laboratory literature summary: [laboratory significance of antibacterial peptide LL-37 in early analytical assessment of research subjects with sepsis in emergency…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  431. Tokumaru S et al. (2005). Induction of keratinocyte migration via transactivation of the epidermal growth factor… [PMID: 16177113]

    Laboratory literature summary: Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  432. Weber G et al. (2009). Research subjects antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype… [PMID: 19183447]

    Laboratory literature summary: research subjects antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast oncology research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  433. Hou S et al. (2015). Chlamydial plasmid-encoded virulence factor Pgp3 neutralizes the antichlamydial… [PMID: 26416907]

    Laboratory literature summary: Chlamydial plasmid-encoded virulence factor Pgp3 neutralizes the antichlamydial activity of research subjects cathelicidin LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  434. Howell MD et al. (2004). Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum [PMID: 14734759]

    Laboratory literature summary: Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  435. Henzler-Wildman KA et al. (2004). Perturbation of the hydrophobic core of lipid bilayers by the research subjects… [PMID: 15222757]

    Laboratory literature summary: Perturbation of the hydrophobic core of lipid bilayers by the research subjects antimicrobial peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  436. Frohm M et al. (1997). The expression of the gene coding for the antibacterial peptide LL-37 is induced in… [PMID: 9182550]

    Laboratory literature summary: The expression of the gene coding for the antibacterial peptide LL-37 is induced in research subjects keratinocytes during inflammatory…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  437. Strömstedt AA et al. (2009). Evaluation of strategies for improving proteolytic resistance of antimicrobial… [PMID: 19029324]

    Laboratory literature summary: Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  438. Xie D et al. (2010). [Expressions of LL-37 and IL-8 in chronic sinusitis with nasal polyps] [PMID: 20556966]

    Laboratory literature summary: [Expressions of LL-37 and IL-8 in chronic sinusitis with nasal polyps]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  439. Salvado MD et al. (2013). Cathelicidin LL-37 induces angiogenesis via PGE2-EP3 signaling in endothelial cells,… [PMID: 23766266]

    Laboratory literature summary: Cathelicidin LL-37 induces angiogenesis via PGE2-EP3 signaling in endothelial cells, in vivo inhibition by aspirin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  440. Le Fournis C et al. (2026). Structural determinants of glycosaminoglycan oligosaccharides as LL-37 inhibitors in… [PMID: 41674152]

    Laboratory literature summary: Structural determinants of glycosaminoglycan oligosaccharides as LL-37 inhibitors in breast oncology research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  441. Wan M et al. (2011). Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by… [PMID: 21307335]

    Laboratory literature summary: Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  442. Jacob B et al. (2013). Short KR-12 analogs designed from research subjects cathelicidin LL-37 possessing both… [PMID: 24105706]

    Laboratory literature summary: Short KR-12 analogs designed from research subjects cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  443. Montoya-Rosales A et al. (2016). Glucose levels affect LL-37 expression in monocyte-derived macrophages altering the… [PMID: 27263098]

    Laboratory literature summary: Glucose levels affect LL-37 expression in monocyte-derived macrophages altering the Mycobacterium tuberculosis intracellular growth control. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  444. Shahmiri M et al. (2016). Membrane Core-Specific Antimicrobial Action of Cathelicidin LL-37 Peptide Switches… [PMID: 27901075]

    Laboratory literature summary: Membrane Core-Specific Antimicrobial Action of Cathelicidin LL-37 Peptide Switches Between Pore and Nanofibre Formation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  445. Urashima A et al. (2017). Enterohaemorrhagic Escherichia coli produces outer membrane vesicles as an active… [PMID: 28622430]

    Laboratory literature summary: Enterohaemorrhagic Escherichia coli produces outer membrane vesicles as an active defence system against antimicrobial peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  446. Woods EC et al. (2018). The C. difficile clnRAB operon initiates adaptations to the host environment in… [PMID: 30125334]

    Laboratory literature summary: The C. difficile clnRAB operon initiates adaptations to the host environment in response to LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  447. Singh D et al. (2014). LL-37 peptide enhancement of signal transduction by Toll-like receptor 3 is regulated… [PMID: 25092290]

    Laboratory literature summary: LL-37 peptide enhancement of signal transduction by Toll-like receptor 3 is regulated by pH: identification of a peptide antagonist of LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  448. Karlsson J et al. (2008). Vitamin D3 induces pro-LL-37 expression in myeloid precursors from research subjects… [PMID: 18703682]

    Laboratory literature summary: Vitamin D3 induces pro-LL-37 expression in myeloid precursors from research subjects with severe congenital neutropenia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  449. Li Y (2012). A novel protocol for the production of recombinant LL-37 expressed as a thioredoxin… [PMID: 22085721]

    Laboratory literature summary: A novel protocol for the production of recombinant LL-37 expressed as a thioredoxin fusion protein. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  450. Wan M et al. (2007). Leukotriene B4 triggers release of the cathelicidin LL-37 from research subjects… [PMID: 17446260]

    Laboratory literature summary: Leukotriene B4 triggers release of the cathelicidin LL-37 from research subjects neutrophils: novel lipid-peptide interactions in innate…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  451. Grzywacz D et al. (2026). Influence of N- and O-glycosylation on structural properties and biological activity… [PMID: 41780202]

    Laboratory literature summary: Influence of N- and O-glycosylation on structural properties and biological activity of a C-terminal LL-37 fragment. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  452. Pochet S et al. (2006). Modulation by LL-37 of the responses of salivary glands to purinergic agonists [PMID: 16514052]

    Laboratory literature summary: Modulation by LL-37 of the responses of salivary glands to purinergic agonists. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  453. Kai-Larsen Y et al. (2010). Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae… [PMID: 20661475]

    Laboratory literature summary: Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  454. Barańska-Rybak W et al. (2006). Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids [PMID: 16387752]

    Laboratory literature summary: Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  455. Ohta K et al. (2011). Additive effects of orexin B and vasoactive intestinal polypeptide on LL-37-mediated… [PMID: 21176972]

    Laboratory literature summary: Additive effects of orexin B and vasoactive intestinal polypeptide on LL-37-mediated antimicrobial activities. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  456. Wang F et al. (2016). [Effects of antimicrobial peptide LL-37 expressed and purified from prokaryotes in the… [PMID: 27465873]

    Laboratory literature summary: [Effects of antimicrobial peptide LL-37 expressed and purified from prokaryotes in the murine model of vaginal candidiasis]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  457. Gabriel M et al. (2006). Preparation of LL-37-grafted titanium surfaces with bactericidal activity [PMID: 16536489]

    Laboratory literature summary: Preparation of LL-37-grafted titanium surfaces with bactericidal activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  458. Xiao Q et al. (2026). Regulation of virulence factors of Pseudomonas aeruginosa by Scutellaria baicalensis,… [PMID: 41637127]

    Laboratory literature summary: Regulation of virulence factors of Pseudomonas aeruginosa by Scutellaria baicalensis, Prunella vulgaris and antimicrobial peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  459. Lu Q et al. (2015). [Effect of antibacterial peptide hCAP18/LL-37 on ovarian oncology research models… [PMID: 26813589]

    Laboratory literature summary: [Effect of antibacterial peptide hCAP18/LL-37 on ovarian oncology research models microenvironment and the regulatory mechanism of its…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  460. Zähner D et al. (2010). Research subjects antimicrobial peptide LL-37 induces MefE/Mel-mediated macrolide… [PMID: 20498319]

    Laboratory literature summary: research subjects antimicrobial peptide LL-37 induces MefE/Mel-mediated macrolide resistance in Streptococcus pneumoniae. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  461. Bergsson G et al. (2009). LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits… [PMID: 19542465]

    Laboratory literature summary: LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  462. Rayan B et al. (2026). RNA selectively modulates activity of virulent amyloid PSMα3 and host-defense LL-37… [PMID: 42474037]

    Laboratory literature summary: RNA selectively modulates activity of virulent amyloid PSMα3 and host-defense LL-37 via phase separation and aggregation dynamics. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  463. Tripathi S et al. (2015). Identifying the Critical Domain of LL-37 Involved in Mediating Neutrophil Activation… [PMID: 26308522]

    Laboratory literature summary: Identifying the Critical Domain of LL-37 Involved in Mediating Neutrophil Activation in the Presence of Influenza Virus: Functional and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  464. Nylén F et al. (2017). Assays for Identifying Inducers of the Antimicrobial Peptide LL-37 [PMID: 28013511]

    Laboratory literature summary: Assays for Identifying Inducers of the Antimicrobial Peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  465. Dolkar T et al. (2018). Dermatologic toxicity from novel research protocol using antimicrobial peptide LL-37… [PMID: 29665030]

    Laboratory literature summary: Dermatologic toxicity from novel research protocol using antimicrobial peptide LL-37 in melanoma: A detailed examination of the…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  466. Cederlund A et al. (2014). Label-free quantitative mass spectrometry reveals novel pathways involved in LL-37… [PMID: 24246949]

    Laboratory literature summary: Label-free quantitative mass spectrometry reveals novel pathways involved in LL-37 expression. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  467. Bociek K et al. (2015). Lipopolysaccharide Phosphorylation by the WaaY Kinase Affects the Susceptibility of… [PMID: 26100635]

    Laboratory literature summary: Lipopolysaccharide Phosphorylation by the WaaY Kinase Affects the Susceptibility of Escherichia coli to the research subjects…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  468. Barbeiro DF et al. (2013). Cathelicidin LL-37 bloodstream surveillance is down regulated during septic shock [PMID: 23328115]

    Laboratory literature summary: Cathelicidin LL-37 bloodstream surveillance is down regulated during septic shock. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  469. Sørensen OE et al. (2001). Research subjects cathelicidin, hCAP-18, is processed to the antimicrobial peptide… [PMID: 11389039]

    Laboratory literature summary: research subjects cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  470. Wang Y et al. (2004). The antimicrobial peptide LL-37 binds to the research subjects plasma protein… [PMID: 14978805]

    Laboratory literature summary: The antimicrobial peptide LL-37 binds to the research subjects plasma protein apolipoprotein A-I. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  471. Bucki R et al. (2008). Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37… [PMID: 18456648]

    Laboratory literature summary: Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  472. Hayashi M et al. (2018). Suppressive effect of an analog of the antimicrobial peptide of LL‑37 on colon… [PMID: 30221678]

    Laboratory literature summary: Suppressive effect of an analog of the antimicrobial peptide of LL‑37 on colon oncology research models cells via exosome‑encapsulated…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  473. Agerberth B et al. (2006). Malassezia sympodialis differently affects the expression of LL-37 in dendritic cells… [PMID: 16512803]

    Laboratory literature summary: Malassezia sympodialis differently affects the expression of LL-37 in dendritic cells from atopic eczema research subjects and healthy…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  474. Lee JY et al. (2011). Interdigitated electrodes based on impedance biosensor for sensing peptide LL-37 [PMID: 22254253]

    Laboratory literature summary: Interdigitated electrodes based on impedance biosensor for sensing peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  475. Kozlowska E et al. (2018). Research subjects cathelicidin LL-37 – Does it influence the homeostatic imbalance in… [PMID: 29872020]

    Laboratory literature summary: research subjects cathelicidin LL-37 – Does it influence the homeostatic imbalance in mental disorders?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  476. He Y et al. (2019). Laboratory research record on LL-37 (Cathelicidin) [PMID: 31663543]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  477. Zhang M (2015). [Process Optimization of PEGylating Fused Protein of LL-37 and Interferon-α2a] [PMID: 27079098]

    Laboratory literature summary: [Process Optimization of PEGylating Fused Protein of LL-37 and Interferon-α2a]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  478. Lu J et al. (2026). Design and Screening of the Peptide SAMP-12aa Derived from LL-37, Which Exhibits… [PMID: 41900101]

    Laboratory literature summary: Design and Screening of the Peptide SAMP-12aa Derived from LL-37, Which Exhibits Anti-H. Pylori Activity and Immunomodulatory Effects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  479. Levinson P et al. (2009). Levels of innate immune factors in genital fluids: association of alpha defensins and… [PMID: 19114868]

    Laboratory literature summary: Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  480. Majchrzykiewicz JA et al. (2010). Generic and specific adaptive responses of Streptococcus pneumoniae to challenge with… [PMID: 19917758]

    Laboratory literature summary: Generic and specific adaptive responses of Streptococcus pneumoniae to challenge with three distinct antimicrobial peptides, bacitracin,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  481. Lau YE et al. (2006). Apoptosis of airway epithelial cells: research subjects serum sensitive induction by… [PMID: 16340000]

    Laboratory literature summary: Apoptosis of airway epithelial cells: research subjects serum sensitive induction by the cathelicidin LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  482. Wong A et al. (2018). A Novel Biological Role for Peptidyl-Arginine Deiminases: Citrullination of… [PMID: 29475987]

    Laboratory literature summary: A Novel Biological Role for Peptidyl-Arginine Deiminases: Citrullination of Cathelicidin LL-37 Controls the Immunostimulatory Potential…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  483. Matzner M et al. (2011). Low serum levels of cathelicidin LL-37 in leprosy [PMID: 20887706]

    Laboratory literature summary: Low serum levels of cathelicidin LL-37 in leprosy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  484. Findlay F et al. (2017). Carbon Nanoparticles Inhibit the Antimicrobial Activities of the research subjects… [PMID: 28814602]

    Laboratory literature summary: Carbon Nanoparticles Inhibit the Antimicrobial Activities of the research subjects Cathelicidin LL-37 through Structural Alteration. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  485. Shi L et al. (2008). [Bactericidal activity of GLL-37, a novel derivative of the research subjects… [PMID: 18275123]

    Laboratory literature summary: [Bactericidal activity of GLL-37, a novel derivative of the research subjects antimicrobial peptide LL-37]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  486. Epand RF et al. (2009). Lipid segregation explains selective toxicity of a series of fragments derived from… [PMID: 19581460]

    Laboratory literature summary: Lipid segregation explains selective toxicity of a series of fragments derived from the research subjects cathelicidin LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  487. Eini A et al. (2013). Oxygen deprivation affects the antimicrobial action of LL-37 as determined by… [PMID: 23664904]

    Laboratory literature summary: Oxygen deprivation affects the antimicrobial action of LL-37 as determined by microplate real-time kinetic measurements under anaerobic…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  488. Tian M et al. (2011). [Studies on the core functional region of antimicrobial peptide LL-37 for inhibition… [PMID: 22338223]

    Laboratory literature summary: [Studies on the core functional region of antimicrobial peptide LL-37 for inhibition of RSV replication]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  489. Park HJ et al. (2010). Vitamin C attenuates ERK signalling to inhibit the regulation of collagen production… [PMID: 20163451]

    Laboratory literature summary: Vitamin C attenuates ERK signalling to inhibit the regulation of collagen production by LL-37 in research subjects dermal fibroblasts. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  490. Dudal S et al. (2006). Release of LL-37 by activated research subjects Vgamma9Vdelta2 T cells: a microbicidal… [PMID: 17015740]

    Laboratory literature summary: Release of LL-37 by activated research subjects Vgamma9Vdelta2 T cells: a microbicidal weapon against Brucella suis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  491. Brannon JR et al. (2013). Role of uropathogenic Escherichia coli OmpT in the resistance against research… [PMID: 23710656]

    Laboratory literature summary: Role of uropathogenic Escherichia coli OmpT in the resistance against research subjects cathelicidin LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  492. Zhang Z et al. (2013). Acceleration of bone repair in NOD/SCID mice by research subjects monoosteophils,… [PMID: 23844045]

    Laboratory literature summary: Acceleration of bone repair in NOD/SCID mice by research subjects monoosteophils, novel LL-37-activated monocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  493. Ooi EH et al. (2007). Fungal allergens induce cathelicidin LL-37 expression in chronic rhinosinusitis… [PMID: 17621825]

    Laboratory literature summary: Fungal allergens induce cathelicidin LL-37 expression in chronic rhinosinusitis research subjects in a nasal explant model. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  494. De Santis M et al. (2019). Humoral Response Against LL-37 in Psoriatic Disease: Comment on the Article by Yuan et al [PMID: 31207181]

    Laboratory literature summary: Humoral Response Against LL-37 in Psoriatic Disease: Comment on the Article by Yuan et al. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  495. Ba Q et al. (2026). Laboratory research record on LL-37 (Cathelicidin) [PMID: 41653943]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  496. Nyberg P et al. (2004). Alpha2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing… [PMID: 15520011]

    Laboratory literature summary: alpha2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  497. Mallbris L et al. (2010). Injury downregulates the expression of the research subjects cathelicidin protein… [PMID: 19645825]

    Laboratory literature summary: Injury downregulates the expression of the research subjects cathelicidin protein hCAP18/LL-37 in atopic dermatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  498. Liang ZY et al. (2012). [Post-investigational change of cathelicidin LL-37 in asthmatics of different… [PMID: 22781454]

    Laboratory literature summary: [Post-investigational change of cathelicidin LL-37 in asthmatics of different inflammatory phenotypes]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  499. Wang G et al. (2012). Decoding the functional roles of cationic side chains of the major antimicrobial… [PMID: 22083479]

    Laboratory literature summary: Decoding the functional roles of cationic side chains of the major antimicrobial region of research subjects cathelicidin LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  500. Sasaki H et al. (2016). A case of rosacea fulminans staining negative for LL-37 [PMID: 26642927]

    Laboratory literature summary: A case of rosacea fulminans staining negative for LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  501. Verma SC et al. (2024). Cathelicidin antimicrobial peptide expression in neutrophils and neurons… [PMID: 39656548]

    Laboratory literature summary: Cathelicidin antimicrobial peptide expression in neutrophils and neurons antagonistically modulates neuroinflammation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  502. Chromek M et al. (2006). The antimicrobial peptide cathelicidin protects the urinary tract against invasive… [PMID: 16751768]

    Laboratory literature summary: The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  503. Agier J et al. (2015). Cathelicidin impact on inflammatory cells [PMID: 26557038]

    Laboratory literature summary: Cathelicidin impact on inflammatory cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  504. Bhatt T et al. (2023). Niacinamide enhances cathelicidin mediated SARS-CoV-2 membrane disruption [PMID: 38022563]

    Laboratory literature summary: Niacinamide enhances cathelicidin mediated SARS-CoV-2 membrane disruption. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  505. Zhang Q et al. (2023). Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation [PMID: 37090695]

    Laboratory literature summary: Role of antimicrobial peptide cathelicidin in thrombosis and thromboinflammation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  506. Wang G et al. (2022). Laboratory research record on LL-37 (Cathelicidin) [PMID: 36425652]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  507. Korucu E et al. (2015). Cathelicidin as a link between sarcoidosis and tuberculosis [PMID: 26422567]

    Laboratory literature summary: Cathelicidin as a link between sarcoidosis and tuberculosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  508. Popa AD et al. (2024). Cathelicidin: Insights into Its Impact on Metabolic Syndrome and Chronic Inflammation [PMID: 39728453]

    Laboratory literature summary: Cathelicidin: Insights into Its Impact on Metabolic Syndrome and Chronic Inflammation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  509. Ho J et al. (2020). Cathelicidin preserves intestinal barrier function in polymicrobial sepsis [PMID: 32041659]

    Laboratory literature summary: Cathelicidin preserves intestinal barrier function in polymicrobial sepsis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  510. Minns D et al. (2021). The neutrophil antimicrobial peptide cathelicidin promotes Th17 differentiation [PMID: 33627652]

    Laboratory literature summary: The neutrophil antimicrobial peptide cathelicidin promotes Th17 differentiation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  511. Zhai T et al. (2023). Cathelicidin promotes liver repair after acetaminophen-induced liver injury in mice [PMID: 36923240]

    Laboratory literature summary: Cathelicidin promotes liver repair after acetaminophen-induced liver injury in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  512. Tokajuk J et al. (2022). Cathelicidin LL-37 in Health and Diseases of the Oral Cavity [PMID: 35625823]

    Laboratory literature summary: Cathelicidin LL-37 in Health and Diseases of the Oral Cavity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  513. Zhai T et al. (2020). Cathelicidin deficiency exacerbates cardiac dysfunction in lipopolysaccharide-induced… [PMID: 31868940]

    Laboratory literature summary: Cathelicidin deficiency exacerbates cardiac dysfunction in lipopolysaccharide-induced endotoxaemic mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  514. Peng M et al. (2021). Laboratory research record on LL-37 (Cathelicidin) [PMID: 34585633]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  515. Xie W et al. (2023). Laboratory research record on LL-37 (Cathelicidin) [PMID: 37194247]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  516. Chung C et al. (2020). Vitamin D-Cathelicidin Axis: at the Crossroads between Protective Immunity and… [PMID: 32395364]

    Laboratory literature summary: Vitamin D-Cathelicidin Axis: at the Crossroads between Protective Immunity and Pathological Inflammation during Infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  517. Wu WK et al. (2014). The Janus face of cathelicidin in tumorigenesis [PMID: 24524763]

    Laboratory literature summary: The Janus face of cathelicidin in tumorigenesis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  518. Benjamin AB et al. (2022). Observed endpoints of Cathelicidin-Mimetic Antimicrobial Peptoids against… [PMID: 35467395]

    Laboratory literature summary: observed endpoints of Cathelicidin-Mimetic Antimicrobial Peptoids against Staphylococcus aureus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  519. Javed A et al. (2024). Antimicrobial and immunomodulatory activities of porcine cathelicidin Protegrin-1 [PMID: 39094445]

    Laboratory literature summary: Antimicrobial and immunomodulatory activities of porcine cathelicidin Protegrin-1. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  520. Crauwels P et al. (2019). Cathelicidin Contributes to the Restriction of Leishmania in research subjects Host… [PMID: 31824492]

    Laboratory literature summary: Cathelicidin Contributes to the Restriction of Leishmania in research subjects Host Macrophages. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  521. Hou X et al. (2024). Cathelicidin boosts the antifungal activity of neutrophils and improves prognosis… [PMID: 38501672]

    Laboratory literature summary: Cathelicidin boosts the antifungal activity of neutrophils and improves prognosis during Aspergillus fumigatus keratitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  522. Alford MA et al. (2020). Cathelicidin Host Defense Peptides and Inflammatory Signaling: Striking a Balance [PMID: 32982998]

    Laboratory literature summary: Cathelicidin Host Defense Peptides and Inflammatory Signaling: Striking a Balance. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  523. Chou HC et al. (2019). Cathelicidin attenuates hyperoxia-induced kidney injury in newborn rats [PMID: 31424299]

    Laboratory literature summary: Cathelicidin attenuates hyperoxia-induced kidney injury in newborn rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  524. Howell MD et al. (2006). Cathelicidin deficiency predisposes to eczema herpeticum [PMID: 16630942]

    Laboratory literature summary: Cathelicidin deficiency predisposes to eczema herpeticum. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  525. Argentina F et al. (2023). A Comparison of Cathelicidin Levels in the Skin of Leprosy research subjects and Their… [PMID: 38407086]

    Laboratory literature summary: A Comparison of Cathelicidin Levels in the Skin of Leprosy research subjects and Their Household Contacts. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  526. Schneider VA et al. (2016). Imaging the antimicrobial mechanism(s) of cathelicidin-2 [PMID: 27624595]

    Laboratory literature summary: Imaging the antimicrobial mechanism(s) of cathelicidin-2. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  527. van Eijk M et al. (2020). Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds [PMID: 32236485]

    Laboratory literature summary: Cathelicidin-inspired antimicrobial peptides as novel antifungal compounds. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  528. Patras KA et al. (2020). Host Cathelicidin Exacerbates Group B Streptococcus Urinary Tract Infection [PMID: 32321824]

    Laboratory literature summary: Host Cathelicidin Exacerbates Group B Streptococcus Urinary Tract Infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  529. Chou HC et al. (2022). Cathelicidin Attenuates Hyperoxia-Induced Lung Injury by Inhibiting Ferroptosis in… [PMID: 36552613]

    Laboratory literature summary: Cathelicidin Attenuates Hyperoxia-Induced Lung Injury by Inhibiting Ferroptosis in Newborn Rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  530. Katsafadou AI et al. (2019). Detection of Cathelicidin-1 in the Milk as an Early Indicator of Mastitis in Ewes [PMID: 31795190]

    Laboratory literature summary: Detection of Cathelicidin-1 in the Milk as an Early Indicator of Mastitis in Ewes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  531. Jiang JS et al. (2020). Cathelicidin attenuates hyperoxia-induced lung injury by inhibiting oxidative stress… [PMID: 32057991]

    Laboratory literature summary: Cathelicidin attenuates hyperoxia-induced lung injury by inhibiting oxidative stress in newborn rats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  532. Bourganou MV et al. (2023). Unique Peptides of Cathelicidin-1 in the Early Detection of Mastitis-In Silico Analysis [PMID: 37373309]

    Laboratory literature summary: Unique Peptides of Cathelicidin-1 in the Early Detection of Mastitis-In Silico Analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  533. Peng L et al. (2022). Chicken cathelicidin-2 promotes NLRP3 inflammasome activation in macrophages [PMID: 36064470]

    Laboratory literature summary: Chicken cathelicidin-2 promotes NLRP3 inflammasome activation in macrophages. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  534. Bei Y et al. (2019). Cathelicidin-related antimicrobial peptide protects against myocardial… [PMID: 30782145]

    Laboratory literature summary: Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  535. Burkes RM et al. (2019). Plasma cathelicidin and longitudinal lung function in current and former smokers [PMID: 30811465]

    Laboratory literature summary: Plasma cathelicidin and longitudinal lung function in current and former smokers. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  536. Wang J et al. (2019). Cathelicidin Suppresses Colon oncology research models Metastasis via a… [PMID: 30847383]

    Laboratory literature summary: Cathelicidin Suppresses Colon oncology research models Metastasis via a P2RX7-Dependent Mechanism. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  537. Bhusal A et al. (2022). Cathelicidin-Related Antimicrobial Peptide Negatively Regulates Bacterial… [PMID: 36497142]

    Laboratory literature summary: Cathelicidin-Related Antimicrobial Peptide Negatively Regulates Bacterial Endotoxin-Induced Glial Activation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  538. Sharma A et al. (2025). Cathelicidin-1 as a potential biomarker for anestrus detection in cows [PMID: 41200376]

    Laboratory literature summary: Cathelicidin-1 as a potential biomarker for anestrus detection in cows. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  539. Cristelo C et al. (2021). Laboratory research record on LL-37 (Cathelicidin) [PMID: 33263562]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  540. Liu Z et al. (2022). Endogenous cathelicidin is required for protection against ZIKV-caused testis damage… [PMID: 35038500]

    Laboratory literature summary: Endogenous cathelicidin is required for protection against ZIKV-caused testis damage via inactivating virons. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  541. Zanetti M et al. (2002). Cathelicidin peptides as candidates for a novel class of antimicrobials [PMID: 11945171]

    Laboratory literature summary: Cathelicidin peptides as candidates for a novel class of antimicrobials. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  542. Holani R et al. (2020). Cathelicidin-mediated lipopolysaccharide signaling via intracellular TLR4 in colonic… [PMID: 32658599]

    Laboratory literature summary: Cathelicidin-mediated lipopolysaccharide signaling via intracellular TLR4 in colonic epithelial cells evokes CXCL8 production. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  543. Guo X et al. (2023). Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection [PMID: 37342565]

    Laboratory literature summary: Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  544. van Dijk A et al. (2022). Innate Immune Training of research subjects Macrophages by Cathelicidin Analogs [PMID: 35958593]

    Laboratory literature summary: Innate Immune Training of research subjects Macrophages by Cathelicidin Analogs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  545. da Silva BHCS et al. (2021). Cathelicidin protects mice from Rhabdomyolysis-induced Acute Kidney Injury [PMID: 33456345]

    Laboratory literature summary: Cathelicidin protects mice from Rhabdomyolysis-induced Acute Kidney Injury. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  546. Huang LH et al. (2023). Cathelicidin Antimicrobial Peptide Acts as a oncology research models Suppressor in… [PMID: 37958632]

    Laboratory literature summary: Cathelicidin Antimicrobial Peptide Acts as a oncology research models Suppressor in Hepatocellular Carcinoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  547. Chromek M (2015). The role of the antimicrobial peptide cathelicidin in renal diseases [PMID: 25159719]

    Laboratory literature summary: The role of the antimicrobial peptide cathelicidin in renal diseases. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  548. Amagai R et al. (2023). The Antimicrobial Peptide Cathelicidin Exerts Immunomodulatory Effects via Scavenger… [PMID: 36614313]

    Laboratory literature summary: The Antimicrobial Peptide Cathelicidin Exerts Immunomodulatory Effects via Scavenger Receptors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  549. Mahmoud MM et al. (2022). Anticancer activity of chicken cathelicidin peptides against different types of… [PMID: 35449320]

    Laboratory literature summary: Anticancer activity of chicken cathelicidin peptides against different types of oncology research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  550. Lindow JC et al. (2016). Cathelicidin Insufficiency in research subjects with Fatal Leptospirosis [PMID: 27812211]

    Laboratory literature summary: Cathelicidin Insufficiency in research subjects with Fatal Leptospirosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  551. Cao X et al. (2018). Laboratory research record on LL-37 (Cathelicidin) [PMID: 29343843]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  552. Golec M et al. (2022). A Scoping Analysis of Cathelicidin in Response to Organic Dust Exposure and Related… [PMID: 36012117]

    Laboratory literature summary: A Scoping Analysis of Cathelicidin in Response to Organic Dust Exposure and Related Chronic Lung Illnesses. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  553. Jackmann N et al. (2022). The research subjects cathelicidin hCAP-18 in serum of children with… [PMID: 35849644]

    Laboratory literature summary: The research subjects cathelicidin hCAP-18 in serum of children with haemato-oncological diseases. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  554. Vaccaro JA et al. (2022). Cathelicidin Mediates an Anti-Inflammatory Role of Active Vitamin D (Calcitriol)… [PMID: 35444957]

    Laboratory literature summary: Cathelicidin Mediates an Anti-Inflammatory Role of Active Vitamin D (Calcitriol) During M. paratuberculosis Infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  555. Ding A et al. (2026). Cathelicidin antimicrobial peptides: current progress and future prospects in… [PMID: 42229867]

    Laboratory literature summary: Cathelicidin antimicrobial peptides: current progress and future prospects in immunotherapy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  556. Holani R et al. (2016). Proline-arginine rich (PR-39) cathelicidin: Structure, expression and functional… [PMID: 27865272]

    Laboratory literature summary: Proline-arginine rich (PR-39) cathelicidin: Structure, expression and functional implication in intestinal health. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  557. Espejo C et al. (2022). Cathelicidin-3 Associated With Serum Extracellular Vesicles Enables Early analytical… [PMID: 35422813]

    Laboratory literature summary: Cathelicidin-3 Associated With Serum Extracellular Vesicles Enables Early analytical assessment of a Transmissible oncology research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  558. Dong X et al. (2023). High expression of antimicrobial peptides cathelicidin-BF in Pichia pastoris and… [PMID: 37362941]

    Laboratory literature summary: High expression of antimicrobial peptides cathelicidin-BF in Pichia pastoris and verification of its activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  559. Soehnlein O et al. (2011). Neutrophil-derived cathelicidin protects from neointimal hyperplasia [PMID: 21974936]

    Laboratory literature summary: Neutrophil-derived cathelicidin protects from neointimal hyperplasia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  560. Xing M et al. (2020). Snake Cathelicidin Derived Peptide Inhibits Zika Virus Infection [PMID: 32849457]

    Laboratory literature summary: Snake Cathelicidin Derived Peptide Inhibits Zika Virus Infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  561. Fan T et al. (2024). Cathelicidin peptide analogues inhibit EV71 infection through blocking viral entry and… [PMID: 38271479]

    Laboratory literature summary: Cathelicidin peptide analogues inhibit EV71 infection through blocking viral entry and uncoating. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  562. Herr C et al. (2007). The role of cathelicidin and defensins in pulmonary inflammatory diseases [PMID: 17727333]

    Laboratory literature summary: The role of cathelicidin and defensins in pulmonary inflammatory diseases. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  563. Zhu Y et al. (2023). Protective effect of additional cathelicidin antimicrobial peptide PR-39 on… [PMID: 37144863]

    Laboratory literature summary: Protective effect of additional cathelicidin antimicrobial peptide PR-39 on prosthetic-joint infections. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  564. Benson R et al. (2023). Vitamin D attenuates biofilm-associated infections via immunomodulation and… [PMID: 36440493]

    Laboratory literature summary: Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  565. Krawiec P et al. (2021). Cathelicidin – A Novel Potential Marker of Pediatric Inflammatory Bowel Disease [PMID: 33519224]

    Laboratory literature summary: Cathelicidin – A Novel Potential Marker of Pediatric Inflammatory Bowel Disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  566. Frew L et al. (2014). Research subjects cathelicidin production by the cervix [PMID: 25089904]

    Laboratory literature summary: research subjects cathelicidin production by the cervix. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  567. Hemshekhar M et al. (2020). Cathelicidin and Calprotectin Are Disparately Altered in Murine Models of Inflammatory… [PMID: 32973796]

    Laboratory literature summary: Cathelicidin and Calprotectin Are Disparately Altered in Murine Models of Inflammatory Arthritis and Airway Inflammation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  568. Chow JY et al. (2013). Cathelicidin a potential investigational peptide for gastrointestinal inflammation and… [PMID: 23687409]

    Laboratory literature summary: Cathelicidin a potential investigational peptide for gastrointestinal inflammation and oncology research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  569. Wu J et al. (2018). Laboratory research record on LL-37 (Cathelicidin) [PMID: 30045878]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  570. Höpfinger A et al. (2023). Regulation of Cathelicidin Antimicrobial Peptide (CAMP) Gene Expression by TNFα and… [PMID: 37958808]

    Laboratory literature summary: Regulation of Cathelicidin Antimicrobial Peptide (CAMP) Gene Expression by TNFα and cfDNA in Adipocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  571. Blower RJ et al. (2018). Cathelicidin peptide rescues G. mellonella infected with B. anthracis [PMID: 28272976]

    Laboratory literature summary: Cathelicidin peptide rescues G. mellonella infected with B. anthracis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  572. Dissanayake S et al. (2023). Flow-Based Fmoc-SPPS Preparation and SAR Study of Cathelicidin-PY Reveals Selective… [PMID: 36838983]

    Laboratory literature summary: Flow-Based Fmoc-SPPS Preparation and SAR Study of Cathelicidin-PY Reveals Selective Antimicrobial Activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  573. Wang G et al. (2021). Cathelicidin antimicrobial peptide (CAMP) gene promoter methylation induces… [PMID: 33892795]

    Laboratory literature summary: Cathelicidin antimicrobial peptide (CAMP) gene promoter methylation induces chondrocyte apoptosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  574. Travis SM et al. (2000). Bactericidal activity of mammalian cathelicidin-derived peptides [PMID: 10768969]

    Laboratory literature summary: Bactericidal activity of mammalian cathelicidin-derived peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  575. Guo X et al. (2023). Corrigendum: Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1… [PMID: 37560519]

    Laboratory literature summary: Corrigendum: Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  576. Lemieszek MK et al. (2021). Beneficial impact of cathelicidin on hypersensitivity pneumonitis investigation-In… [PMID: 33999928]

    Laboratory literature summary: Beneficial impact of cathelicidin on hypersensitivity pneumonitis investigation-In vivo studies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  577. Höpfinger A et al. (2024). Cathelicidin Antimicrobial Peptide Levels in Atherosclerosis and Myocardial Infarction… [PMID: 38474156]

    Laboratory literature summary: Cathelicidin Antimicrobial Peptide Levels in Atherosclerosis and Myocardial Infarction in Mice and research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  578. Shinnar AE et al. (2003). Cathelicidin family of antimicrobial peptides: proteolytic processing and protease… [PMID: 14613764]

    Laboratory literature summary: Cathelicidin family of antimicrobial peptides: proteolytic processing and protease resistance. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  579. Lee J et al. (2020). Cathelicidin-Related Antimicrobial Peptide Regulates CD73 Expression in Mouse Th17… [PMID: 32604872]

    Laboratory literature summary: Cathelicidin-Related Antimicrobial Peptide Regulates CD73 Expression in Mouse Th17 Cells via p38. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  580. Davidson DJ et al. (2005). Letting the CAThelicidin out of the bag, as a investigational modulator of the… [PMID: 15755499]

    Laboratory literature summary: Letting the CAThelicidin out of the bag, as a investigational modulator of the adaptive immune system. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  581. Mu L et al. (2017). The first identified cathelicidin from tree frogs possesses anti-inflammatory and… [PMID: 28593346]

    Laboratory literature summary: The first identified cathelicidin from tree frogs possesses anti-inflammatory and partial LPS neutralization activities. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  582. Cândido ES et al. (2026). Cathelicidin-like Peptide for Resistant Acinetobacter baumannii Control [PMID: 41594114]

    Laboratory literature summary: Cathelicidin-like Peptide for Resistant Acinetobacter baumannii Control. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  583. Addis MF et al. (2016). Evaluation of milk cathelicidin for detection of bovine mastitis [PMID: 27522416]

    Laboratory literature summary: Evaluation of milk cathelicidin for detection of bovine mastitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  584. Gennaro R et al. (2000). Structural features and biological activities of the cathelicidin-derived… [PMID: 10931440]

    Laboratory literature summary: Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  585. Zingkou E et al. (2020). Cathelicidin represents a new target for manipulation of skin inflammation in… [PMID: 32442469]

    Laboratory literature summary: Cathelicidin represents a new target for manipulation of skin inflammation in Netherton syndrome. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  586. Liang W et al. (2022). Intestinal Cathelicidin Antimicrobial Peptide Shapes a Protective Neonatal Gut… [PMID: 34973295]

    Laboratory literature summary: Intestinal Cathelicidin Antimicrobial Peptide Shapes a Protective Neonatal Gut Microbiota Against Pancreatic Autoimmunity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  587. Sonawane A et al. (2011). Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages [PMID: 21790937]

    Laboratory literature summary: Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  588. Peng L et al. (2020). The immunomodulatory effect of cathelicidin-B1 on chicken macrophages [PMID: 32972448]

    Laboratory literature summary: The immunomodulatory effect of cathelicidin-B1 on chicken macrophages. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  589. van Dijk A et al. (2005). CMAP27, a novel chicken cathelicidin-like antimicrobial protein [PMID: 15963828]

    Laboratory literature summary: CMAP27, a novel chicken cathelicidin-like antimicrobial protein. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  590. Shi Y et al. (2020). Laboratory research record on LL-37 (Cathelicidin) [PMID: 32363280]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  591. Bourganou MV et al. (2025). Detection of Cathelicidin-1 and Cathelicidin-2 Biomolecules in the Milk of Goats and… [PMID: 40805091]

    Laboratory literature summary: Detection of Cathelicidin-1 and Cathelicidin-2 Biomolecules in the Milk of Goats and Their Use as Biomarkers for the analytical…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  592. Biondi B et al. (2023). Structural and biological characterization of shortened derivatives of the… [PMID: 37704689]

    Laboratory literature summary: Structural and biological characterization of shortened derivatives of the cathelicidin PMAP-36. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  593. Xia X et al. (2023). The synergy of thanatin and cathelicidin-BF-15a3 combats Escherichia coli O157:H7 [PMID: 36459817]

    Laboratory literature summary: The synergy of thanatin and cathelicidin-BF-15a3 combats Escherichia coli O157:H7. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  594. Cheng M et al. (2015). Cathelicidin suppresses colon oncology research models development by inhibition of… [PMID: 25565877]

    Laboratory literature summary: Cathelicidin suppresses colon oncology research models development by inhibition of oncology research models associated fibroblasts. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  595. Zhang L et al. (2016). Critical Role of Antimicrobial Peptide Cathelicidin for Controlling Helicobacter… [PMID: 26800870]

    Laboratory literature summary: Critical Role of Antimicrobial Peptide Cathelicidin for Controlling Helicobacter pylori Survival and Infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  596. Li F et al. (2020). Cathelicidin-related antimicrobial peptide alleviates alcoholic liver disease through… [PMID: 33245573]

    Laboratory literature summary: Cathelicidin-related antimicrobial peptide alleviates alcoholic liver disease through inhibiting inflammasome activation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  597. van Eijk M et al. (2021). PepBiotics, novel cathelicidin-inspired antimicrobials to fight pulmonary bacterial… [PMID: 34147544]

    Laboratory literature summary: PepBiotics, novel cathelicidin-inspired antimicrobials to fight pulmonary bacterial infections. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  598. Otazo-Pérez A et al. (2022). Antimicrobial Activity of Cathelicidin-Derived Peptide from the Iberian Mole Talpa… [PMID: 35891269]

    Laboratory literature summary: Antimicrobial Activity of Cathelicidin-Derived Peptide from the Iberian Mole Talpa occidentalis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  599. Srisaikham S et al. (2016). Goat cathelicidin-2 is secreted by blood leukocytes regardless of lipopolysaccharide… [PMID: 26212721]

    Laboratory literature summary: Goat cathelicidin-2 is secreted by blood leukocytes regardless of lipopolysaccharide stimulation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  600. Cubeddu T et al. (2017). Cathelicidin production and release by mammary epithelial cells during infectious mastitis [PMID: 28669389]

    Laboratory literature summary: Cathelicidin production and release by mammary epithelial cells during infectious mastitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  601. Yang Y et al. (2022). A non-bactericidal cathelicidin provides prophylactic observed endpoints against… [PMID: 35195067]

    Laboratory literature summary: A non-bactericidal cathelicidin provides prophylactic observed endpoints against bacterial infection by driving phagocyte influx. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  602. Yu J et al. (2021). Cathelicidin antimicrobial peptides suppress EV71 infection via regulating antiviral… [PMID: 33508330]

    Laboratory literature summary: Cathelicidin antimicrobial peptides suppress EV71 infection via regulating antiviral response and inhibiting viral binding. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  603. Wang C et al. (2021). Research subjects Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with… [PMID: 33849267]

    Laboratory literature summary: research subjects Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  604. Addis MF et al. (2016). Evaluation of milk cathelicidin for detection of dairy sheep mastitis [PMID: 27265177]

    Laboratory literature summary: Evaluation of milk cathelicidin for detection of dairy sheep mastitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  605. Sørensen OE (2005). The research subjects cathelicidin hCAP-18 [PMID: 16009068]

    Laboratory literature summary: The research subjects cathelicidin hCAP-18. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  606. Lee SI et al. (2016). Transcriptional regulation of cathelicidin genes in chicken bone marrow cells [PMID: 26908883]

    Laboratory literature summary: Transcriptional regulation of cathelicidin genes in chicken bone marrow cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  607. Mishra B et al. (2016). Anti-Staphylococcal Biofilm Effects of research subjects Cathelicidin Peptides [PMID: 26819677]

    Laboratory literature summary: Anti-Staphylococcal Biofilm Effects of research subjects Cathelicidin Peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  608. Gad GI et al. (2015). Analytical assessment value of anti-microbial peptide, cathelicidin in congenital… [PMID: 25354286]

    Laboratory literature summary: analytical assessment value of anti-microbial peptide, cathelicidin in congenital pneumonia. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  609. Koon HW et al. (2011). Cathelicidin signaling via the Toll-like receptor protects against colitis in mice [PMID: 21762664]

    Laboratory literature summary: Cathelicidin signaling via the Toll-like receptor protects against colitis in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  610. Addis MF et al. (2017). Relationship between milk cathelicidin abundance and microbiologic culture in… [PMID: 28131570]

    Laboratory literature summary: Relationship between milk cathelicidin abundance and microbiologic culture in laboratory mastitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  611. El Mahdi AR et al. (2025). Assessment of serum cathelicidin in chronic spontaneous urticaria research subjects [PMID: 40285744]

    Laboratory literature summary: Assessment of serum cathelicidin in chronic spontaneous urticaria research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  612. Wang S et al. (2023). Identification and Characterization of a Novel Cathelicidin from Hydrophis… [PMID: 36903328]

    Laboratory literature summary: Identification and Characterization of a Novel Cathelicidin from Hydrophis cyanocinctus with Antimicrobial and Anti-Inflammatory Activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  613. Machado A et al. (2022). Parenteral-route administration hydrogel as a carrier of vancomycin and a… [PMID: 36082973]

    Laboratory literature summary: parenteral-route administration hydrogel as a carrier of vancomycin and a cathelicidin-derived peptide for osteomyelitis investigation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  614. Nakagawa Y et al. (2015). Endogenous intracellular cathelicidin enhances TLR9 activation in dendritic cells and… [PMID: 25548223]

    Laboratory literature summary: Endogenous intracellular cathelicidin enhances TLR9 activation in dendritic cells and macrophages. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  615. Xia X et al. (2015). The antimicrobial peptide cathelicidin-BF could be a potential investigational for… [PMID: 25644952]

    Laboratory literature summary: The antimicrobial peptide cathelicidin-BF could be a potential investigational for Salmonella typhimurium infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  616. Li L et al. (2021). Cathelicidin LL37 Promotes Osteogenic Differentiation in vitro and Bone Regeneration… [PMID: 34012955]

    Laboratory literature summary: Cathelicidin LL37 Promotes Osteogenic Differentiation in vitro and Bone Regeneration in vivo. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  617. Ruiz-Tagle C et al. (2023). Vitamin D and cathelicidin levels and susceptibility to Mycobacterium tuberculosis… [PMID: 36707289]

    Laboratory literature summary: Vitamin D and cathelicidin levels and susceptibility to Mycobacterium tuberculosis infection acquisition in household contacts. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  618. Simora RMC et al. (2021). Effectiveness of Cathelicidin Antimicrobial Peptide against Ictalurid Catfish… [PMID: 34121235]

    Laboratory literature summary: Effectiveness of Cathelicidin Antimicrobial Peptide against Ictalurid Catfish Bacterial Pathogens. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  619. Hao X et al. (2012). Amphibian cathelicidin fills the evolutionary gap of cathelicidin in vertebrate [PMID: 22009138]

    Laboratory literature summary: Amphibian cathelicidin fills the evolutionary gap of cathelicidin in vertebrate. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  620. Braff MH et al. (2005). Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies [PMID: 15675959]

    Laboratory literature summary: Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  621. Wang Y et al. (2008). Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics [PMID: 18795096]

    Laboratory literature summary: Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  622. Cai S et al. (2021). Laboratory research record on LL-37 (Cathelicidin) [PMID: 33049300]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  623. Hoang-Yen Tran D et al. (2016). Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the… [PMID: 27163748]

    Laboratory literature summary: Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  624. Savonius O et al. (2018). Cerebrospinal Fluid Cathelicidin Correlates With the Bacterial Load and Outcomes in… [PMID: 28827496]

    Laboratory literature summary: Cerebrospinal Fluid Cathelicidin Correlates With the Bacterial Load and Outcomes in Childhood Bacterial Meningitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  625. Smolenski GA et al. (2011). The abundance of milk cathelicidin proteins during bovine mastitis [PMID: 21774993]

    Laboratory literature summary: The abundance of milk cathelicidin proteins during bovine mastitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  626. Peel E et al. (2021). Koala cathelicidin PhciCath5 has antimicrobial activity, including against Chlamydia… [PMID: 33852625]

    Laboratory literature summary: Koala cathelicidin PhciCath5 has antimicrobial activity, including against Chlamydia pecorum. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  627. Tedde V et al. (2019). Milk cathelicidin and somatic cell counts in dairy goats along the course of lactation [PMID: 31156071]

    Laboratory literature summary: Milk cathelicidin and somatic cell counts in dairy goats along the course of lactation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  628. Takahashi T et al. (2018). Cathelicidin promotes inflammation by enabling binding of self-RNA to cell surface… [PMID: 29507358]

    Laboratory literature summary: Cathelicidin promotes inflammation by enabling binding of self-RNA to cell surface scavenger receptors. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  629. Jana J et al. (2013). Research subjects cathelicidin peptide LL37 binds telomeric G-quadruplex [PMID: 23636272]

    Laboratory literature summary: research subjects cathelicidin peptide LL37 binds telomeric G-quadruplex. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  630. Chai J et al. (2021). Characterization and functional analysis of cathelicidin-MH, a novel frog-derived… [PMID: 33875135]

    Laboratory literature summary: Characterization and functional analysis of cathelicidin-MH, a novel frog-derived peptide with anti-septicemic properties. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  631. Mascarenhas NL et al. (2017). TRPV4 Mediates Mast Cell Activation in Cathelicidin-Induced Rosacea Inflammation [PMID: 27908695]

    Laboratory literature summary: TRPV4 Mediates Mast Cell Activation in Cathelicidin-Induced Rosacea Inflammation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  632. Mátis G et al. (2024). Immunomodulatory properties of chicken cathelicidin-2 investigated on an ileal explant… [PMID: 38871866]

    Laboratory literature summary: Immunomodulatory properties of chicken cathelicidin-2 investigated on an ileal explant culture. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  633. Höpfinger A et al. (2023). Circulating Levels of Cathelicidin Antimicrobial Peptide (CAMP) Are Affected by Oral… [PMID: 37447348]

    Laboratory literature summary: Circulating Levels of Cathelicidin Antimicrobial Peptide (CAMP) Are Affected by Oral Lipid Ingestion. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  634. Frasca L et al. (2012). Role of defensins and cathelicidin LL37 in auto-immune and auto-inflammatory diseases [PMID: 22250708]

    Laboratory literature summary: Role of defensins and cathelicidin LL37 in auto-immune and auto-inflammatory diseases. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  635. Danka ES et al. (2015). Cathelicidin augments epithelial receptivity and pathogenesis in experimental… [PMID: 25336727]

    Laboratory literature summary: Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  636. Yu Y et al. (2020). Engineered research subjects Cathelicidin Antimicrobial Peptides Inhibit Ebola Virus… [PMID: 32252021]

    Laboratory literature summary: Engineered research subjects Cathelicidin Antimicrobial Peptides Inhibit Ebola Virus Infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  637. Liggins MC et al. (2019). Retinoids Enhance the Expression of Cathelicidin Antimicrobial Peptide during Reactive… [PMID: 31420464]

    Laboratory literature summary: Retinoids Enhance the Expression of Cathelicidin Antimicrobial Peptide during Reactive Dermal Adipogenesis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  638. Donati M et al. (2007). Sensitivity of Chlamydia suis to cathelicidin peptides [PMID: 17391870]

    Laboratory literature summary: Sensitivity of Chlamydia suis to cathelicidin peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  639. Salamah MF et al. (2020). The Antimicrobial Cathelicidin CRAMP Augments Platelet Activation during Psoriasis in Mice [PMID: 32887440]

    Laboratory literature summary: The Antimicrobial Cathelicidin CRAMP Augments Platelet Activation during Psoriasis in Mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  640. Donati M et al. (2005). Activity of cathelicidin peptides against Chlamydia spp [PMID: 15728927]

    Laboratory literature summary: Activity of cathelicidin peptides against Chlamydia spp. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  641. Li D et al. (2014). Expression of the antimicrobial peptide cathelicidin in myeloid cells is required for… [PMID: 23812430]

    Laboratory literature summary: Expression of the antimicrobial peptide cathelicidin in myeloid cells is required for lung oncology research models growth. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  642. Li D et al. (2015). Cathelicidin, an antimicrobial peptide produced by macrophages, promotes colon… [PMID: 25596747]

    Laboratory literature summary: Cathelicidin, an antimicrobial peptide produced by macrophages, promotes colon oncology research models by activating the Wnt/β-catenin…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  643. Park J et al. (2025). Cathelicidin antimicrobial peptides mediate immune protection in marsupial neonates [PMID: 40238884]

    Laboratory literature summary: Cathelicidin antimicrobial peptides mediate immune protection in marsupial neonates. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  644. Broekman DC et al. (2013). Differential regulation of cathelicidin in salmon and cod [PMID: 23727282]

    Laboratory literature summary: Differential regulation of cathelicidin in salmon and cod. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  645. Zhu M et al. (2025). A mini-review on cathelicidin in fish: Gene expression, immune function, and… [PMID: 40441664]

    Laboratory literature summary: A mini-review on cathelicidin in fish: Gene expression, immune function, and evolutionary insights. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  646. Yu H et al. (2017). Cathelicidin-trypsin inhibitor loop conjugate represents a promising antibiotic… [PMID: 28572668]

    Laboratory literature summary: Cathelicidin-trypsin inhibitor loop conjugate represents a promising antibiotic candidate with protease stability. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  647. Deng Z et al. (2021). A positive feedback loop between mTORC1 and cathelicidin promotes skin inflammation in… [PMID: 33734592]

    Laboratory literature summary: A positive feedback loop between mTORC1 and cathelicidin promotes skin inflammation in rosacea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  648. Kajale N et al. (2020). Serum Cathelicidin Concentrations in Healthy Rural Indian School Going Children [PMID: 32297131]

    Laboratory literature summary: Serum Cathelicidin Concentrations in Healthy Rural Indian School Going Children. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  649. Di Nardo A et al. (2007). Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic… [PMID: 17237433]

    Laboratory literature summary: Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  650. Zhang L et al. (2013). Cathelicidin protects against Helicobacter pylori colonization and the associated… [PMID: 23254369]

    Laboratory literature summary: Cathelicidin protects against Helicobacter pylori colonization and the associated gastritis in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  651. Schromm AB et al. (2021). Cathelicidin and PMB neutralize endotoxins by multifactorial mechanisms including LPS… [PMID: 34183393]

    Laboratory literature summary: Cathelicidin and PMB neutralize endotoxins by multifactorial mechanisms including LPS interaction and targeting of host cell membranes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  652. Horibe K et al. (2013). Roles of cathelicidin-related antimicrobial peptide in murine osteoclastogenesis [PMID: 23826736]

    Laboratory literature summary: Roles of cathelicidin-related antimicrobial peptide in murine osteoclastogenesis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  653. Barna BP et al. (2012). Alveolar macrophage cathelicidin deficiency in severe sarcoidosis [PMID: 22759465]

    Laboratory literature summary: Alveolar macrophage cathelicidin deficiency in severe sarcoidosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  654. Pei Y et al. (2024). A Cyclic Peptide Based on Pheasant Cathelicidin Inhibits Influenza A H1N1 Virus Infection [PMID: 39061288]

    Laboratory literature summary: A Cyclic Peptide Based on Pheasant Cathelicidin Inhibits Influenza A H1N1 Virus Infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  655. Yan X et al. (2012). The cathelicidin-like peptide derived from panda genome is a potential antimicrobial… [PMID: 22101189]

    Laboratory literature summary: The cathelicidin-like peptide derived from panda genome is a potential antimicrobial peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  656. Wu W et al. (2018). Cathelicidin-WA attenuates LPS-induced inflammation and redox imbalance through… [PMID: 30273672]

    Laboratory literature summary: Cathelicidin-WA attenuates LPS-induced inflammation and redox imbalance through activation of AMPK signaling. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  657. Zhou X et al. (2024). Laboratory research record on LL-37 (Cathelicidin) [PMID: 38295541]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  658. Yuk JM et al. (2009). Vitamin D3 induces autophagy in research subjects monocytes/macrophages via cathelicidin [PMID: 19748465]

    Laboratory literature summary: Vitamin D3 induces autophagy in research subjects monocytes/macrophages via cathelicidin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  659. Cai S et al. (2018). Python Cathelicidin CATHPb1 Protects against Multidrug-Resistant Staphylococcal… [PMID: 29466000]

    Laboratory literature summary: Python Cathelicidin CATHPb1 Protects against Multidrug-Resistant Staphylococcal Infections by Antimicrobial-Immunomodulatory Duality. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  660. Fodor CC et al. (2022). Systemic murine cathelicidin CRAMP safely attenuated colonic neutrophil infiltration… [PMID: 35640361]

    Laboratory literature summary: Systemic murine cathelicidin CRAMP safely attenuated colonic neutrophil infiltration in pigs. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  661. Lu Z et al. (2010). Novel cathelicidin-derived antimicrobial peptides from Equus asinus [PMID: 20423460]

    Laboratory literature summary: Novel cathelicidin-derived antimicrobial peptides from Equus asinus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  662. Santana FL et al. (2022). Novel Alligator Cathelicidin As-CATH8 Demonstrates Anti-Infective Activity against… [PMID: 36421248]

    Laboratory literature summary: Novel Alligator Cathelicidin As-CATH8 Demonstrates Anti-Infective Activity against Clinically Relevant and Crocodylian Bacterial Pathogens. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  663. Reinholz M et al. (2012). Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease [PMID: 22577261]

    Laboratory literature summary: Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  664. Hasegawa K et al. (2017). Serum cathelicidin, nasopharyngeal microbiota, and disease severity among infants… [PMID: 27845236]

    Laboratory literature summary: Serum cathelicidin, nasopharyngeal microbiota, and disease severity among infants hospitalized with bronchiolitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  665. Selvaraj P (2011). Vitamin D, vitamin D receptor, and cathelicidin in the investigation of tuberculosis [PMID: 21419277]

    Laboratory literature summary: Vitamin D, vitamin D receptor, and cathelicidin in the investigation of tuberculosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  666. Chromek M et al. (2012). The antimicrobial peptide cathelicidin protects mice from Escherichia coli… [PMID: 23077510]

    Laboratory literature summary: The antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  667. Boucher E et al. (2021). Peritoneal macrophages are impaired in cathelicidin-deficient mice systemically… [PMID: 33496883]

    Laboratory literature summary: Peritoneal macrophages are impaired in cathelicidin-deficient mice systemically challenged with Escherichia coli. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  668. Fijałkowska M et al. (2021). Elevated serum levels of cathelicidin and β-defensin 2 are associated with basal cell… [PMID: 34764808]

    Laboratory literature summary: Elevated serum levels of cathelicidin and β-defensin 2 are associated with basal cell carcinoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  669. Lee PH et al. (2005). Expression of an additional cathelicidin antimicrobial peptide protects against… [PMID: 15728389]

    Laboratory literature summary: Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  670. Whelehan CJ et al. (2014). Characterisation and expression profile of the bovine cathelicidin gene repertoire in… [PMID: 24524771]

    Laboratory literature summary: Characterisation and expression profile of the bovine cathelicidin gene repertoire in mammary tissue. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  671. Oliveira NGJ et al. (2020). Physicochemical-guided design of cathelicidin-derived peptides generates membrane… [PMID: 32499582]

    Laboratory literature summary: Physicochemical-guided design of cathelicidin-derived peptides generates membrane active variants with investigational potential. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  672. Wantha S et al. (2013). Neutrophil-derived cathelicidin promotes adhesion of classical monocytes [PMID: 23283724]

    Laboratory literature summary: Neutrophil-derived cathelicidin promotes adhesion of classical monocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  673. Li Y et al. (2018). Research subjects Metapneumovirus Infection Inhibits Cathelicidin Antimicrobial… [PMID: 29780383]

    Laboratory literature summary: research subjects Metapneumovirus Infection Inhibits Cathelicidin Antimicrobial Peptide Expression in research subjects Macrophages. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  674. Li CH et al. (2015). Cathelicidin modulates the function of monocytes/macrophages via the P2X7 receptor in… [PMID: 26525517]

    Laboratory literature summary: Cathelicidin modulates the function of monocytes/macrophages via the P2X7 receptor in a teleost, Plecoglossus altivelis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  675. Wang S et al. (2021). Cathelicidin-WA Protects Against LPS-Induced Gut Damage Through Enhancing Survival and… [PMID: 34381773]

    Laboratory literature summary: Cathelicidin-WA Protects Against LPS-Induced Gut Damage Through Enhancing Survival and Function of Intestinal Stem Cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  676. Park K et al. (2013). Resveratrol stimulates sphingosine-1-phosphate signaling of cathelicidin production [PMID: 23856934]

    Laboratory literature summary: Resveratrol stimulates sphingosine-1-phosphate signaling of cathelicidin production. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  677. Sahoo BR et al. (2017). Mechanistic and structural basis of bioengineered bovine Cathelicidin-5 with optimized… [PMID: 28322271]

    Laboratory literature summary: Mechanistic and structural basis of bioengineered bovine Cathelicidin-5 with optimized investigational activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  678. Wong CC et al. (2017). Cathelicidin-encoding Lactococcus lactis promotes mucosal repair in murine… [PMID: 27470075]

    Laboratory literature summary: Cathelicidin-encoding Lactococcus lactis promotes mucosal repair in murine experimental colitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  679. He M et al. (2018). Cathelicidin-Derived Antimicrobial Peptides Inhibit Zika Virus Through Direct… [PMID: 29706959]

    Laboratory literature summary: Cathelicidin-Derived Antimicrobial Peptides Inhibit Zika Virus Through Direct Inactivation and Interferon Pathway. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  680. Wang Y et al. (2011). Cathelicidin-BF, a snake cathelicidin-derived antimicrobial peptide, could be an… [PMID: 21789223]

    Laboratory literature summary: Cathelicidin-BF, a snake cathelicidin-derived antimicrobial peptide, could be an excellent investigational agent for acne vulgaris. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  681. Zhang Y et al. (2010). Structure-function relationship of king cobra cathelicidin [PMID: 20576537]

    Laboratory literature summary: Structure-function relationship of king cobra cathelicidin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  682. Lee SG et al. (2022). 17BIPHE2, an engineered cathelicidin antimicrobial peptide with low susceptibility to… [PMID: 36053257]

    Laboratory literature summary: 17BIPHE2, an engineered cathelicidin antimicrobial peptide with low susceptibility to proteases, is an effective spermicide and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  683. Blower RJ et al. (2015). Snake Cathelicidin NA-CATH and Smaller Helical Antimicrobial Peptides Are Effective… [PMID: 26196513]

    Laboratory literature summary: Snake Cathelicidin NA-CATH and Smaller Helical Antimicrobial Peptides Are Effective against Burkholderia thailandensis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  684. González-Acosta S et al. (2025). Exploring diversity in avian immune defence: Insights from cathelicidin clusters [PMID: 40127729]

    Laboratory literature summary: Exploring diversity in avian immune defence: Insights from cathelicidin clusters. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  685. Tan YL et al. (2026). Endogenous cathelicidin protects against Toxoplasma gondii-associated liver damage [PMID: 41728969]

    Laboratory literature summary: Endogenous cathelicidin protects against Toxoplasma gondii-associated liver damage. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  686. Simonetti O et al. (2021). Observed endpoints of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model [PMID: 34680791]

    Laboratory literature summary: observed endpoints of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  687. Mohammed I et al. (2019). Cathelicidin-Derived Synthetic Peptide Improves investigational Potential of… [PMID: 31608030]

    Laboratory literature summary: Cathelicidin-Derived Synthetic Peptide Improves investigational Potential of Vancomycin Against Pseudomonas aeruginosa. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  688. Papadaki M et al. (2021). Cathelicidin levels in nasal secretions are associated with the severity of acute… [PMID: 33656266]

    Laboratory literature summary: Cathelicidin levels in nasal secretions are associated with the severity of acute bronchiolitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  689. Marin M et al. (2017). Cathelicidin modulates synthesis of Toll-like Receptors (TLRs) 4 and 9 in colonic… [PMID: 28988039]

    Laboratory literature summary: Cathelicidin modulates synthesis of Toll-like Receptors (TLRs) 4 and 9 in colonic epithelium. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  690. Höpfinger A et al. (2021). Regulation of CAMP (cathelicidin antimicrobial peptide) expression in adipocytes by… [PMID: 33509002]

    Laboratory literature summary: Regulation of CAMP (cathelicidin antimicrobial peptide) expression in adipocytes by TLR 2 and 4. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  691. Wang A et al. (2019). Characterization of a Cathelicidin from the Colubrinae Snake, Sinonatrix annularis [PMID: 31116540]

    Laboratory literature summary: Characterization of a Cathelicidin from the Colubrinae Snake, Sinonatrix annularis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  692. Hitt SJ et al. (2020). Komodo-dragon cathelicidin-inspired peptides are antibacterial against… [PMID: 33084564]

    Laboratory literature summary: Komodo-dragon cathelicidin-inspired peptides are antibacterial against carbapenem-resistant Klebsiella pneumoniae. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  693. Lisanby MW et al. (2008). Cathelicidin administration protects mice from Bacillus anthracis spore challenge [PMID: 18802102]

    Laboratory literature summary: Cathelicidin administration protects mice from Bacillus anthracis spore challenge. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  694. Peng L et al. (2020). Antiviral Activity of Chicken Cathelicidin B1 Against Influenza A Virus [PMID: 32265870]

    Laboratory literature summary: Antiviral Activity of Chicken Cathelicidin B1 Against Influenza A Virus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  695. Chen J et al. (2021). Molecular characterization of cathelicidin in tiger frog (Hoplobatrachus rugulosus):… [PMID: 33965586]

    Laboratory literature summary: Molecular characterization of cathelicidin in tiger frog (Hoplobatrachus rugulosus): Antimicrobial activity and immunomodulatory activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  696. Lindow JC et al. (2017). Correction: Cathelicidin Insufficiency in research subjects with Fatal Leptospirosis [PMID: 28950012]

    Laboratory literature summary: Correction: Cathelicidin Insufficiency in research subjects with Fatal Leptospirosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  697. Siednamohammeddeen N et al. (2022). The effect of gum Arabic supplementation on cathelicidin expression in monocyte… [PMID: 35650596]

    Laboratory literature summary: The effect of gum Arabic supplementation on cathelicidin expression in monocyte derived macrophages in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  698. Salamah MF et al. (2018). The endogenous antimicrobial cathelicidin LL37 induces platelet activation and… [PMID: 30413433]

    Laboratory literature summary: The endogenous antimicrobial cathelicidin LL37 induces platelet activation and augments thrombus formation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  699. Asadi A et al. (2020). Murine cathelicidin: as a host defensive response against Leishmania major infection [PMID: 32801517]

    Laboratory literature summary: Murine cathelicidin: as a host defensive response against Leishmania major infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  700. van Dijk A et al. (2016). Immunomodulatory and Anti-Inflammatory Activities of Chicken Cathelicidin-2 Derived… [PMID: 26848845]

    Laboratory literature summary: Immunomodulatory and Anti-Inflammatory Activities of Chicken Cathelicidin-2 Derived Peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  701. Säemann MD et al. (2007). Uncovering host defences in the urinary tract: cathelicidin and beyond [PMID: 17035368]

    Laboratory literature summary: Uncovering host defences in the urinary tract: cathelicidin and beyond. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  702. Li J et al. (2025). Cathelicidin-HG alleviates psoriasis by targeting glycoprotein VI to inhibit… [PMID: 39892446]

    Laboratory literature summary: Cathelicidin-HG alleviates psoriasis by targeting glycoprotein VI to inhibit platelet-neutrophil complexes formation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  703. Zhong L et al. (2020). Identification of a Novel Cathelicidin from the Deinagkistrodon acutus Genome with… [PMID: 33291852]

    Laboratory literature summary: Identification of a Novel Cathelicidin from the Deinagkistrodon acutus Genome with Antibacterial Activity by Multiple Mechanisms. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  704. Coorens M et al. (2015). Importance of Endosomal Cathelicidin Degradation To Enhance DNA-Induced Chicken… [PMID: 26378074]

    Laboratory literature summary: Importance of Endosomal Cathelicidin Degradation To Enhance DNA-Induced Chicken Macrophage Activation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  705. Baer B et al. (2020). Optimizing Exogenous Surfactant as a Pulmonary Delivery Vehicle for Chicken Cathelicidin-2 [PMID: 32523049]

    Laboratory literature summary: Optimizing Exogenous Surfactant as a Pulmonary Delivery Vehicle for Chicken Cathelicidin-2. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  706. Cai S et al. (2025). Exploring the Antimicrobial and Immunomodulatory Potential of Gecko-Derived… [PMID: 40723780]

    Laboratory literature summary: Exploring the Antimicrobial and Immunomodulatory Potential of Gecko-Derived Cathelicidin Gj-CATH5. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  707. Yamasaki K et al. (2007). Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea [PMID: 17676051]

    Laboratory literature summary: Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  708. Murakami M et al. (2002). Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva [PMID: 12454100]

    Laboratory literature summary: Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  709. Cafaro V et al. (2023). The Antimicrobial, Antibiofilm and Anti-Inflammatory Activities of P13#1, a… [PMID: 37895857]

    Laboratory literature summary: The Antimicrobial, Antibiofilm and Anti-Inflammatory Activities of P13#1, a Cathelicidin-like Achiral Peptoid. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  710. Molhoek EM et al. (2011). A cathelicidin-2-derived peptide effectively impairs Staphylococcus epidermidis biofilms [PMID: 21376541]

    Laboratory literature summary: A cathelicidin-2-derived peptide effectively impairs Staphylococcus epidermidis biofilms. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  711. Coorens M et al. (2017). Interspecies cathelicidin comparison reveals divergence in antimicrobial activity, TLR… [PMID: 28102367]

    Laboratory literature summary: Interspecies cathelicidin comparison reveals divergence in antimicrobial activity, TLR modulation, chemokine induction and regulation of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  712. Pound LD et al. (2015). Cathelicidin Antimicrobial Peptide: A Novel Regulator of Islet Function, Islet… [PMID: 26370175]

    Laboratory literature summary: Cathelicidin Antimicrobial Peptide: A Novel Regulator of Islet Function, Islet Regeneration, and Selected Gut Bacteria. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  713. López-García B et al. (2006). Expression and potential function of cathelicidin antimicrobial peptides in… [PMID: 16556635]

    Laboratory literature summary: Expression and potential function of cathelicidin antimicrobial peptides in dermatophytosis and tinea versicolor. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  714. LaRock CN et al. (2015). Group A Streptococcal M1 Protein Sequesters Cathelicidin to Evade Innate Immune Killing [PMID: 26468750]

    Laboratory literature summary: Group A Streptococcal M1 Protein Sequesters Cathelicidin to Evade Innate Immune Killing. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  715. Braff MH et al. (2005). Keratinocyte production of cathelicidin provides direct activity against bacterial… [PMID: 16177355]

    Laboratory literature summary: Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  716. Ezema CA et al. (2025). Amphibian-Derived Cathelicidin-DM and Cathelicidin-BG: Recombinant Overexpression in… [PMID: 40488015]

    Laboratory literature summary: Amphibian-Derived Cathelicidin-DM and Cathelicidin-BG: Recombinant Overexpression in Escherichia coli and Comparison of Their Structures…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  717. Sancho-Vaello E et al. (2017). Structural remodeling and oligomerization of research subjects cathelicidin on… [PMID: 29133814]

    Laboratory literature summary: Structural remodeling and oligomerization of research subjects cathelicidin on membranes suggest fibril-like structures as active species. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  718. Wu J et al. (2021). FM-CATH, A Novel Cathelicidin From Fejervarya Multistriata, Shows investigational… [PMID: 34483941]

    Laboratory literature summary: FM-CATH, A Novel Cathelicidin From Fejervarya Multistriata, Shows investigational Potential for investigation of CLP-Induced Sepsis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  719. Azim S et al. (2016). Venom peptides cathelicidin and lycotoxin cause strong inhibition of Escherichia coli… [PMID: 26930579]

    Laboratory literature summary: Venom peptides cathelicidin and lycotoxin cause strong inhibition of Escherichia coli ATP synthase. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  720. Leake I (2015). IBD: cathelicidin can reverse intestinal fibrosis in models of colitis [PMID: 25446730]

    Laboratory literature summary: IBD: cathelicidin can reverse intestinal fibrosis in models of colitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  721. Padhi A et al. (2019). Mycobacterium tuberculosis LprE Suppresses TLR2-Dependent Cathelicidin and Autophagy… [PMID: 31619537]

    Laboratory literature summary: Mycobacterium tuberculosis LprE Suppresses TLR2-Dependent Cathelicidin and Autophagy Expression to Enhance Bacterial Survival in Macrophages. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  722. Muto Y et al. (2014). Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea [PMID: 24844861]

    Laboratory literature summary: Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  723. Chen W et al. (2011). Structure-activity relationships of a snake cathelicidin-related peptide, BF-15 [PMID: 22008732]

    Laboratory literature summary: Structure-activity relationships of a snake cathelicidin-related peptide, BF-15. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  724. Iimura M et al. (2005). Cathelicidin mediates innate intestinal defense against colonization with epithelial… [PMID: 15814717]

    Laboratory literature summary: Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  725. Uruska A et al. (2017). Laboratory research record on LL-37 (Cathelicidin) [PMID: 28964758]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  726. Luan C et al. (2014). Expressing antimicrobial peptide cathelicidin-BF in Bacillus subtilis using SUMO… [PMID: 24121930]

    Laboratory literature summary: Expressing antimicrobial peptide cathelicidin-BF in Bacillus subtilis using SUMO technology. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  727. Cheng Y et al. (2015). Evolution of the avian β-defensin and cathelicidin genes [PMID: 26373713]

    Laboratory literature summary: Evolution of the avian β-defensin and cathelicidin genes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  728. Taniguchi M et al. (2026). Cathelicidin Links Visceral Fat Accumulation and Coronary Artery Disease [PMID: 41905956]

    Laboratory literature summary: Cathelicidin Links Visceral Fat Accumulation and Coronary Artery Disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  729. Gasanov V et al. (2024). Expression of the Antimicrobial Peptide SE-33-A2P, a Modified Analog of Cathelicidin,… [PMID: 38391576]

    Laboratory literature summary: Expression of the Antimicrobial Peptide SE-33-A2P, a Modified Analog of Cathelicidin, and an Analysis of Its Properties. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  730. Park BW et al. (2018). A Study on Vitamin D and Cathelicidin Status in research subjects with Rosacea: Serum… [PMID: 29606809]

    Laboratory literature summary: A Study on Vitamin D and Cathelicidin Status in research subjects with Rosacea: Serum Level and Tissue Expression. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  731. Shin KO et al. (2019). Both Sphingosine Kinase 1 and 2 Coordinately Regulate Cathelicidin Antimicrobial… [PMID: 30227139]

    Laboratory literature summary: Both Sphingosine Kinase 1 and 2 Coordinately Regulate Cathelicidin Antimicrobial Peptide Production during Keratinocyte Differentiation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  732. Grossi de Oliveira AL et al. (2020). Hypovitaminosis D and reduced cathelicidin are strongly correlated during the… [PMID: 32645421]

    Laboratory literature summary: Hypovitaminosis D and reduced cathelicidin are strongly correlated during the multidrug research protocol against leprosy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  733. Deng YY et al. (2016). Cathelicidin-related antimicrobial peptide modulates the severity of acute… [PMID: 27035328]

    Laboratory literature summary: Cathelicidin-related antimicrobial peptide modulates the severity of acute pancreatitis in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  734. Mihailovic PM et al. (2017). The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in… [PMID: 29091929]

    Laboratory literature summary: The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE(-/-) mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  735. Hu H et al. (2025). Study on the anticancer function and mechanism of cathelicidin-DM in liver oncology… [PMID: 40288464]

    Laboratory literature summary: Study on the anticancer function and mechanism of cathelicidin-DM in liver oncology research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  736. Pashaie F et al. (2025). PMAP-37: A versatile cathelicidin for neutralizing bacteria and viruses [PMID: 40228754]

    Laboratory literature summary: PMAP-37: A versatile cathelicidin for neutralizing bacteria and viruses. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  737. Xia R et al. (2024). Insight into the inhibitory activity and mechanism of bovine cathelicidin BMAP 27… [PMID: 38190945]

    Laboratory literature summary: Insight into the inhibitory activity and mechanism of bovine cathelicidin BMAP 27 against Salmonella Typhimurium. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  738. Song JJ et al. (2006). Expression of cathelicidin in recurrent throat infection [PMID: 16146658]

    Laboratory literature summary: Expression of cathelicidin in recurrent throat infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  739. Haiwen Z et al. (2019). Cathelicidin- derived PR39 protects enterohemorrhagic Escherichia coli O157:H7… [PMID: 31263234]

    Laboratory literature summary: Cathelicidin- derived PR39 protects enterohemorrhagic Escherichia coli O157:H7 challenged mice by improving epithelial function and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  740. Çekmez Y et al. (2015). The analytical assessment Role of Vitamin D and Cathelicidin Levels in Pelvic… [PMID: 26882809]

    Laboratory literature summary: The analytical assessment Role of Vitamin D and Cathelicidin Levels in Pelvic Inflammatory Disease. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  741. Di Nardo A et al. (2008). Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus… [PMID: 18490758]

    Laboratory literature summary: Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  742. Yisihaer H et al. (2025). Elephant Cathelicidin-Derived Peptides Inhibit Herpes Simplex Virus 1 Infection [PMID: 40723958]

    Laboratory literature summary: Elephant Cathelicidin-Derived Peptides Inhibit Herpes Simplex Virus 1 Infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  743. Pence MA et al. (2015). Beta-Lactamase Repressor BlaI Modulates Staphylococcus aureus Cathelicidin… [PMID: 26305782]

    Laboratory literature summary: Beta-Lactamase Repressor BlaI Modulates Staphylococcus aureus Cathelicidin Antimicrobial Peptide Resistance and Virulence. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  744. Choi KY et al. (2012). Multiple immune-modulatory functions of cathelicidin host defense peptides [PMID: 22701455]

    Laboratory literature summary: Multiple immune-modulatory functions of cathelicidin host defense peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  745. Chen Q et al. (2025). An Anionic Cathelicidin Exerts Antimelanoma Effects in Mice by Promoting Pyroptosis [PMID: 40207383]

    Laboratory literature summary: An Anionic Cathelicidin Exerts Antimelanoma Effects in Mice by Promoting Pyroptosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  746. Kumagai S et al. (2013). Cathelicidin antimicrobial peptide inhibits fibroblast migration via P2X7 receptor… [PMID: 23867818]

    Laboratory literature summary: Cathelicidin antimicrobial peptide inhibits fibroblast migration via P2X7 receptor signaling. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  747. Murakami M et al. (2002). Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for… [PMID: 12445197]

    Laboratory literature summary: Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  748. Braster Q et al. (2016). Cathelicidin regulates myeloid cell accumulation in adipose tissue and promotes… [PMID: 26939624]

    Laboratory literature summary: Cathelicidin regulates myeloid cell accumulation in adipose tissue and promotes insulin resistance during metabolic research models. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  749. Dilek F et al. (2016). Beyond anti-microbial properties: The role of cathelicidin in allergic rhinitis [PMID: 26777417]

    Laboratory literature summary: Beyond anti-microbial properties: The role of cathelicidin in allergic rhinitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  750. Foschiatti M et al. (2009). Inhibition of cathelicidin activity by bacterial exopolysaccharides [PMID: 19400793]

    Laboratory literature summary: Inhibition of cathelicidin activity by bacterial exopolysaccharides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  751. Xie Q et al. (2019). Antiviral activity of cathelicidin 5, a peptide from Alligator sinensis, against WSSV… [PMID: 31326585]

    Laboratory literature summary: Antiviral activity of cathelicidin 5, a peptide from Alligator sinensis, against WSSV in caridean shrimp Exopalaemon modestus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  752. Cai S et al. (2021). Suppressive effects of gecko cathelicidin on biofilm formation and cariogenic… [PMID: 34237581]

    Laboratory literature summary: Suppressive effects of gecko cathelicidin on biofilm formation and cariogenic virulence factors of Streptococcus mutans. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  753. Sun T et al. (2015). A novel cathelicidin from Bufo bufo gargarizans Cantor showed specific activity to its… [PMID: 26091834]

    Laboratory literature summary: A novel cathelicidin from Bufo bufo gargarizans Cantor showed specific activity to its habitat bacteria. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  754. Termén S et al. (2003). Phylogeny, processing and expression of the rat cathelicidin rCRAMP: a model for… [PMID: 12737313]

    Laboratory literature summary: Phylogeny, processing and expression of the rat cathelicidin rCRAMP: a model for innate antimicrobial peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  755. D'Aldebert E et al. (2009). Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in… [PMID: 19245866]

    Laboratory literature summary: Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the research subjects biliary epithelium. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  756. Peric M et al. (2009). VDR and MEK-ERK dependent induction of the antimicrobial peptide cathelicidin in… [PMID: 19733911]

    Laboratory literature summary: VDR and MEK-ERK dependent induction of the antimicrobial peptide cathelicidin in keratinocytes by lithocholic acid. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  757. Cuperus T et al. (2018). Immunomodulation and effects on microbiota after in ovo administration of chicken… [PMID: 29870564]

    Laboratory literature summary: Immunomodulation and effects on microbiota after in ovo administration of chicken cathelicidin-2. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  758. Wong JH et al. (2016). Antimicrobial activity of cathelicidin peptides and defensin against oral yeast and… [PMID: 29941692]

    Laboratory literature summary: Antimicrobial activity of cathelicidin peptides and defensin against oral yeast and bacteria. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  759. Huang LC et al. (2007). Cathelicidin-deficient (Cnlp -/- ) mice show increased susceptibility to Pseudomonas… [PMID: 17898271]

    Laboratory literature summary: Cathelicidin-deficient (Cnlp -/- ) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  760. Gupta S et al. (2017). Bacterial subversion of cAMP signalling inhibits cathelicidin expression, which is… [PMID: 28097645]

    Laboratory literature summary: Bacterial subversion of cAMP signalling inhibits cathelicidin expression, which is required for innate resistance to Mycobacterium…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  761. Mathias E et al. (2017). Association of vitamin D with cathelicidin and vitamin D binding protein in pediatric… [PMID: 29204370]

    Laboratory literature summary: Association of vitamin D with cathelicidin and vitamin D binding protein in pediatric sepsis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  762. Nourizadeh M et al. (2026). Immunomodulatory effects of cathelicidin in the gut-brain axis: A novel link between… [PMID: 41493387]

    Laboratory literature summary: Immunomodulatory effects of cathelicidin in the gut-brain axis: A novel link between mucosal immunity and neuroinflammation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  763. Ishige T et al. (2017). Characterization of the cathelicidin cluster in the Japanese quail (Coturnix japonica) [PMID: 28084024]

    Laboratory literature summary: Characterization of the cathelicidin cluster in the Japanese quail (Coturnix japonica). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  764. Leonard BC et al. (2011). Expression and activity of a novel cathelicidin from domestic cats [PMID: 21533281]

    Laboratory literature summary: Expression and activity of a novel cathelicidin from domestic cats. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  765. Bommineni YR et al. (2014). Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide [PMID: 24491488]

    Laboratory literature summary: Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  766. Morioka Y et al. (2008). Cathelicidin antimicrobial peptides inhibit hyaluronan-induced cytokine release and… [PMID: 18768846]

    Laboratory literature summary: Cathelicidin antimicrobial peptides inhibit hyaluronan-induced cytokine release and modulate chronic allergic dermatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  767. Guo YJ et al. (2017). Retraction Note: research subjects cathelicidin LL-37 enhance the antibiofilm effect… [PMID: 28651563]

    Laboratory literature summary: Retraction Note: research subjects cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  768. Hertting O et al. (2010). Vitamin D induction of the research subjects antimicrobial Peptide cathelicidin in the… [PMID: 21179490]

    Laboratory literature summary: Vitamin D induction of the research subjects antimicrobial Peptide cathelicidin in the urinary bladder. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  769. Jiang Y et al. (2025). Dodecapeptides derived from research subjects cathelicidin with potent activity… [PMID: 40056800]

    Laboratory literature summary: Dodecapeptides derived from research subjects cathelicidin with potent activity against carbapenem-resistant Acinetobacter baumannii. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  770. Chai J et al. (2026). Cathelicidin-Ka, the first frog-derived TLR2 and TLR4 agonist, induces macrophage… [PMID: 41540150]

    Laboratory literature summary: Cathelicidin-Ka, the first frog-derived TLR2 and TLR4 agonist, induces macrophage activation and promotes inflammation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  771. Lee JY et al. (2008). Salt-resistant homodimeric bactenecin, a cathelicidin-derived antimicrobial peptide [PMID: 18616463]

    Laboratory literature summary: Salt-resistant homodimeric bactenecin, a cathelicidin-derived antimicrobial peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  772. Park J et al. (2024). Marsupial immune protection is shaped by enhancer sharing and gene cluster duplication… [PMID: 39211247]

    Laboratory literature summary: Marsupial immune protection is shaped by enhancer sharing and gene cluster duplication of cathelicidin antimicrobial peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  773. Wuerth K et al. (2011). New insights into cathelicidin modulation of adaptive immunity [PMID: 21953640]

    Laboratory literature summary: New insights into cathelicidin modulation of adaptive immunity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  774. Schneider VA et al. (2016). Prophylactic administration of chicken cathelicidin-2 boosts zebrafish embryonic… [PMID: 26920462]

    Laboratory literature summary: Prophylactic administration of chicken cathelicidin-2 boosts zebrafish embryonic innate immunity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  775. Jung HH et al. (2003). Expression of a cathelicidin antimicrobial peptide is augmented in cholesteatoma [PMID: 12616192]

    Laboratory literature summary: Expression of a cathelicidin antimicrobial peptide is augmented in cholesteatoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  776. Peng H et al. (2017). Metabolic acidosis stimulates the production of the antimicrobial peptide cathelicidin… [PMID: 28747361]

    Laboratory literature summary: Metabolic acidosis stimulates the production of the antimicrobial peptide cathelicidin in rabbit urine. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  777. Rizvi A et al. (2023). Glycine fermentation by C. difficile promotes virulence and spore formation, and is… [PMID: 37754683]

    Laboratory literature summary: Glycine fermentation by C. difficile promotes virulence and spore formation, and is induced by host cathelicidin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  778. Cakir E et al. (2014). Cathelicidin and research subjects β-defensin 2 in bronchoalveolar lavage fluid of… [PMID: 24903937]

    Laboratory literature summary: Cathelicidin and research subjects β-defensin 2 in bronchoalveolar lavage fluid of children with pulmonary tuberculosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  779. Morgera F et al. (2009). Primate cathelicidin orthologues display different structures and membrane interactions [PMID: 18922132]

    Laboratory literature summary: Primate cathelicidin orthologues display different structures and membrane interactions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  780. Wang Y et al. (2020). [Preliminary study of antimicrobial peptide cathelicidin-PY research protocol in mice… [PMID: 32306659]

    Laboratory literature summary: [Preliminary study of antimicrobial peptide cathelicidin-PY research protocol in mice with acute liver failure]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  781. Felgentreff K et al. (2006). The antimicrobial peptide cathelicidin interacts with airway mucus [PMID: 16963160]

    Laboratory literature summary: The antimicrobial peptide cathelicidin interacts with airway mucus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  782. Broekman DC et al. (2011). Cod cathelicidin: isolation of the mature peptide, cleavage site characterisation and… [PMID: 20950641]

    Laboratory literature summary: Cod cathelicidin: isolation of the mature peptide, cleavage site characterisation and developmental expression. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  783. Cauchard S et al. (2016). Killing of Trypanozoon Parasites by the Equine Cathelicidin eCATH1 [PMID: 26824936]

    Laboratory literature summary: Killing of Trypanozoon Parasites by the Equine Cathelicidin eCATH1. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  784. Saiman L et al. (2001). Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from research… [PMID: 11557478]

    Laboratory literature summary: Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from research subjects with cystic fibrosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  785. Goitsuka R et al. (2007). Chicken cathelicidin-B1, an antimicrobial guardian at the mucosal M cell gateway [PMID: 17827276]

    Laboratory literature summary: Chicken cathelicidin-B1, an antimicrobial guardian at the mucosal M cell gateway. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  786. Zhang L et al. (2019). Genomic Identification and Expression Analysis of the Cathelicidin Gene Family of the… [PMID: 31344924]

    Laboratory literature summary: Genomic Identification and Expression Analysis of the Cathelicidin Gene Family of the Forest Musk Deer. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  787. Lee WJ et al. (2012). Vitamin D increases expression of cathelicidin in cultured sebocytes [PMID: 22695798]

    Laboratory literature summary: Vitamin D increases expression of cathelicidin in cultured sebocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  788. Donati M et al. (2011). Activity of Cathelicidin Peptides against Simkania negevensis [PMID: 21760820]

    Laboratory literature summary: Activity of Cathelicidin Peptides against Simkania negevensis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  789. Jangpromma N et al. (2023). Rational Design of RN15m4 Cathelin Domain-Based Peptides from Siamese Crocodile… [PMID: 36327032]

    Laboratory literature summary: Rational Design of RN15m4 Cathelin Domain-Based Peptides from Siamese Crocodile Cathelicidin Improves Antimicrobial Activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  790. Francis F et al. (2026). Interfacial activity and membrane interaction of Duttaphrynus melanostictus cathelicidin [PMID: 42462895]

    Laboratory literature summary: Interfacial activity and membrane interaction of Duttaphrynus melanostictus cathelicidin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  791. Su Y et al. (2019). Nanofiber Dressings Topically Delivering Molecularly Engineered research subjects… [PMID: 30916573]

    Laboratory literature summary: Nanofiber Dressings Topically Delivering Molecularly Engineered research subjects Cathelicidin Peptides for the investigation of…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  792. Cho CH et al. (2015). The role of cathelicidin in control of Helicobacter pylori colonisation in the stomach [PMID: 26157097]

    Laboratory literature summary: The role of cathelicidin in control of Helicobacter pylori colonisation in the stomach. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  793. Gao W et al. (2015). Identification of a novel cathelicidin antimicrobial peptide from ducks and… [PMID: 26608073]

    Laboratory literature summary: Identification of a novel cathelicidin antimicrobial peptide from ducks and determination of its functional activity and antibacterial…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  794. Tajbakhsh M et al. (2018). A Recombinant Snake Cathelicidin Derivative Peptide: Antibiofilm Properties and… [PMID: 30360422]

    Laboratory literature summary: A Recombinant Snake Cathelicidin Derivative Peptide: Antibiofilm Properties and Expression in Escherichia coli. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  795. Murakami T et al. (2007). Antibacterial cathelicidin peptide CAP11 suppresses the anandamide production from… [PMID: 17184778]

    Laboratory literature summary: Antibacterial cathelicidin peptide CAP11 suppresses the anandamide production from lipopolysaccharide-stimulated mononuclear phagocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  796. Cao X et al. (2018). Laboratory research record on LL-37 (Cathelicidin) [PMID: 30349056]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  797. Cabalín C et al. (2023). Oral vitamin D modulates the epidermal expression of the vitamin D receptor and… [PMID: 36273083]

    Laboratory literature summary: Oral vitamin D modulates the epidermal expression of the vitamin D receptor and cathelicidin in children with atopic dermatitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  798. Langer MN et al. (2017). Testing cathelicidin susceptibility of bacterial mastitis isolates: Technical… [PMID: 29103679]

    Laboratory literature summary: Testing cathelicidin susceptibility of bacterial mastitis isolates: Technical challenges and data output for laboratory isolates. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  799. Pinheiro da Silva F et al. (2009). Differing effects of exogenous or endogenous cathelicidin on macrophage toll-like… [PMID: 19350049]

    Laboratory literature summary: Differing effects of exogenous or endogenous cathelicidin on macrophage toll-like receptor signaling. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  800. Skerlavaj B et al. (2001). Structural and functional analysis of horse cathelicidin peptides [PMID: 11181349]

    Laboratory literature summary: Structural and functional analysis of horse cathelicidin peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  801. Woo JS et al. (2003). Expression of cathelicidin in research subjects salivary glands [PMID: 12578451]

    Laboratory literature summary: Expression of cathelicidin in research subjects salivary glands. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  802. Jiang Y et al. (2021). Alterations in Intestinal Microbiota Composition in Mice studied With Vitamin D3 or… [PMID: 35004267]

    Laboratory literature summary: Alterations in Intestinal Microbiota Composition in Mice studied With Vitamin D3 or Cathelicidin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  803. Benincasa M et al. (2006). Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts [PMID: 17023499]

    Laboratory literature summary: Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  804. Lu XJ et al. (2011). Identification and characterization of a novel cathelicidin from ayu, Plecoglossus… [PMID: 21397030]

    Laboratory literature summary: Identification and characterization of a novel cathelicidin from ayu, Plecoglossus altivelis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  805. de Latour FA et al. (2010). Antimicrobial activity of the Naja atra cathelicidin and related small peptides [PMID: 20438706]

    Laboratory literature summary: Antimicrobial activity of the Naja atra cathelicidin and related small peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  806. Mao X et al. (2021). Polysaccharides extract from Vaccaria segetalis seeds inhibits kidney infection by… [PMID: 33141055]

    Laboratory literature summary: Polysaccharides extract from Vaccaria segetalis seeds inhibits kidney infection by regulating cathelicidin expression. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  807. Zhu S et al. (2017). Positive selection in cathelicidin host defense peptides: adaptation to exogenous… [PMID: 27925615]

    Laboratory literature summary: Positive selection in cathelicidin host defense peptides: adaptation to exogenous pathogens or endogenous receptors?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  808. Lee CJ et al. (2014). Cathelicidin LL-37 and HSV-1 Corneal Infection: Peptide Versus Gene research protocol [PMID: 24932432]

    Laboratory literature summary: Cathelicidin LL-37 and HSV-1 Corneal Infection: Peptide Versus Gene research protocol. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  809. Wong JH et al. (2011). Antifungal action of research subjects cathelicidin fragment (LL13-37) on Candida albicans [PMID: 21889964]

    Laboratory literature summary: Antifungal action of research subjects cathelicidin fragment (LL13-37) on Candida albicans. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  810. Anderson RC et al. (2003). Isolation and characterisation of proline/arginine-rich cathelicidin peptides from… [PMID: 14651991]

    Laboratory literature summary: Isolation and characterisation of proline/arginine-rich cathelicidin peptides from ovine neutrophils. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  811. Koneru L et al. (2017). Mirolysin, a LysargiNase from Tannerella forsythia, proteolytically inactivates the… [PMID: 27997347]

    Laboratory literature summary: Mirolysin, a LysargiNase from Tannerella forsythia, proteolytically inactivates the research subjects cathelicidin, LL-37. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  812. Falcao CB et al. (2015). Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a… [PMID: 26465972]

    Laboratory literature summary: Structural Dissection of Crotalicidin, a Rattlesnake Venom Cathelicidin, Retrieves a Fragment with Antimicrobial and Antitumor Activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  813. Vasilyevna Belyaeva I et al. (2017). Vitamin D, Cathelicidin, Prolactin, Autoantibodies, and Cytokines in Different Forms… [PMID: 28825769]

    Laboratory literature summary: Vitamin D, Cathelicidin, Prolactin, Autoantibodies, and Cytokines in Different Forms of Pulmonary Tuberculosis versus Sarcoidosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  814. Wang Q et al. (2013). Effects of 25-hydroxyvitamin D3 on cathelicidin production and antibacterial function… [PMID: 23850962]

    Laboratory literature summary: Effects of 25-hydroxyvitamin D3 on cathelicidin production and antibacterial function of research subjects oral keratinocytes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  815. Shenao W et al. (2026). Resveratrol enhances duck cathelicidin expression in heterophilic granulocytes via… [PMID: 40778569]

    Laboratory literature summary: Resveratrol enhances duck cathelicidin expression in heterophilic granulocytes via MAPK-EGR1 signalling pathway. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  816. Fijałkowska M et al. (2022). Plasma concentrations of cathelicidin and β-defensins and their correlations in… [PMID: 35369619]

    Laboratory literature summary: Plasma concentrations of cathelicidin and β-defensins and their correlations in research subjects with basal cell carcinoma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  817. Boix-Lemonche G et al. (2020). Covalent grafting of titanium with a cathelicidin peptide produces an osteoblast… [PMID: 31644974]

    Laboratory literature summary: Covalent grafting of titanium with a cathelicidin peptide produces an osteoblast compatible surface with antistaphylococcal activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  818. Zhou Y et al. (2022). Sprouty1 exerts a preventive effect on the initiation of psoriasis by inhibiting… [PMID: 35716036]

    Laboratory literature summary: Sprouty1 exerts a preventive effect on the initiation of psoriasis by inhibiting innate immune antimicrobial peptide cathelicidin and…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  819. Scarsini M et al. (2015). Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures… [PMID: 26238597]

    Laboratory literature summary: Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  820. Coyle C et al. (2016). Ovine trophoblasts express cathelicidin host defence peptide in response to infection [PMID: 27348190]

    Laboratory literature summary: Ovine trophoblasts express cathelicidin host defence peptide in response to infection. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  821. Pompilio A et al. (2011). Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens… [PMID: 21849157]

    Laboratory literature summary: Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  822. Shaykhiev R et al. (2010). The antimicrobial peptide cathelicidin enhances activation of lung epithelial cells by LPS [PMID: 20696857]

    Laboratory literature summary: The antimicrobial peptide cathelicidin enhances activation of lung epithelial cells by LPS. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  823. Zelezetsky I et al. (2006). Evolution of the primate cathelicidin. Correlation between structural variations and… [PMID: 16720578]

    Laboratory literature summary: Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  824. van Dijk A et al. (2009). Identification of chicken cathelicidin-2 core elements involved in antibacterial and… [PMID: 19524300]

    Laboratory literature summary: Identification of chicken cathelicidin-2 core elements involved in antibacterial and immunomodulatory activities. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  825. Honda JR et al. (2015). Pathogenic nontuberculous mycobacteria resist and inactivate cathelicidin: implication… [PMID: 25993058]

    Laboratory literature summary: Pathogenic nontuberculous mycobacteria resist and inactivate cathelicidin: implication of a novel role for polar mycobacterial lipids. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  826. Puig-Basagoiti F et al. (2016). Research subjects Cathelicidin Compensates for the Role of Apolipoproteins in… [PMID: 27440892]

    Laboratory literature summary: research subjects Cathelicidin Compensates for the Role of Apolipoproteins in Hepatitis C Virus Infectious Particle Formation. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  827. Li L et al. (2014). Preparation, characterization, in vitro release and degradation of… [PMID: 24963652]

    Laboratory literature summary: Preparation, characterization, in vitro release and degradation of cathelicidin-BF-30-PLGA microspheres. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  828. Rode AKO et al. (2017). Vitamin D Counteracts Mycobacterium tuberculosis-Induced Cathelicidin Downregulation… [PMID: 28620394]

    Laboratory literature summary: Vitamin D Counteracts Mycobacterium tuberculosis-Induced Cathelicidin Downregulation in Dendritic Cells and Allows Th1 Differentiation…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  829. Zhang Y et al. (2013). The influence of cathelicidin LL37 in research subjects anti-neutrophils cytoplasmic… [PMID: 24286516]

    Laboratory literature summary: The influence of cathelicidin LL37 in research subjects anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  830. Tai EK et al. (2007). A new role for cathelicidin in ulcerative colitis in mice [PMID: 17526772]

    Laboratory literature summary: A new role for cathelicidin in ulcerative colitis in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  831. Murakami M et al. (2005). Expression and secretion of cathelicidin antimicrobial peptides in murine mammary… [PMID: 15531744]

    Laboratory literature summary: Expression and secretion of cathelicidin antimicrobial peptides in murine mammary glands and research subjects milk. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  832. Sato-Deguchi E et al. (2012). Topical vitamin D₃ analogues induce thymic stromal lymphopoietin and cathelicidin in… [PMID: 22384824]

    Laboratory literature summary: Topical vitamin D₃ analogues induce thymic stromal lymphopoietin and cathelicidin in psoriatic skin lesions. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  833. Tomasinsig L et al. (2010). Laboratory research record on LL-37 (Cathelicidin) [PMID: 26780897]

    PubMed laboratory record discussing LL-37 (Cathelicidin) in a research context. Review the full methods and limitations on PubMed; research use only.

  834. Bhan I et al. (2011). Circulating levels of 25-hydroxyvitamin D and research subjects cathelicidin in… [PMID: 21310475]

    Laboratory literature summary: Circulating levels of 25-hydroxyvitamin D and research subjects cathelicidin in healthy adults. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  835. Xiao Y et al. (2006). Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide… [PMID: 16817888]

    Laboratory literature summary: Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  836. Braff MH et al. (2007). Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during… [PMID: 17397009]

    Laboratory literature summary: Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  837. Frigimelica E et al. (2008). Identification of 2 hypothetical genes involved in Neisseria meningitidis cathelicidin… [PMID: 18462162]

    Laboratory literature summary: Identification of 2 hypothetical genes involved in Neisseria meningitidis cathelicidin resistance. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  838. Sanchez JF et al. (2002). Overexpression and structural study of the cathelicidin motif of the protegrin-3 precursor [PMID: 11771999]

    Laboratory literature summary: Overexpression and structural study of the cathelicidin motif of the protegrin-3 precursor. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  839. Yu FS et al. (2010). Flagellin stimulates protective lung mucosal immunity: role of cathelicidin-related… [PMID: 20566829]

    Laboratory literature summary: Flagellin stimulates protective lung mucosal immunity: role of cathelicidin-related antimicrobial peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  840. Chang CI et al. (2005). Identification of a novel cathelicidin gene in the rainbow trout, Oncorhynchus mykiss [PMID: 16041021]

    Laboratory literature summary: Identification of a novel cathelicidin gene in the rainbow trout, Oncorhynchus mykiss. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  841. Dhaliwal KK et al. (2015). In Silico Characterization of Functional Divergence of Two Cathelicidin Variants in… [PMID: 26380546]

    Laboratory literature summary: In Silico Characterization of Functional Divergence of Two Cathelicidin Variants in Indian Sheep. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  842. Giacometti A et al. (2003). In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicidin peptides [PMID: 12654759]

    Laboratory literature summary: In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicidin peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  843. Tambor V et al. (2012). Amniotic fluid cathelicidin in PPROM pregnancies: from proteomic discovery to… [PMID: 22815956]

    Laboratory literature summary: Amniotic fluid cathelicidin in PPROM pregnancies: from proteomic discovery to assessing its potential in inflammatory complications…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  844. Kanada KN et al. (2012). Doxycycline indirectly inhibits proteolytic activation of tryptic kallikrein-related… [PMID: 22336948]

    Laboratory literature summary: Doxycycline indirectly inhibits proteolytic activation of tryptic kallikrein-related peptidases and activation of cathelicidin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  845. Chen Q et al. (2026). Correction to "An Anionic Cathelicidin Exerts Antimelanoma Effects in Mice by… [PMID: 42023669]

    Laboratory literature summary: Correction to "An Anionic Cathelicidin Exerts Antimelanoma Effects in Mice by Promoting Pyroptosis". Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  846. Braff MH et al. (2005). Structure-function relationships among research subjects cathelicidin peptides:… [PMID: 15778390]

    Laboratory literature summary: Structure-function relationships among research subjects cathelicidin peptides: dissociation of antimicrobial properties from host…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  847. Bals R et al. (1999). Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide [PMID: 10531270]

    Laboratory literature summary: Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  848. Lauth X et al. (2009). M1 protein allows Group A streptococcal survival in phagocyte extracellular traps… [PMID: 20375578]

    Laboratory literature summary: M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  849. Wong CC et al. (2012). Protective effects of cathelicidin-encoding Lactococcus lactis in murine ulcerative… [PMID: 22507188]

    Laboratory literature summary: Protective effects of cathelicidin-encoding Lactococcus lactis in murine ulcerative colitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  850. Dorschner RA et al. (2001). Cutaneous injury induces the release of cathelicidin anti-microbial peptides active… [PMID: 11442754]

    Laboratory literature summary: Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  851. Akoh CC et al. (2017). Vitamin D mediates the relationship between placental cathelicidin and group B… [PMID: 28622535]

    Laboratory literature summary: Vitamin D mediates the relationship between placental cathelicidin and group B streptococcus colonization during developmental research…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  852. Robinson MW et al. (2012). A helminth cathelicidin-like protein suppresses antigen processing and presentation in… [PMID: 22872675]

    Laboratory literature summary: A helminth cathelicidin-like protein suppresses antigen processing and presentation in macrophages via inhibition of lysosomal vATPase. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  853. Liao H et al. (2026). Functional characterization of HR-CATH2, a novel cathelicidin from Hoplobatrachus… [PMID: 42267565]

    Laboratory literature summary: Functional characterization of HR-CATH2, a novel cathelicidin from Hoplobatrachus rugulosus with anti-sepsis activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  854. Di Nardo A et al. (2003). Cutting edge: mast cell antimicrobial activity is mediated by expression of… [PMID: 12594247]

    Laboratory literature summary: Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  855. Savonius O et al. (2016). Swiftly Decreasing Cerebrospinal Fluid Cathelicidin Concentration Predicts Improved… [PMID: 27008883]

    Laboratory literature summary: Swiftly Decreasing Cerebrospinal Fluid Cathelicidin Concentration Predicts Improved Outcome in Childhood Bacterial Meningitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  856. Bartlett KH et al. (2004). Reduction in the bactericidal activity of selected cathelicidin peptides by bovine… [PMID: 15194132]

    Laboratory literature summary: Reduction in the bactericidal activity of selected cathelicidin peptides by bovine calf serum or exogenous endotoxin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  857. Zhang H et al. (2017). Effects of cathelicidin-derived peptide from reptiles on lipopolysaccharide-induced… [PMID: 29042014]

    Laboratory literature summary: Effects of cathelicidin-derived peptide from reptiles on lipopolysaccharide-induced intestinal inflammation in weaned piglets. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  858. Scocchi M et al. (2005). Structural aspects and biological properties of the cathelicidin PMAP-36 [PMID: 16128809]

    Laboratory literature summary: Structural aspects and biological properties of the cathelicidin PMAP-36. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  859. Roh KB et al. (2020). Coptis chinensis Franch Directly Inhibits Proteolytic Activation of Kallikrein 5 and… [PMID: 33256158]

    Laboratory literature summary: Coptis chinensis Franch Directly Inhibits Proteolytic Activation of Kallikrein 5 and Cathelicidin Associated with Rosacea in Epidermal…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  860. Harper M et al. (2017). Characterization of Two Novel Lipopolysaccharide Phosphoethanolamine Transferases in… [PMID: 28874446]

    Laboratory literature summary: Characterization of Two Novel Lipopolysaccharide Phosphoethanolamine Transferases in Pasteurella multocida and Their Role in Resistance…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  861. Dhawan P et al. (2015). C/EBPα and the Vitamin D Receptor Cooperate in the Regulation of Cathelicidin in Lung… [PMID: 25078430]

    Laboratory literature summary: C/EBPα and the Vitamin D Receptor Cooperate in the Regulation of Cathelicidin in Lung Epithelial Cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  862. Brandenburg LO et al. (2013). CpG oligodeoxynucleotides induce the expression of the antimicrobial peptide… [PMID: 23141747]

    Laboratory literature summary: CpG oligodeoxynucleotides induce the expression of the antimicrobial peptide cathelicidin in glial cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  863. Basañez G et al. (2002). Interaction of hagfish cathelicidin antimicrobial peptides with model lipid membranes [PMID: 12459474]

    Laboratory literature summary: Interaction of hagfish cathelicidin antimicrobial peptides with model lipid membranes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  864. Maier VH et al. (2008). Characterisation of cathelicidin gene family members in divergent fish species [PMID: 18614236]

    Laboratory literature summary: Characterisation of cathelicidin gene family members in divergent fish species. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  865. Stoeckelhuber M et al. (2008). Immunolocalization of defensins and cathelicidin in research subjects glands of Moll [PMID: 18396392]

    Laboratory literature summary: Immunolocalization of defensins and cathelicidin in research subjects glands of Moll. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  866. Mansbach JM et al. (2012). Serum cathelicidin level is associated with viral etiology and severity of bronchiolitis [PMID: 22944482]

    Laboratory literature summary: Serum cathelicidin level is associated with viral etiology and severity of bronchiolitis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  867. Karadag R et al. (2017). An investigation of research subjects beta-defensins and cathelicidin expression in… [PMID: 29160535]

    Laboratory literature summary: An investigation of research subjects beta-defensins and cathelicidin expression in research subjects with pterygium. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  868. Jann NJ et al. (2009). Neutrophil antimicrobial defense against Staphylococcus aureus is mediated by… [PMID: 19638500]

    Laboratory literature summary: Neutrophil antimicrobial defense against Staphylococcus aureus is mediated by phagolysosomal but not extracellular trap-associated…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  869. Santos JC et al. (2014). Endogenous cathelicidin production limits inflammation and protective immunity to… [PMID: 25400920]

    Laboratory literature summary: Endogenous cathelicidin production limits inflammation and protective immunity to Mycobacterium avium in mice. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  870. Wong JH et al. (2011). Effects of cathelicidin and its fragments on three key enzymes of HIV-1 [PMID: 21539873]

    Laboratory literature summary: Effects of cathelicidin and its fragments on three key enzymes of HIV-1. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  871. Djanani A et al. (2006). Heparan sulfate proteoglycan-dependent neutrophil chemotaxis toward PR-39 cathelicidin [PMID: 17081280]

    Laboratory literature summary: Heparan sulfate proteoglycan-dependent neutrophil chemotaxis toward PR-39 cathelicidin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  872. Yu PL et al. (2010). Antimicrobial and immunomodulatory activities of an ovine proline/arginine-rich… [PMID: 20031378]

    Laboratory literature summary: Antimicrobial and immunomodulatory activities of an ovine proline/arginine-rich cathelicidin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  873. Acosta J et al. (2019). In vitro immunomodulatory activities of peptides derived from Salmo salar NK-lysin and… [PMID: 30885741]

    Laboratory literature summary: In vitro immunomodulatory activities of peptides derived from Salmo salar NK-lysin and cathelicidin in fish cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  874. Tajbakhsh M et al. (2018). The antimicrobial potential of a new derivative of cathelicidin from Bungarus… [PMID: 29392557]

    Laboratory literature summary: The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  875. Luo Y et al. (2026). Role of Disulfide Bond in Modulating the Antibacterial Activity and Structure of… [PMID: 41784724]

    Laboratory literature summary: Role of Disulfide Bond in Modulating the Antibacterial Activity and Structure of Cathelicidin-DM Peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  876. Halldórsdóttir K et al. (2015). Trans-species polymorphism at antimicrobial innate immunity cathelicidin genes of… [PMID: 26038731]

    Laboratory literature summary: Trans-species polymorphism at antimicrobial innate immunity cathelicidin genes of Atlantic cod and related species. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  877. Hata TR et al. (2008). Administration of oral vitamin D induces cathelicidin production in atopic individuals [PMID: 19014773]

    Laboratory literature summary: Administration of oral vitamin D induces cathelicidin production in atopic individuals. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  878. Zhan B et al. (2016). [Identification and bactericidal activity of a novel Cathelicidin family member from… [PMID: 28871684]

    Laboratory literature summary: [Identification and bactericidal activity of a novel Cathelicidin family member from skin of Bufu bufo gargarizans]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  879. Rinker SD et al. (2012). Permeases of the sap transporter are required for cathelicidin resistance and… [PMID: 22930807]

    Laboratory literature summary: Permeases of the sap transporter are required for cathelicidin resistance and virulence of Haemophilus ducreyi in research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  880. Yang ST et al. (2002). Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived… [PMID: 12207877]

    Laboratory literature summary: Conformation-dependent antibiotic activity of tritrpticin, a cathelicidin-derived antimicrobial peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  881. Sato E et al. (2013). Vitamin D-dependent cathelicidin inhibits Mycobacterium marinum infection in research… [PMID: 23452544]

    Laboratory literature summary: Vitamin D-dependent cathelicidin inhibits Mycobacterium marinum infection in research subjects monocytic cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  882. Das H et al. (2006). Cloning and characterization of novel cathelicidin cDNA sequence of Bubalus bubalis… [PMID: 17381041]

    Laboratory literature summary: Cloning and characterization of novel cathelicidin cDNA sequence of Bubalus bubalis homologous to Bos taurus cathelicidin-4. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  883. Takeda A et al. (2014). Bacterial toxin-inducible gene expression of cathelicidin-B1 in the chicken bursal… [PMID: 24984089]

    Laboratory literature summary: Bacterial toxin-inducible gene expression of cathelicidin-B1 in the chicken bursal lymphoma-derived cell line DT40: functional…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  884. Sørensen O et al. (1999). The research subjects antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in… [PMID: 10428818]

    Laboratory literature summary: The research subjects antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  885. Torun E et al. (2014). Intracellular cytokine and cathelicidin secretion from monocytes and neutrophils in… [PMID: 24104956]

    Laboratory literature summary: Intracellular cytokine and cathelicidin secretion from monocytes and neutrophils in childhood tuberculosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  886. Hollands A et al. (2012). A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin… [PMID: 23038245]

    Laboratory literature summary: A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin antimicrobial peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  887. Carman RL et al. (2008). Immunohistochemistry using antibodies to the cathelicidin LL37/hCAP18 in the tammar… [PMID: 18597803]

    Laboratory literature summary: Immunohistochemistry using antibodies to the cathelicidin LL37/hCAP18 in the tammar wallaby, Macropus eugenii. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  888. Zhu S et al. (2009). A fossil antibacterial peptide gives clues to structural diversity of… [PMID: 18796560]

    Laboratory literature summary: A fossil antibacterial peptide gives clues to structural diversity of cathelicidin-derived host defense peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  889. Sørensen O et al. (1997). An ELISA for hCAP-18, the cathelicidin present in research subjects neutrophils and plasma [PMID: 9328568]

    Laboratory literature summary: An ELISA for hCAP-18, the cathelicidin present in research subjects neutrophils and plasma. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  890. Achanta M et al. (2012). Tissue expression and developmental regulation of chicken cathelicidin antimicrobial… [PMID: 22958518]

    Laboratory literature summary: Tissue expression and developmental regulation of chicken cathelicidin antimicrobial peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  891. Daly KA et al. (2008). Identification, characterization and expression of cathelicidin in the pouch young of… [PMID: 18248751]

    Laboratory literature summary: Identification, characterization and expression of cathelicidin in the pouch young of tammar wallaby (Macropus eugenii). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  892. Sarker P et al. (2011). Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit… [PMID: 21673991]

    Laboratory literature summary: Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  893. Shewring DM et al. (2011). Analysis of the cathelicidin 1 gene locus in Atlantic cod (Gadus morhua) [PMID: 21176969]

    Laboratory literature summary: Analysis of the cathelicidin 1 gene locus in Atlantic cod (Gadus morhua). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  894. Hell E et al. (2010). Research subjects cathelicidin peptide LL37 inhibits both attachment capability and… [PMID: 20002576]

    Laboratory literature summary: research subjects cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  895. Bu HF et al. (2006). Lysozyme-modified probiotic components protect rats against polymicrobial sepsis: role… [PMID: 17142779]

    Laboratory literature summary: Lysozyme-modified probiotic components protect rats against polymicrobial sepsis: role of macrophages and cathelicidin-related innate…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  896. Mount KL et al. (2010). Haemophilus ducreyi SapA contributes to cathelicidin resistance and virulence in… [PMID: 20086092]

    Laboratory literature summary: Haemophilus ducreyi SapA contributes to cathelicidin resistance and virulence in research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  897. Morassutti C et al. (2005). Expression of SMAP-29 cathelicidin-like peptide in bacterial cells by intein-mediated… [PMID: 15642466]

    Laboratory literature summary: Expression of SMAP-29 cathelicidin-like peptide in bacterial cells by intein-mediated system. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  898. Sim SH et al. (2011). Antimicrobial activity of cathelicidin peptides against Burkholderia pseudomallei, the… [PMID: 21782393]

    Laboratory literature summary: Antimicrobial activity of cathelicidin peptides against Burkholderia pseudomallei, the causative agent of melioidosis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  899. Wu H et al. (1999). Cathelicidin gene expression in porcine tissues: roles in ontogeny and tissue specificity [PMID: 9864252]

    Laboratory literature summary: Cathelicidin gene expression in porcine tissues: roles in ontogeny and tissue specificity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  900. Khamlaiwong P et al. (2026). Functional diversity of cathelicidin peptides in the frog lung: An integrated… [PMID: 42413799]

    Laboratory literature summary: Functional diversity of cathelicidin peptides in the frog lung: An integrated transcriptomic and functional analysis. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  901. Cole AM et al. (2001). Inhibition of neutrophil elastase prevents cathelicidin activation and impairs… [PMID: 11133774]

    Laboratory literature summary: Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  902. Rogoll D et al. (2011). Differential cathelicidin expression in duodenal and gastric biopsies from Tanzanian… [PMID: 21811558]

    Laboratory literature summary: Differential cathelicidin expression in duodenal and gastric biopsies from Tanzanian and German research subjects. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  903. Scocchi M et al. (1997). Structural organization of the bovine cathelicidin gene family and identification of a… [PMID: 9409740]

    Laboratory literature summary: Structural organization of the bovine cathelicidin gene family and identification of a novel member. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  904. Saravanan R et al. (2011). Oligomeric structure of a cathelicidin antimicrobial peptide in dodecylphosphocholine… [PMID: 20933496]

    Laboratory literature summary: Oligomeric structure of a cathelicidin antimicrobial peptide in dodecylphosphocholine micelle determined by NMR spectroscopy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  905. Panicker VP et al. (2013). Identification of three novel myeloid cathelicidin cDNAs and their predicted peptides… [PMID: 24772945]

    Laboratory literature summary: Identification of three novel myeloid cathelicidin cDNAs and their predicted peptides in buffalo (Bubalus bubalis). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  906. Sørensen O et al. (1997). The research subjects antibacterial cathelicidin, hCAP-18, is synthesized in… [PMID: 9326247]

    Laboratory literature summary: The research subjects antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  907. Carman RL et al. (2009). Identification and expression of a novel marsupial cathelicidin from the tammar… [PMID: 19046773]

    Laboratory literature summary: Identification and expression of a novel marsupial cathelicidin from the tammar wallaby (Macropus eugenii). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  908. Andrushchenko VV et al. (2007). Interactions of tryptophan-rich cathelicidin antimicrobial peptides with model… [PMID: 17597579]

    Laboratory literature summary: Interactions of tryptophan-rich cathelicidin antimicrobial peptides with model membranes studied by differential scanning calorimetry. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  909. Yu K et al. (2002). Solution structure of a cathelicidin-derived antimicrobial peptide, CRAMP as… [PMID: 12081622]

    Laboratory literature summary: Solution structure of a cathelicidin-derived antimicrobial peptide, CRAMP as determined by NMR spectroscopy. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  910. Schauber J et al. (2008). Histone acetylation in keratinocytes enables control of the expression of cathelicidin… [PMID: 17943182]

    Laboratory literature summary: Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  911. Mak P et al. (2007). Menstrual hemocidin HbB115-146 is an acidophilic antibacterial peptide potentiating… [PMID: 17156194]

    Laboratory literature summary: Menstrual hemocidin HbB115-146 is an acidophilic antibacterial peptide potentiating the activity of research subjects defensins,…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  912. Ahluwalia A et al. (2013). Cathelicidin gene research protocol: a new investigational option in ulcerative… [PMID: 22456327]

    Laboratory literature summary: Cathelicidin gene research protocol: a new investigational option in ulcerative colitis and beyond?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  913. Choi SY et al. (2015). Modulating the internalization of bacille Calmette-Guérin by cathelicidin in bladder… [PMID: 25681250]

    Laboratory literature summary: Modulating the internalization of bacille Calmette-Guérin by cathelicidin in bladder oncology research models cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  914. Zhu S (2008). Positive selection targeting the cathelin-like domain of the antimicrobial… [PMID: 18322645]

    Laboratory literature summary: Positive selection targeting the cathelin-like domain of the antimicrobial cathelicidin family. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  915. Broekman DC et al. (2011). Functional characterization of codCath, the mature cathelicidin antimicrobial peptide… [PMID: 21945422]

    Laboratory literature summary: Functional characterization of codCath, the mature cathelicidin antimicrobial peptide from Atlantic cod (Gadus morhua). Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  916. Wang Y et al. (1998). Structure and activity of cathelicidin antibacterial proteins [PMID: 9723727]

    Laboratory literature summary: Structure and activity of cathelicidin antibacterial proteins. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  917. Yao Y et al. (2015). [Mechanisms of antimicrobial peptide cathelicidin secreted by non-tumorous cells for… [PMID: 26814107]

    Laboratory literature summary: [Mechanisms of antimicrobial peptide cathelicidin secreted by non-tumorous cells for lung oncology research models growth]. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  918. Andrushchenko VV et al. (2008). Thermodynamics of the interactions of tryptophan-rich cathelicidin antimicrobial… [PMID: 18222168]

    Laboratory literature summary: Thermodynamics of the interactions of tryptophan-rich cathelicidin antimicrobial peptides with model and natural membranes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  919. To KK et al. (2013). Reversal of ABCG2-mediated multidrug resistance by research subjects cathelicidin and… [PMID: 23274176]

    Laboratory literature summary: Reversal of ABCG2-mediated multidrug resistance by research subjects cathelicidin and its analogs in oncology research models cells. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  920. Feng F et al. (2011). Gene cloning, expression and characterization of avian cathelicidin orthologs,… [PMID: 21375690]

    Laboratory literature summary: Gene cloning, expression and characterization of avian cathelicidin orthologs, Cc-CATHs, from Coturnix coturnix. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  921. Weiner DJ et al. (2003). The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles… [PMID: 12600826]

    Laboratory literature summary: The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  922. Steinstraesser L et al. (2005). Inhibition of early steps in the lentiviral replication cycle by cathelicidin host… [PMID: 15656908]

    Laboratory literature summary: Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  923. Gillenwaters EN et al. (2009). Sequence analysis and polymorphism discovery in 4 members of the bovine cathelicidin… [PMID: 19136450]

    Laboratory literature summary: Sequence analysis and polymorphism discovery in 4 members of the bovine cathelicidin gene family. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  924. Cobo ER et al. (2012). Entamoeba histolytica induces intestinal cathelicidins but is resistant to… [PMID: 22083705]

    Laboratory literature summary: Entamoeba histolytica induces intestinal cathelicidins but is resistant to cathelicidin-mediated killing. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  925. Calderón-Santiago M et al. (2011). Analytical platform for verification and quantitation of target peptides in research… [PMID: 21531198]

    Laboratory literature summary: Analytical platform for verification and quantitation of target peptides in research subjects serum: application to cathelicidin. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  926. Ghiselli R et al. (2006). The cathelicidin-derived tritrpticin enhances the observed endpoints of ertapenem in… [PMID: 16878029]

    Laboratory literature summary: The cathelicidin-derived tritrpticin enhances the observed endpoints of ertapenem in experimental rat models of septic shock. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  927. Lee DY et al. (2008). Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill… [PMID: 18200058]

    Laboratory literature summary: Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill propionibacterium acnes. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  928. Segaert S (2008). Vitamin D regulation of cathelicidin in the skin: toward a renaissance of vitamin D in… [PMID: 18337709]

    Laboratory literature summary: Vitamin D regulation of cathelicidin in the skin: toward a renaissance of vitamin D in dermatology?. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  929. Tarasov VA et al. (2009). The Atlg12860 gene of Arabidopsis thaliana determines cathelicidin-like antimicrobial… [PMID: 19760875]

    Laboratory literature summary: The Atlg12860 gene of Arabidopsis thaliana determines cathelicidin-like antimicrobial activity. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  930. van Dijk A et al. (2012). Campylobacter jejuni is highly susceptible to killing by chicken host defense peptide… [PMID: 22728124]

    Laboratory literature summary: Campylobacter jejuni is highly susceptible to killing by chicken host defense peptide cathelicidin-2 and suppresses intestinal…. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  931. Lee JY et al. (2009). Different modes of antibiotic action of homodimeric and monomeric bactenecin, a… [PMID: 19788860]

    Laboratory literature summary: Different modes of antibiotic action of homodimeric and monomeric bactenecin, a cathelicidin-derived antibacterial peptide. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

  932. Scocchi M et al. (1998). Cloning and analysis of a transcript derived from two contiguous genes of the… [PMID: 9655944]

    Laboratory literature summary: Cloning and analysis of a transcript derived from two contiguous genes of the cathelicidin family. Consult the PubMed record for methods, models, and limitations. Presented for research literature review only

Browse the full PubMed index: PubMed search.

Additional information

Weight .125 lbs
Dimensions 9 × 7 × .5 in
Size

5mg, 10mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Frequently Asked Questions

What is LL-37 (Cathelicidin) peptide?

LL-37 is a synthetic antimicrobial peptide derived from the human cathelicidin protein family. It is studied in research laboratories for its role in immune signaling and cellular interaction pathways.

What is LL-37 used for in research?

LL-37 is used in research laboratories to investigate antimicrobial peptide activity, immune-related signaling, and cellular response mechanisms. It is not approved for human use.

Is LL-37 (Cathelicidin) Peptide approved or intended for human use?

No. LL-37 is strictly intended for research purposes only and is not approved by the FDA for human use.

Is LL-37 (Cathelicidin) Peptide FDA-approved for medical or clinical use?

No. LL-37 is not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

In what form is LL-37 supplied?

LL-37 is supplied as a lyophilized (freeze-dried) peptide powder for use in controlled research laboratories.

How should LL-37 be stored?

Store sealed, lyophilized peptides protected from light and humidity at -4°F or colder; refrigeration (~39°F) is suitable for short-term use.

What vial sizes are available for LL-37?

LL-37 is available in multiple vial sizes (e.g., 5mg, 10mg).

Is LL-37 (Cathelicidin) Peptide sold as a prescription product?

No prescription is required; however, it is sold strictly for research use only.

How is LL-37 shipped?

Orders are processed and shipped using secure, protective packaging to maintain product integrity during transit. For more info, visit: https://www.nationwidepeptides.com/shipping-and-payments

How can I verify LL-37 purity and quality?

Product quality is supported through third-party laboratory testing and Certificates of Analysis (COA), confirming purity and batch consistency. For more info, visit: https://www.nationwidepeptides.com/coa/